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Summary 
 
With about 10 000 copies per cell the voltage-dependent anion channels (VDACs) are the most 
abundant proteins of the mitochondrial outer membrane and are known to be involved in 
mitochondrial processes such as ATP-, calcium or ROS-transport. Beside this, they were 
identified as key players of mitochondrial physiology such as being involved in the mitochondrial 
related apoptotic pathway. Because of their strategic location as well as interaction with pro- and 
anti-apoptotic proteins, VDACs are involved in various diseases like Alzheimer, Down syndrome, 
cancer, stroke, and amylotrophic lateral sclerosis. Because of this multifunctionality, VDACs are 
important targets for medical approaches. 
After their discovery, VDACs have been extensively studied in terms of their structural 
organisation and their gating mechanism. The N-terminal region in the pores interior fuelled 
further debates about the gating mechanism of VDACs. VDACs reply to an applied voltage in a 
symmetric manner showing one open and several closed states. In this work I classified the closed 
states into at least three major states. With these quantitative electrophysiological measurements I 
demonstrated for the first time that a conformational variability of the N-terminus is essential for 
VDACs function. Through engineering of double-cysteine mVDAC1-variants affixing the N-
terminal segment at the bottom and midpoint of the pore I verified that the N-terminus is the 
major trigger of VDAC´s gating. Additionally, it was shown that channel transitions are not solely 
dependent on the N-terminus. By analysing EMP as minimal model system for β-barrel gating, I 
revealed that a loop-independent gating exists, similar to that observed in the double-cysteine 
mVDAC1 variants. 
Given VDACs that interact with a plethora of effector proteins, I focused on the pro-apoptotic 
VDAC-effector Bid/tBid. Recent studies imply that Bid is a key player in neuronal cell death 
pathways. Accordingly, Bid seems to promote mitochondrial demise by release of death 
promoting proteins in the cytosol and the acceleration of oxidative stress. Furthermore, Bid-
deficient neurons are highly resistant to cell death stimuli including oxygen-glucose deprivation 
(OGD) and glutamate-induced excitotoxicity in vitro and show reduced damage after cerebral 
ischemia and brain trauma in vivo. Here I could show a direct interaction between mVDAC1 and 
Bid/tBid and characterised the electrophysiological influence on VDAC in a quantitative manner. 
Biophysical analyse by SRCD, SROCD and EPR measurements give first insights into the 
structure of the VDAC-tBid complex. These data highlight the critical role for VDAC1 as a 
mitochondrial receptor for Bid thus providing a major control point of neuronal demise. 

Zusammenfassung 
 
Mit rund 10 000 Kopien pro Zelle sind die voltage dependent anion channels (VDACs) die am 
häufigsten vorkommenden Proteine der äußeren mitochondrialen Membran. VDACs regulieren 
mitochondriale Prozesse, wie z. B. ATP-, Calcium- und ROS-Transport. Neben dieser klassischen 
Rolle wurden VDACs als wichtigste Komponente der Mitochondrien-Physiologie und der damit 
verbundenen intrinsischen apoptotischen Signalwege identifiziert. Wegen ihrer strategischen Lage 
sowie der Interaktion mit pro- und anti-apoptotischen Proteinen, wurden VDACs mit 
verschiedenen Krankheiten wie Alzheimer, Down Syndrome, Krebs, Schlaganfall, und 
amylotrophischer lateraler Sklerose in Verbindung gebracht. Aufgrund dieser Multifunktionalität 
sind VDACs wichtige Ziele für medizinisch-therapeutische Behandlungsansätze. 
Nach ihrer Entdeckung wurden VDACs in Bezug auf ihre Struktur und den Schaltmechanismus 
untersucht. Der N-Terminus im Inneren der Pore wurde als das verantwortliche Schalt-Element 
diskutiert. Durch Anlegen einer externen Spannung, können VDACs in einen offenen und 
mehrere geschlossene Zustände schalten die ein physiologisches Verhalten imitieren. In dieser 
Arbeit konnte ich diese geschlossenen Zustände in mindestens drei Haupt-Zustände unterteilen. 
Mit diesen quantitativen elektrophysiologischen Messungen habe ich zum ersten Mal deutlich 
gemacht, dass die konformationelle Variabilität des N-Terminus für VDACs Schaltverhalten 
entscheidend ist. Durch das Erzeugen von Doppel-Cystein Varianten, die den N-Terminus am 
unteren Rand und in der Mitte die Pore arretieren, konnte ich zeigen, dass der N-terminus den 
dominanten Teil beim Schalten von VDACs darstellt. Daneben wurde auch gezeigt, dass 
zusätzliche Schaltvorgänge in einen geschlossenen Zustand unabhängig vom N-terminus auftreten 
können. Durch die Analyse von EMP als minimales Modellsystem konnte ich solch ein 
loop-unabhängiges Schalten in Porinen demonstrieren.  
VDACs interagieren mit pro- und anti-apoptotischen Effektorproteinen. Der Fokus meiner Arbeit 
lag auf der Aufklärung der VDAC-Bid/tBid Interaktion. Bid als pro-apoptotisches Effektorprotein 
wurde als wichtiger Akteur im neuronalen Zelltod identifiziert, indem es die Freisetzung von 
apoptotischen Proteinen in das Zytosol fördert. Darüber hinaus, zeigen Bid-defiziente neuronale 
Zellen eine hohe Resistenz gegen Zelltod-auslösende Reize wie z.B. Glutamattoxizität. Ich konnte 
die direkte Interaktion von VDAC1 und tBid zeigen und den funktionellen Einfluss mittels 
elektrophysiologischen Messungen quantifizieren. Biophysikalische Analysen (CD/OCD/EPR) 
ergaben erste Einblicke in den Protein-Komplex und verdeutlichen die Bedeutung der VDAC1-
tBid Interaktion für die Viabilität von Neuronen. 
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1. Introduction 
 
1.1 Biological membranes and membrane proteins 
 
In cells, biological membranes ensure a proper metabolism by building compartments. These 
compartments are formed as bilayers of lipids providing a barrier for polar substances. 
Membranes are able to separate toxic or reactive substances that are formed during 
metabolism. Furthermore, membranes ensure different ion- or substrate concentration on both 
compartments that are needed for a proper metabolism. Accordingly, a harmonious flow 
equilibrium of energy, substrates or reagents is needed so that the membranes have to be 
permeable to these molecules or ions in a selective and regulated manner.[1] To guarantee 
selective transport membranes contain particular proteins. The protein content differs 
depending on the organism and the tissue. For example, myelin sheaths of the nerve cells 
obtain a protein to lipid ratio of 0.23 compared to a 3.2 ratio in the outer mitochondrial 
membrane.[2] 
 
Membrane proteins ensure or catalyse transport processes through the membrane and are 
therefore essential for life itself. Mutations or the absence of particular membrane proteins 
lead to a changed or missing transport of substrates through the membrane and are therefore 
known to be responsible for various metabolic disturbances. For example, in the so called 
Hartnup-disease the sodium-dependent and chloride-independent neutral amino acid 
transporter SLC6A19 that is responsible for the transport of aromatic and hydrophobic amino 
acids is missing.[3] As consequence, these patients suffer of a systemic lack of amino acids in 
the organism. Another example is the altered expression of ATP-binding cassette (ABC) 
transporters at the blood-brain-barrier that accompanies several neuropathologies. For 
example, a reduced expression or transport of P-glycoprotein is associated with Alzheimer's, 
Creutzfeldt-Jakob or Parkinson's disease.[4] Because of these crucial functions membrane 
proteins are often targets of therapeutics and therefore gained interest in medicine and 
pharmacy. 
Usually, membrane proteins can be classified into different classes depending on their 
location relative to the membrane. These classes are peripheral, lipid-bound and integral or 
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transmembrane proteins. An overview about the different membrane protein classes is shown 
in Figure 1. 
 
 
Figure 1:[5] Schematic view of the Singer-mosaic-model highlighting the membrane proteins. Usually membrane 
proteins are classified according to their location to the membrane. There are membrane-associated, peripheral, 
GPI-anchored and integral, i.e. membrane-spanning, membrane proteins. 
 
Peripheral membrane proteins are located along the membrane surface and can therefore 
easily be extracted, e.g. by highly alkaline buffers. Lipid-bound membrane proteins are 
anchored to the membrane and therefore an extraction is only possible by the addition of 
detergents. The class of membrane proteins that are essential for metabolism and substrate 
transport are the integral or transmembrane proteins. These membrane proteins span the 
whole membrane and are therefore amphiphilic. The membrane-facing parts of these proteins 
are hydrophilic, whereas the membrane-embedded residues are lipophilic, to anchor and 
stabilise them in the membrane. Because of this transmembrane proteins can link two cell 
compartments and are therefore of special interest among the membrane proteins.[1]  
Transmembrane proteins are built of either α-helices, β-barrels or a combination of both, and 
can be further subdivided according to their function to transporters, channels and pores. 
Transporters like the previously mentioned ABC transporters are transporting ions against a 
gradient by utilizing ATP hydrolysis as energy source.[6] In contrast, channels like the voltage 
dependent anion channel (VDAC) control the flux of ions by opening and closing.[7] 
Furthermore, pores are just able to provide a possibility for substrate flow without further 
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control. For example, aquaporins mediate the flux of water through cells to prevent osmotic 
swelling.[8] 
Among the transmembrane channels there is a sub-class, the so called porins. Porins are 
β-barrel transmembrane proteins and represent the most abundant proteins in the outer 
membrane of gram-negative bacteria, chloroplasts and mitochondria. [9] 
 
1.2 Mitochondria and the related apoptotic processes 
 
Mitochondria (Greek: mitos: strand; chondros: grains) are cell organelles in eukaryotic cells, 
in which the oxidative metabolism takes place (Figure 2). In mitochondria, the pyruvate 
dehydrogenase, the enzymes of the citric acid cycle, the enzymes for fatty acid oxidation and 
the redox enzymes involved in the oxidative phosphorylation and electron transport can be 
found. Other important functions of the mitochondria are, inter alia, the synthesis of 
iron-sulphur clusters, the haem synthesis and a crucial role in programmed cell death 
(apoptosis) in the intrinsic pathway. Therefore the mitochondria are the central hub of the 
metabolic pathways. 
 
 
Figure 2:[10] Architecture of the mitochondria, (a) schematic view of the overall structure of mitochondria, (b) 
electron microscopic picture of a mitochondrion 
 
According to the endosymbiont theory mitochondria as well as chloroplasts have developed 
by ingestion of prokaryotes in precursor eucytes, from which the similar structure of the 
mitochondrial membrane compared to the membrane of gram-negative bacteria can be 
explained. [11] The size of mitochondria varies significantly depending on their occurrences 
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and metabolic state. Usually, mitochondria are of elliptic shape of about 0.5 x 1.0 µm, which 
corresponds to the size of bacteria. [2] 
The mitochondria are surrounded by a smooth outer membrane and an invaginated inner 
membrane, the so called christea (lat: crista: coxcomb). The space between the two 
membranes is called the intermembrane space and harbours proteins and substrates crucial for 
metabolism and apoptosis. The outer membrane of mitochondria contains, similar to the outer 
membrane of gram- negative bacteria, porins, which allow a free diffusion of molecules up to 
5 kDa.[12] The inner membrane is composed of about three-quarters of proteins and thus is the 
membrane with the highest protein to lipid ratio. [13] The ion and substrate transport between 
the intermembrane space and the matrix is controlled by the proteins of the inner membrane. 
This strictly regulated permeability allows the formation of a concentration gradient between 
cytosol and matrix and therefore the induction of a membrane potential. Especially the 
membrane potential attracted further interest for regulation because some of the outer 
mitochondrial membrane proteins show a voltage response. For example, the most abundant 
mitochondrial outer membrane protein, the voltage dependent anion channel 1 (VDAC1), 
respond in a symmetric way to an applied voltage. Accordingly, the existence of a membrane 
potential along the outer membrane was questioned. As direct measurements of the 
mitochondrial membrane potential are difficult, there are currently only theoretical 
justifications of its existence. The first theoretical model was based on the Donnan-potential, 
where a potential is evolved by an ion gradient.[14, 15] As the outer membrane of mitochondria 
is highly permeable for ions, this theory is unlikely. Alternatively, metabolically derived 
potentials may complement the Donnan potential across the outer mitochondrial membrane, 
thus contributing to the generation of its membrane potential.[16] However, the calculated 
potential of this model is up to 30 mV and thus too low for a voltage response by VDACs. In 
later studies, Lemeshko [17, 18] postulated a non-Mitchell mechanism for driving the outer 
membrane potentials up to 80 mV, sufficiently high to trigger voltage-sensitive outer 
membrane proteins. When suitably coupled to the creatine-phosphate metabolism and the 
adenine nucleotide transport through the inner membrane, this model claims that the 
membrane-resident VDAC-hexokinase complexes could convert cytosolic glucose to glucose-
6-phosphate under the generation of a transmembrane potential. Clearly, such a model would 
couple the VDAC transport activity to the metabolic flux, but suffers from a lack of direct 
experimental evidence. Still the origin and existence of membrane potentials along the outer 
mitochondrial membrane remain elusive. 
 
  1. Introduction 
 
5 
1.2.1 Mitochondria as an interface for intrinsic cell death (apoptosis)  
 
Beside the regulation of metabolic transport, the mitochondria are known to be a crucial 
interface in apoptotic processes. Apoptosis is essential for all multicellular life in growth and 
development. Cells that are no longer needed or are a threat to the organism are rebuilt by a 
rigorously regulated suicide process. Apoptosis can occur within either during normal cell 
growth (intrinsic) or upon cell damage (extrinsic). The intrinsic apoptotic pathway is initiated 
by cellular stress factors such as an excess of Ca2+, the presence of reactive oxygen species 
(ROS) or DNA damage. After the initiation of apoptosis a rupture of the outer mitochondrial 
membrane occurs and as consequence apoptogenic factors like cytochrome c, the apoptosis 
inducing factor (AIF), Smac/DIABLO (second mitochondria derived activator of 
caspase/direct IAP-binding protein with low pI) or endonuclease G are released from the 
intermembrane space to the cytosol. Cytochrome c itself causes the activation of caspases by 
interacting with the apoptosis protease-activating factor-1 (Apaf-1) through assembly of 
caspase-3/cytochrome c/Apaf-1 comprising apoptosomes.[19] In the presence of caspases other 
pro-apoptotic proteins such as Bid (BH3-interacting death agonist) are activated and assemble 
at the outer mitochondrial membrane. This process induces the permeabilisation of the 
mitochondrial outer membrane (e.g. as a mitochondrial transition pore), which presents the 
point of no return in the intrinsic apoptotic pathway and causes finally cell death. A schematic 
view of apoptosis is shown in Figure 3. 
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How cytochrome c is released from the intermembrane space to the cytosol is still highly 
discussed. Lill et al. identified release systems for cytochrome c including the translocase of 
the outer membrane (TOM) and the translocase of the inner membrane (TIM).[21] 
Furthermore, VDAC1 was identified as crucial key player when releasing cytochrome c as 
well. It has been demonstrated that many pro- and anti-apoptotic proteins are able to bind to 
VDAC1[22] and that VDAC1 is classified to be pro-apoptotic.[23] Furthermore, VDACs are 
known to induce cytochrome c release over an unknown mechanism but depending on their 
oligomerisation grade. [24, 25]  Nevertheless, VDAC1 as multi-functional protein in the outer 
mitochondrial membrane is a pharmaceutically relevant target to induce or prevent apoptosis.  
 
1.3 Voltage dependent anion channel (VDAC) 
 
With about 10 000 copies per cell the voltage-dependent anion channels (VDACs) are the 
most abundant proteins of the mitochondrial outer membrane (OM).[26] These porin-like 
channels attract considerable biochemical, biophysical and biomedical interest because of: 
a) their general occurrence in eukaryotes, b) the common physiological functions in terms of 
metabolite transport, c) their role in the induction of the intrinsic cell death (apoptosis) and 
d) the exceptional β-barrel architecture of their transmembrane domains. VDACs were first 
discovered in 1976 by Schein et al while working on the mitochondrial membrane of 
paramecium (Paramecium aurelia). [26] At this early stage the authors described VDAC as 
channel that a) has its maximum conductance when the potential is zero, b) responds 
symmetrically to positive and negative voltages, c) dwell times of the open state depends on 
the applied voltage, d) its high conductance state is about 5 nS in 0.1 to 1.0 M salt-solution 
and e) exhibits a preference for Cl- that is 7 times higher than for K+. Most of these early 
observations held true till today. Later, more isoforms of VDACs were discovered proving 
VDACs to be ubiquitous in eukaryotes. VDACs appear in eukaryotes in various isoforms, 
depending on the organism. Phylogenetic analyses show that the ancestral members of the 
multifunctional VDAC family separated early during eukaryotic evolution, where different 
VDAC paralougs were usually formed by gene duplication.[27] Metazoa, like fruit fly, human 
or fish harbour up to three mitochondrial isoforms, whereas higher plant genomes comprise 
up to ten paralogues.[27-30] 
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Although an inward α-helical movement could control the channel’s activity through 
blockage, it fails to account for the channel’s ion selectivity, a situation that an outward-
movement model claims to address more adequately.[34] None of the proposed models, 
however, has received strong experimental support.  
 
Beside their function in metabolite regulation VDACs were determined to be involved in the 
intrinsic or mitochondrial apoptotic pathway. In the last decade, VDAC was identified to 
interact directly with a plethora of pro- or anti-apoptotic proteins with their N-terminus 
providing a putative interaction-site. [22, 35, 36] The participation of VDACs in the apoptotic 
cascade are discussed as a) a minor component incorporated into the mitochondrial transition 
pore complex, b) a major a priori component that creates the huge outer membrane pore itself 
by homo- or hetero-oligomerisation, c) an indirect trigger for pore formation, e.g. by 
chaperoning its assembly within the membrane, or d) an inducer for the formation of lipidic 
pores. Apart from their classic roles in metabolite regulation in the cytosol and apoptosis, 
mammalian VDACs were found to be involved in controlling the amount of reactive oxygen 
species (ROS) [37], e.g. by a closure of VDAC and simultaneous decrease of cytosolic ROS 
levels. Because of their multi-functionality VDACs are associated with a variety of diseases 
like Alzheimer, Down syndrome, cancer, stroke, and amyotrophic lateral sclerosis (reviewed 
in [29, 38]). Furthermore, certain VDAC isoforms are essential for reproductive functions. For 
example, VDAC3-deficient mice are infertile due to a lack of sperm mobility and VDAC1 
knockdown mice show high embryonic mortality although the procreation seemed to be 
unaffected. [39, 40] Anyway, because of their importance in metabolite regulation and 
involvement in various diseases this thesis addresses the elucidation of VDACs gating as well 
as the interaction with the pro-apoptotic protein Bid. 
 
1.4 The bacterial porins, OmpF, LamB, OmpG and OmpA 
and the toxin α-HL 
 
The most abundant proteins of the outer membranes of gram-negative bacteria, mitochondria 
and chloroplast are the so called porins.[41] In bacteria, the outer membrane harbours up to 105 
copies of different porins, that can be subdivided into 5 different subgroups. These subgroups 
are classified upon their ability to mediate substance transport. They are divided into common 
  1. Introduction 
 
10 
porins as OmpF, specific porins as LamB, toxins as α-hemolysin, transporter porins as FhuA 
and pore-less porins as OmpA.[42, 43] Usually, porins harbour a β-barrel structure with a 
molecular mass of 30 - 50 kDa and occur as monomers (OmpG or OmpA) or trimers (OmpF 
or LamB). Porins are mediating the passive transport of charged substances like sugars, 
nucleotides, amino acids and small peptides up to 600 Da.[9] The number of β-strands varies 
in bacterial porins from 8-24 strands but the β-barrels are usually formed by an even number 
of β-strands. [44, 45] Beside the photoreaction centre of Rhodopseudomonas vividris0F1, [46] porins 
were one of the first membrane proteins characterized by X-ray crystallography. In the next 
paragraph a selection of common and substrate-specific porins will be introduced. 
 
One of the best studied porins is the trimeric outer membrane protein F (OmpF) 
(Figure 5). In 1995 its crystal structure was solved by Cowan et al [47]and since then OmpF 
suits as model systems for porins and ion-channel-engineering.[48] OmpF is mediating the 
passage of small molecules up to 600 Da including mono-, di- and trisaccharides to control 
the osmotic pressure. Additionally, if the cell is under osmotic pressure, the OmpF homologue 
OmpC is built to guarantee an appropriate flux of nutrients. The overall structure of OmpF 
consists of three separate monomers connected by a loop (loop2). The monomeric channels 
are formed by 16 β-strands of 340 amino acids, whereby the pore is constricted by an 
additional loop (loop 3, L3) located at the middle of each barrel (Figure 5).[47] The periplasmic 
regions are formed of small β-turns whereas the extracellular regions exhibit small loops. 
Loop 2 at the extracellular side of these porins is necessary to form the biological active 
trimers by hydrophobic interactions of its side chains. Loop 3 is found to affect the flux of 
substrates and constricts the channel to 7-11 Å depending on the loop position. [49]  
 
                                                 
 
1 The first structure of a membrane protein was the photosynthetic reaction centre of Rhodopseudomonas vividris 
elucidated in 1984 by Michel, Huber and Deisenhofer. This first crystallization and x-ray structure determination 
was awarded in 1988 with the Nobel-prize for chemistry.  
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2. Materials 
 
2.1 Chemicals and consumables and equipment 
All chemicals, not mentioned in tables 2 and 3, were ordered from Sigma Aldrich (Hamburg), 
VWR (Darmstadt) or Carl Roth GmbH + Co. KG (Karlsruhe).  
All consumables, not mentioned in table 4 were ordered from Eppendorf AG (Wesseling-
Berzdorf), Sarstedt AG & Co. (Nümbrecht) or Greiner Bio-One (Frickenhausen).  
Chemicals for crystallization were ordered from Sigma Aldrich (Hamburg) with the highest 
possible purity. 
Crystallization Screens were ordered from Qiagen. 
 
All Enzymes not mentioned in Table 1 were ordered from New England Biolabs (NEB, 
Ipswich, MA, USA) and used following manufacturer’s instructions. 
 
2.1.1 Technical Equipment 
 
Table 1: Technical equipment. 
Device Model (manufacturer) 
LC systems 
Äkta-Prime® P100 (GE Healthcare) 
Äkta-Purifier® 100 (GE Healthcare) 
NGC (Biorad) 
BLM-device 
Warner Instruments 
polystyrene cuvette: CP2A (Warner 
Instruments) 
bilayer chamber: BCH-22A (Warner 
Instruments) 
detector Multpatch 700B patch-clamp 
amplifier combined with a Digidata 1440A 
A/D converter with pClamp 10.2 software 
(Axon Instruments) 
Digital-camera D70s (Nikon), lens: DX SWM ED (Nikon), UV filter (SEK) 
Electroporation device MicroPulserTM (Biorad) 
Fluidiser EmulsiFlex C5 (Avestin) 
French press 
French-pressure cell-Version 5.1 (Sim 
Aminco) 
French-pressure cell (Philipps University 
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Marburg unit for precision engineering) 
Autoclave T-lineTM (Fedegari) 
CD-spectrophotometer J-810 or J-815 spectropolarimeter (Jasco) 
Documentation systems 
Agarose gels 
 
Crystallisation 
 
UV-transilluminator (Herolab) 
 
Rock ImagerTM (Formulatrix) 
Gelelectrophoresis 
SDS-PAGES trays/tanks 
 
Power boxes 
 
Mighty Small II SE250 (HoeferScientific 
Instruments), 
PerfectBlue two-gel system Twin M 
(PEQLAB) 
Model 453 (ISCO), EPS 300 (GE Health 
care) 
Crystallisation robot 
Cartesian MicroSysTM 4004 (Genomic 
Solutions) 
Digilab Honeybee 963TM  (Zinsser analytic) 
pH-meter Basic Meter PB-11 (Sartorius) 
Homogenizer After Potter-Elvehjem (B. Braun) KPG-stirrer (Heidolph) 
Gel shaker Model 3013 (GFL), Kottermann 4010 (Kottermann) 
Incubator Incubator (Heraeus), BFED-53 (WTB Binder) 
Ultrapure water dispenser Seralpur Pro90CN (Seral), Milli-Q (Millipore) 
Peristaltic pump P1 (GE Health care) 
Shakers 
CertomatR IS (Sartorius), G25 (New 
Brunswick Scientific), 
Multitron 2 (Infors), TH 25 (Edmund Buhler) 
Centrifuges 
2K15 (Sigma), Biofuge 13R (Heraeus), 
Biofuge fresco/pico (Heraeus), 
Centrifuge 5417C/5910R (Eppendorf), 
DiscoveryTM 90SE (Sorvall), EvolutionRC 
(Sorvall), 
J2-HS / J2-21 M/E (Beckmann), Minifuge 
GL (Heraeus Christ) 
UV/Vis-spectrophotometer Ultrospec™ 3100pro (Biochrom) Nanodrop® ND-1000 (peqLab) 
Quartz glass cuvettes 110-QS 10 mm, Suprasil 10 mm (Hellma) 
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2.1.2. Consumables 
 
Table 2: Consumables. 
Consumable Model (manufacturer) 
Cuvettes REF 67.742 (Sarstedt) 
FPLC columns 
Fractogel® EMD SE Hitrap M (Merck) 
Fractogel® DEAE- Hitrap (Merck)  
Superdex 200 Size-exclusion-column 16/60 
(GE Healthcare) 
Ni-NTA Protino column (MACHERY-
NAGEL) 
TALON metal affinity column (GE 
Healthcare) 
Desalting column PD Mini Trap G-25 desalting column (GE Healthcare)  
Protein concentration devices 
Amicon ultra - 15 Centrifugal Filter Devices 
Amicon ultra - 30 Centrifugal Filter Devices 
Amicon ultra- 0.5 Filter Devices  
10000 / 3000 Da MWCO(Milipore) 
Crystallisation consumables 
Cover slides O = 22 mm (Hampton 
Research) 
96-well inovaplate (Innovadyne)  
SilverSeal (Greiner Bio-one), 
VIEWsealTM adhesive sheets (Greiner Bio-
one) 
CryoCaps with Data Matrix  
(Molecular Dimension) 
Cryschem Plate (Hampton Research)  
CrystalCap HAT (Hampton Research)  
CrystalCap HT Vial  (Hampton Research)  
Crystal Clear Sealing Tape  (Hampton 
Research)  
Dialysis cassettes Slide-A-LyzerR Mini Dialysis Units 10000 MWCO (Pierce) 
Dialysis membrane Pore size 0.025 μm, O = 25 mm (Millipore) 
Disposable cuvettes Cuvettes REF 67.742 (Sardstedt) 
Sterilisation filters 
Filtropur S 0.2, (Sarstedt) 
Filtropur S 0.45, (Sarstedt) 
Ultrafree®-MC (Milipore)  
Steritop Bottletop MF-Membrane Filters 
0.025 µm VSWP (Milipore) 
Electroporation cuvettes 400 µL, 2 mm gap (VWR))  
Molecular biology consumables QIAprep Spin Miniprep Kit (Qiagen) QIAquick PCR Purification Kit (Qiagen) 
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2.1.3 Chemicals  
 
Table 3: Chemicals. 
Chemical Company 
Acetonitrile HPLC-grade J.T.Baker 
Bacto® trypton Becton, Dickinson and Company 
Bacto® yeast extract Becton, Dickinson and Company 
Coomassie-brilliant blue G250 Serva 
D(+)-glucose  Merck KGaA 
Dichloromethane Merck KGaA 
Dipotassium hydrogenphosphate Merck KGaA 
Dithiothreitol Biomo 
Guanidiniumchloride Merck KGaA 
Urea Merck KGaA 
Potassium dihydrogen phosphate KMF optichem 
Lauryl-dimethylamin-oxide (LDAO)  Fluka 
Sodium dodecyl sulfate Serva 
Sodium hydroxide Fluka 
Protein markers SM0431 Unstained Protein Molecular Weight Marker (Fermentas) 
Hydrochloric acid Riedel de Haën 
Virkon® Antec International 
(1-Oxyl-2,2,5,5-tetramethylpyrroline-3-
methyl)methanethiosulfate (MTSSL) Enzo Life Science 
Alexa Fluor® 532 C5-maleimide Inivitrogen 
Isopropyl-β-D-thio-galacto-pyranoside  
 
Duchefa  
 
Ampicillin (sodium salt)  
 
Applichem GmbH  
 
Asolectin (from soybeans)  
 
Avanti Polar Lipids  
 
BC Assay Protein Quantification Kit  
 
Uptima by Interchim  
 
1,2-Diphytanoyl-sn-glycero-3-
phosphocholine (DPhPC) Avanti Polar Lipids  
Mass Ruler DNA-Ladder-Mix (SM0403)  Fermentas GmbH 
n-Octyltetraoxyethylene (C8E4) Bachem AG  
n-Octyl-β-D-glucopyranoside (n-OG) Glycon Biochemicals  
1,2-Dimyristoyl-sn-glycero-3-
phosphocoline (DMPC) Avanti Polar Lipids 
n-Decyl-β-maltoside (DM) Glycon Biochemicals 
n-Decyl-β-D-gluco-pyranoside (n-DG) Glycon Biochemicals 
n-Octyl-β-D-thio-gluco-pyranoside (OTG) Glycon Biochemicals 
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2.1.4 Enzymes 
 
Table 4: Enzymes. 
Enzymes and antibodies Company 
Lysozyme  Boehringer Mannheim GmbH  
Phusion High Fidelity DNA Polymerase  Finnzymes  
Caspase 8 Merck Milipore 
Trypsin Gold (Mass Spectrometry Grade)  Promega Corp. 
 
 
2.2 Biological Materials 
 
2.2.1 E. coli strains 
 
E. coli DH5α 
 
Genotype: F-, Φ80lacZΔM15, Δ(lacZYA-argF) U169, recA.1, endA1, hsdR17 (rk-, mk+), 
phoA, supE44, λ-, thi-1, gyrA96, relA1 
 
E. coli DH5α cells (Invitrogen) harbour a very high yield of plasmid DNA because of high 
replication rates. The cells were used as propagation strains because they are mutated for recA 
and rK- which means that they do not restrict the foreign modified genetic material (e.g. 
plasmid). They are therefore well suited for preparation and isolation of recombinant DNA. 
These cells were used for all tasks of plasmid construction and preparation.[78] 
 
 
E. coli BL21 (DE3) omp9 
 
Genotype: F-, ompT, hsdSB (rB- mB-), gal dcm (DE3), ΔlamB, ompF: :Tn5, ΔompA, ΔompC, 
     ΔompN 
 
E. coli BL21 (DE3) cells (Novagen) are designed for gene expression using T7-polymerase 
vectors like the pET series. These cells harbour the λ-prophage region encoding a T7 RNA 
polymerase, which is required for recognition of the T7 promoter on the used vectors, but is 
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itself under the control of the lac UV5 promoter. Therefore an IPTG based gen-expression for 
the production of recombinant proteins is possible. 
E. coli BL21 (DE3) omp9 cells are based on E. coli BL21 (DE3) (Novagen), suitable for the 
expression of outer membrane proteins because of several incorporated gene deletions for the 
major E. coli porins. Namely, they lack the genes for a) the maltose-maltodextrin transporter 
LamB, b) the outer membrane-protease VII OmpT and c) the outer membrane proteins 
OmpA, OmpF, OmpC and OmpN. These cells ensure the lack of unwanted contaminants 
following the target protein´s gene expression.[79, 80] In addition, this strain harbours genes 
encoding for kanamycin and streptomycin resistances. 
This strain was provided by Ralf Koebnik et al. (Biozentrum Universität Basel) and was used 
for the recombinant overproduction of all membrane proteins used in this work. 
 
E. coli Rosetta (DE3) 
 
Genotype: F-, ompT, hsdSB (rB- mB-), gal dcm (DE3), pRARE (CamR)  
 
E.coli Rosetta (DE3) cells are based on the E.coli BL21 (DE3) strain (see above). They were 
designed for the overexpression of eukaryotic proteins whose genes contained codons rarely 
used by the bacterial host. Rosetta cells provide tRNAs for the rare codons AGG, AGA, 
AUA, CUA, CCC and GGA on an extra-chromosomal plasmid resistant to 
chloramphenicol.[81] In this work, this cell line was used for the expression of BID in 
pET-15b(+). 
 
2.2.2 Vectors 
 
pET-20b(+)®  
 
The pET-20b(+) vector (Novagen) in combination with E. coli DH5α and E. coli BL21 (DE3) 
Omp9 was used for cloning, mutagenesis and recombinant overproduction of all membrane 
proteins in this thesis. Wildtype and mVDAC1-variants were inserted in pET-20b(+) using 
HindII and NdeI whereas EcoRI and NdeI sites were used for the wildtype mVDAC2-variants. 
The minimal porin-gene was inserted using XhoI and NdeI as restriction sites. pET-20b(+) 
has a length of 3716 bp and is a medium copy plasmid harbouring ampicillin resistance. The 
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2.2.3 Primers 
 
Sequencing of all constructs was performed by GATC or Qiagen using following 
oligonucleotides: 
 
T7-Primer:    5' TAATACGACTCACTATAGGG 
pET-RP:    5’ CTAGTTATTGCTCAGCGG 
 
 
Primers for VDAC variants used in this work are listed in table 5, melting temperatures were 
calculated using the OligoAnalyzer 3.1 from IDTDNA.[84] Primers 1-5 were designed for de 
novo cloning whereas primer 6-25 were designed for mutagenesis of cloned genes. All 
primers were ordered from Metabion. Upon arrival the lyophilized primers were dissolved in 
EB to achieve 100 µM of oligonucleotide solution. The stock solutions were stored at -20 °C 
until further use. All stock solutions were diluted to 10 µM before use. When possible, an 
analytical restriction site was introduced. Analytical restrictions sites are underlined, 
mutations are represented in bold. 
 
Table 5: Primers for de novo and quick change mutagenesis cloning. 
Nr Primer Tm 
Analytical 
restriction 
side 
mutation 
11 
 5´-TTAATACTCGAGTTATGCTTGAAATT 
CCAGTCCTAGGC 
 5´-TATACGCATATGAGAGGATCGCATCACC
ATCAC 
 61.5 °C 
 
 61.9°C 
XhoI 
NdeI mVDAC1 
21 
 5’-GCACATCAACCTCGGGGCTGACGTGGA
CTTTGAC 
 5’-GTCAAAGTCCACGTCAGCCCCGAGGTTG
ATGTGC 
 68.4 ºC  --- C127A 
31 
 5’-CCAAGTATCAGGTGGATCCTGATGCCGC
CTTTTCGGCCAAAG 
 5’-CTTTGGCCGAAAAGGCGGCATCAGGAT
CCACCAGATACTTGG 
 69.4 ºC --- C232A 
41 
 5´-TTAATACTCGAGTTATGCTTGAAATTCC
AGTCCTAGGC 
 5´-TATAGACATATGTGTTCCGCCAGGGATG
TCTTC 
 61.5 °C 
 
 61.8 °C 
XhoI 
NdeI 
Δ1-11-
K12C 
51 
 5´-TTAATACTCGAGTTATGCTTGAAATTCC
AGTCCTAGGC 
 5´-ATAAATCATATGTGCGGCTTTGGCTTAA
TAAAACTTGATTTGAAAAC
 61.5 °C 
 
 62.0 °C 
XhoI 
NdeI 
Δ1-21- 
Y22C 
61  5´-TTAATACTCGAGTTATGCTTGAAATTCCAGTCCTAGGC  61.5 °C XhoI Δ1-25- 
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 5´-AGAGATCATATGTGTATAAAACTTGATT
TGAAAACGAAGTCAGAGAATG 
 
 61.5 °C 
NdeI L26C 
71 
 5´-GAAGGAGATATCCATATGTGCGTGCCTC
CCAC 
 5´-GTGGGAGGCACGCACATATGGATATCT
CCTTC 
 64.2 ºC EcoRV A2C 
8 
 5´-GAAGGAGATATCCATATGGCCTGCCCT
CCCACATACG 
 5´-CGTATGTGGGAGGGCAGGCCATATGGA
TATCTCCTTC 
 66.4 °C EcoRV V3C 
91  5´-CGCCGATCTTGGCTGCTCCGCCAGGG  5´-CCCTGGCGGAGCAGCCAAGATCGGCG  70.8 °C --- K12C 
102  5’-CTTGGCAAGTCCTGCAGGGATGTCTTC  5’-GAAGACATCCCTGCAGGACTTGCCAAG  63.0 ºC  PstI A14C 
11 
 5´-TTTGGCTTAATATGTCTTGATTTAAAAA
CGAAG 
 5´-CTTCGTTTTTAAATCAAGACATATTAAG
CCAAA 
 55.4 °C DraI K28C 
12 
 5´-GGCTTAATAAAGCTTTGTTTGAAAACG
AAG 
 3´-CCGAATTATTTCGAAACAAACTTTTGCT
TC 
 56.0 °C HindIII D30C 
13 
 5´-TTAATAAAGCTTGATTTGTGTACGAAGT
CAGAG 
 5´-AATTATTTCGAACTAAACACATGCTTCA
GTCTC 
 57.2 ºC  HindIII K32C 
14 
 5´-AAAACGAAGTCATGTAATGGATTGGAA
TTCACCAGCTCAGGC 
 5´-GCCTGAGCTGGTGAATTCCAATCCATTA
CATGACTTCGTTTT 
 65.4 ºC EcoRI E36C 
15 
 5´-AAAGTGAACGGCTGTCTAGAAACCAAG
TAC 
 5´-TTTCACTTGCCGACAGATCTTTGGTTCA
TG 
 60.1 °C XbaI S57C 
161 
 5´-CCAAAGTGAACGGAAGCTTGTGCACCA
AGTACAGATGG 
 5’-CCATCTGTACTTGGTGCACAAGCTTCCG
TTCACTTTGG 
 66.3 °C HindIII E59C 
17  5´-AAGTGGAACACATGCAACACCCTGGGC  5´-GCCCAGGGTGTTGCATGTGTTCCACTT  65.2 °C --- D78C 
18  5´-GAGATCACTGTGTGTGACCAGCTTGCT  5´-AGCAAGCTGGTCACACACAGTGATCTC  62.3°C DraIII E88C 
19 
 5´-CAAGACAGGGTACTGCAGGGAGCACAT
CAACC 
 5´-GGTTGATGTGCTCCCTGCAGTACCCTGT
CTTG 
 66.0 ºC --- K119C 
201 
 5’-GGGTACAAGAGGTGCCACATCAACCTC
GG 
 5’-CCGAGGTTGATGTGGCACCTCTTGTACC
C 
 65.4 ºC --- E121C 
21 
 5´-GACTTTGACATCTGTGGGCCCTCGATCC
GCGGCGCTCTGGTG 
 5´-CACCAGAGCGCCGCGGATCGAGGGCCC
ACAGATGTCAAAGTC 
 73.0 °C AccII A134C 
22 
 5´-GAGGGTTGGCTAGCTGGCTACTGTATGA
ATTTTGAG 
 5´-CTCAAAATTCATACAGTAGCCAGCTAGC
CAACCCTC 
 63.6 °C NheI Q154C 
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23  5´-TGGCTATAAGACATGTGAATTCCAGCT  5´-AGCTGGAATTCACATGTCTTATAGCCA  58.0 °C PciI D176C 
241 
 5´-CAGAGTTTGGTGGCTGCATTTACCAGA
AGG 
 5´-CCTTCTGGTAAATGCAGCCACCAAACTC
TG 
 62.7 ºC --- S193C 
25 
 5´-AATCTCGCCTGGACGGCAGGATGCAGT
AACACTCGC 
 5´-GCGAGTGTTACTGCATCCTGCCGTCCAG
GCGAGATT 
  
 69.6 °C BglI N214C 
26 
 5´-TCAGCCCTGCTCTGTGGCAAGAACGTC
AACGCGGGTGGCTTT 
 5´-AAAGCCACCCGCGTTGACGTTCTTGCCA
CAGAGCAGGGCTGA 
 73.3°C HincII D264C 
1 Primer planned by Dr Wolfgang Grosse  
 
2.3 Recombinant proteins 
 
mVDAC1 and the cysteineless variant mVDAC1-C127A-C232A were cloned into the pET-
20b(+) vector using XhoI and NdeI as restriction sides. All other VDAC1 variants were cloned 
based on one of these templates using the primers of table 5. For further notion all VDAC1 
constructs with cysteine mutations were based on the cysteineless variant mVDAC1-C127A-
C232A and are therefore designated as CL. mVDAC2 and EMP were ordered from GeneArt 
and their gene sequence were optimised for E.coli based expressions. mVDAC2 was supplied 
in the donor vector pMT-R whereas the EMP was delivered in the pMA vector. Both vectors 
encoded for ampicillin resistance. The inserts were flanked with EcoRI/NdeI (mVDAC2) and 
XhoI/NdeI (EMP) allowing cloning into pET-20b(+) using EcoRI/NdeI and XhoI/NdeI 
respectively. A BID coding pET-15b(+) vector was kindly provided by Prof. C. Culmsee. 
Cloning details as well as usage of recombinant proteins are provided in Table 6.  
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Table 6: VDAC variants, EMP and BID produced with the pairs of primers used in the PCR-based mutagenesis. 
Nr Recombinant protein description Primers used for cloning 
11 mVDAC1  wildtype 1 
2 mVDAC2 wildtype --- 
31 mVDAC1-C127A-C232A (CL) cysteineless variant (CL) 2 / 3 
41 Δ1-11-mVDAC1-K12C N-terminal deletion variant  4 
51 Δ1-21-mVDAC1-Y22C N-terminal deletion variant 5 
61 Δ1-25-mVDAC1-L26C N-terminal deletion variant 6 
72 mVDAC1-CL-A2C-E121C cysteine variant to fix the N-terminus in an open state 7 / 20 
83 mVDAC1-CL-V3C-K119C cysteine variant to fix the N-terminus in an open state 8 / 19 
9 mVDAC1-CL-K12C cysteine variant for cw/ DEER measurements 9 
10 mVDAC1-CL-K12C-D30C cysteine variant for cw/ DEER measurements 9 / 12 
11 mVDAC1-CL-K12C-K32C cysteine variant for cw/ DEER measurements 9 / 13 
12 mVDAC1-CL-K12C-S57C cysteine variant for cw/ DEER measurements 9 / 15 
132 mVDAC1-CL-K12C-E59C cysteine variant for cw/ DEER measurements 9 / 16 
142 mVDAC1-CL-A14C-S193C cysteine variant to fix the N-terminus in an open state 10 / 24 
15 mVDAC1-CL-K28C-Q154C cysteine variant for cw/ DEER measurements 11 / 22 
16 mVDAC1-CL-K32C cysteine variant for cw/ DEER measurements 13 
17 mVDAC1-CL-E36C-D176C cysteine variant for cw/ DEER measurements 14 / 23 
182 mVDAC1-CL-E59C cysteine variant for cw/ DEER measurements 16 
19 mVDAC1-CL-E59C-S193C  cysteine variant for cw/ DEER measurements 16 / 24 
20 mVDAC1-CL -D78C-N214C cysteine variant for cw/ DEER measurements 17 / 25 
21 mVDAC1-CL-E88C-K119C cysteine variant for cw/ DEER measurements 18 / 19 
22 mVDAC1-CL-A134C-D264C cysteine variant for cw/ DEER measurements 21 / 26 
234 Minimal porin optimized porin for ion channel engineering  --- 
24 BID pro-apoptotic effector protein for VDAC --- 
1 Cloned by Anastasia Salisowski[85], 2 Cloned by Kathrin Back[86], 3 Cloned by Dr Georgios Psakis, 4 
Constructed and cloned by Dr Wolfgang Grosse. 
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2.4 Media, stock solutions and buffers 
 
2.4.1 Media 
 
Lysogeny-broth (LB) media were employed for heterologous expression of genes listed 
above.[87] In addition LB-media were used in all molecular biological experiments (liquid 
cultures and agar plates). All components listed in table 7 were dissolved in dH2O and 
autoclaved immediately after preparation (30 min at 121 °C and 2 bar).  
Liquid media were stored under sterile conditions at room temperature until further use. For 
recombinant overproduction of membrane proteins (mVDAC1 variants, mVDAC2 and EMP) 
glucose (1% w/v) and ampicillin (100 µg/mL end concentration) were added prior to 
inoculation. For recombinant overproduction of BID only ampicillin (100 µg/mL end 
concentration) was added prior to inoculation.  
The solid media were heated and cooled to approximately 50 °C before addition of ampicillin 
(100 µg/mL end concentration). The media were poured into petri dishes under sterile 
conditions and stored at 8 °C until further use.  
 
Table 7: Composition of LB based media. 
LB-media LB-agar 
10 g/L Bacto®-tryptone 10 g/L Bacto®-tryptone 
5 g/L Bacto®-yeast-extract 5 g/L Bacto®-yeast-extract 
10 g/L NaCl 10 g/L NaCl 
400 µL/L NaOH (10M) 400 µL/L NaOH (10M) 
 15 g/L agar-agar 
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2.4.2 Stock solutions 
 
The following solutions were regularly prepared as stocks: 
 
Table 8: Diverse stock solutions. 
Stock solutions 
Ampicillin 100 mg/mL (in ddH20) 
DTT 1 M (in ddH20) 
EDTA 0,1 M (in ddH20) 
IPTG 1 M (in ddH20) 
PMSF 0.2 M (in isopropanole) 
Glucose 20% w/v (in ddH20) 
TCA 72% w/v (in ddH20) 
 
2.4.3 Protein buffers 
 
2.4.3.1 Buffers for molecular biological experiments 
 
The following table contains the buffer compositions for standard molecular biological 
techniques. 
 
Table 9: Agarose gel electrophoresis stock solutions. 
Agarose gel TBE buffer (10x) 
1 % (w/v) agarose in TBE 1 M Tris 
 1M boric acid 
 20 mM EDTA 
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2.4.3.2 Buffers for protein analysis  
 
The compositions of buffers used for analysis of the proteins generated in this work are shown 
below: 
 
Table 10: SDS-PAGE gel buffers 
SDS resolving gel buffer SDS stacking gel buffer 
1.125 M Tris / HCl, pH 8.8 625 mM Tris / HCl, pH 6.8 
30% (w/v) sucrose  
 
Table 11: SDS-PAGE buffers 
SDS running buffer (10x) SDS sample buffer 
0.25 M Tris 62.5 mM Tris / HCl, pH 6.8 
2 M glycine 15% (v/v) glycerol 
1% (w/v) SDS 15% (w/v) SDS 
 0.001% (w/v) bromo-phenol-blue 
 4% (v/v) 2-mercaptoethanol 
 
 
Table 12: BN-PAGE running-buffer 
BN-PAGE buffer 
0.25 M Tris (pH 8.6 – 9.0) 
1.94 M glycine 
2 mM EGTA 
 
 
Table 13: SDS-PAGE stainer and destainer 
SDS-Stainer SDS-Destainer 
25% (w/v) Coomassie brilliant blue G250 5% (v/v) acetic acid 
5% (v/v) acetic acid 28% (v/v) 2-propanol 
50% (v/v) ethanol  
 
2.4.3.3 Buffers for protein purification  
 
All buffers for protein purification were prepared according to the compositions mentioned in 
chapter 3 (methods) using dH2O. All buffers were sterile filtered (0.025 µm) before use and 
stored at 8°C.  
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3. Methods 
 
3.1 Molecular biology 
 
The following section will describe the methods used to manipulate, modify and obtain DNA. 
mVDAC1 genes were cloned by Anastasia Salisovsky[85], Katrin Back[86], Georgios Psakis 
or myself (see Table 6 for details). 
 
3.1.1 mVDAC1 constructs  
 
Plasmid vectors, harbouring the mVDAC1 gene, were kindly provided by Dr Jeff Abramson 
(University of California LA). The mVDAC1 gene was amplified by PCR according to the 
manufacturer´s instructions, using the primers 1 (see table 5), introducing the XhoI and NdeI 
restriction sites respectively. PCR products were digested and PCR cleaned. The acceptor 
vector pET-20b(+) was pre-digested with the same enzymes and dephosphorylated with 
alkaline phosphatase (NEB) (1 unit for every pmol of DNA ends) to obtain complementary 
restriction sides. Subsequent ligation was performed with T4-ligase (NEB) according to the 
manufacturer’s instructions. DH5α cells were transformed with the ligated product. 
The N-terminal deletion variants (constructs 4-6) were PCR amplified using the primers 3, 4 
or 5 which contained XhoI and NdeI restriction sides. The PCR product was digested with 
XhoI/NdeI according to the manufacturer’s instructions and PCR cleaned. Subsequent ligation 
was performed with T4-ligase (NEB) in a 3:1 ratio with pre-digested and dephosphorylated 
pET-20b(+) vector. DH5α cells were transformed with the ligated product. 
To obtain the cysteineless mVDAC1-C127A-C232A construct the PCR-based QuickChange 
mutagenesis method was used. QuickChangeTM mutagenesis is a quick and easy way for in 
vitro site-specific mutation. During this procedure complementary primers harbouring the 
desired mutation are used to amplify the entire circular molecule. For this, primers 2 were 
used and PCR was performed according to QIAGEN quick change kit´s manual with the 
exception that DpnI (NEB) treatment was prolonged relative to the manufacturer’s 
instructions.[88] Following confirmation of the first mutation by DNA sequencing the second 
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was introduced using the same protocol but using primers 3 and mVDAC1-C127A as 
template. The identity of the final construct was also confirmed by DNA sequencing (GATC 
or Qiagen). 
All other VDAC1 genes were cloned by the QuickChange PCR-based mutagenesis using the 
cysteine-free mVDAC1 plasmid as template. All primers for the different constructs are listed 
in table 5 and the protocol as described above was similarly used for all mVDAC1 genes. The 
identity of all constructs was confirmed by DNA sequencing (Qiagen and GATC). 
 
3.1.2 mVDAC2 construct 
 
The mvdac2-gene was ordered from GeneArt as an E.coli optimized gene construct. The 
pMT-R vector containing the mVDAC2 gene flanked with NdeI and EcoRI restriction sides 
was transformed in DH5α cells to amplify the desired plasmid (see section 3.1.5 for details). 
The mvdac2-gene was digested using NdeI and EcoRI according to manufacturer’s 
instruction. The ligation was performed with T4-ligase in a 3:1 ratio with pre-digested and 
dephosphorylated pET20b(+) vector. DH5α cells were transformed with the ligated product. 
 
3.1.3 Minimal porin 
 
The molecular biological work for EMP was conducted by Dr Wolfgang Grosse. The EMP-
gene was ordered from GeneArt in pMA donor vector. The gene sequence had been optimised 
for expression in E.coli. The desired EMP-gene was flanked with NdeI and XhoI restriction 
sites and DH5α were transformed with the donor plasmid (see section 3.1.5 for details). The 
EMP-gene was digested using NdeI and XhoI according to manufacturer’s instruction and the 
ligation was performed with T4-ligase in a 3:1 ratio with a pre-digested and dephosphorylated 
pET20b(+) vector. DH5α cells were transformed with the ligated product. 
 
3.1.4 Preparation of competent E.coli cells 
 
For the preparation of E.coli competent cells two different methods are commonly used, 
electro transformation and chemical transformation using a heat shock.[89] Competent E.coli 
cells are able to uptake plasmid DNA. This ability is needed while working with manipulated 
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DNA. After preparation the competency of the cells was determined using the following 
formula.[90] 
 
transformants	per	microgram	of	plasmid	DNA
ൌ 		 ݊ݑܾ݉݁ݎ	݋݂	ݐݎܽ݊ݏ݂݋ݎ݉ܽ݊ݐݏ	ሺܿ݋݈݋݊݅݁ݏሻ݉݅ܿݎ݋݃ݎܽ݉	݋݂	݌݈ܽݏ݉݅݀	ܦܰܣ ∙
݂݈݅݊ܽ	ݒ݋݈ݑ݉݁	ܽݐ	ݎ݁ܿ݋ݒ݁ݎݕ	ሺ݉ܮሻ
ݒ݋݈ݑ݉݁	݌݈ܽݐ݁݀	ሺ݉ܮሻ  
(Eq 1) 
3.1.4.1. Preparation of chemically competent cells  
 
Chemically competent cells were prepared using the RbCl method.[91] The RbCl method is 
basically the same method than the CaCl2 method but yields better DNA uptake 
efficiencies.[92, 93] Chemically competent DH5α cells were used for re-transformations of 
plasmids and chemically competent BL21 (DE3) Omp9 and Rosetta cells were used for 
recombinant gene expression. 
To prepare a new batch of chemically competent cells 5 mL of liquid LB medium was 
inoculated with a single colony from a LB-agar plate. Cells were grown over night at 37 °C. 
100 mL of liquid LB-medium was inoculated with 1 mL of the overnight culture and was left 
to grow at 37 °C and 225 rpm until an OD600 of 0.5 – 0.6 was reached. The cells were then 
cooled in ice-water and pelleted (12300 g, 10 min, 4 °C). The pellet were resuspended in 30 
mL TFBI buffer (100 mM RbCl, 50 mM MnCl2, 30 mM KOAc, 10 mM CaCl2, 15% (v/v) 
glycerine) and incubated for 2h on ice. Following the incubation, cells were again pelleted 
(12300 g, 10 min, 4 °C) and resuspended in 4 mL precooled TFBII buffer (10 mM MOPS, 10 
mM RbCl, 75 mM CaCl2, 15% (v/v) glycerine). The cells were then immediately divided in 
50 µL aliquots and shock-frozen in liquid nitrogen. Aliquots were stored at -80 °C until 
further use. 
 
3.1.4.2 Preparation of electro-competent cells  
 
Compared to chemically competent cells, electro-competent cells may achieve a higher yield 
of DNA uptake. The efficiency of a transformation using a heat shock is about 106-108 
colonies per µg DNA, whereas the transformation efficiency using the electroporation 
methods is up to 1010 colonies per µg DNA.[89] Thus, electro-competent DH5α cells were used 
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for all transformations following the QuickChange mutagenesis or ligations. The method is 
based on a protocol from Dower (1988).[94] 
To prepare a new batch of electro-competent cells 50 mL of liquid LB-media were inoculated 
with a single colony from a fresh LB-Agar plate and were left to grow at 37 °C and 225 rpm 
overnight. 1L pre-warmed LB medium was inoculated with 10 mL of overnight culture and 
were left to grow until an OD600 of 0.8 was reached. The cells were immediately cooled in 
ice-water for 20 min and pelleted afterwards (12300 g, 10 min, 4 °C). The pellet was 
resuspended in 450 mL ice-cold water and again pelleted (12300 g, 10 min, 4 °C). This step 
was repeated once. After this the pellet was resuspended in 450 mL of ice cold glycerol 
solution (10% v/v) and pelleted again (12300 g, 10 min, 4 °C). Finally the pellets were 
resuspended in 2.5 mL of ice cold glycerol solution (10% v/v) and immediately divided in 
50 µL aliquots. The aliquots were shock frozen in liquid nitrogen and stored at -80 °C until 
further use. 
 
3.1.5 Transformation of competent cells 
 
The uptake of foreign DNA in prokaryotic cells is known as transformation. Generally 
speaking, there are different methods to force competent cells to uptake plasmid DNA. In this 
thesis two different methods were used, the chemical transformation and the electroporation. 
As mentioned above the chemical transformation was used for all gene expressions whereas 
the electroporation was used following the PCR-based and QuickChange mutagenesis.  
 
3.1.5.1 Transformation of electro-competent cells 
 
During electroporation the competent cells were treated with a short but high voltage pulse. 
Although the mechanism is not completely understood,[95] this pulse allows DNA to enter the 
cytoplasm of the cell.  
10 µL of the ligation and 10 µL of the QuickChange mutagenesis assay were dialyzed for at 
least 4 h. 50 µL of chilled DH5α cells were treated with 4 µL of the dialyzed solution and 
transferred to an electroporation cell. The sample was then pulsed with a surge of 1-2 keV for 
3.0 -6.0 ms and 950 mL liquid LB-medium was added immediately. The cells were then 
grown at 37 °C for 1.5 h with shaking (225 rpm). Cells were subsequently harvested 
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(centrifuged), resuspended in approximately 20 µL and plated on LB agar plates containing 
ampicillin as selection marker. The plates were incubated at 37 °C overnight. 
3.1.5.2 Transformation of chemically competent cells 
 
During chemical transformation the cells are treated with a heat shock to weaken the cell 
walls allowing the DNA to enter the cytoplasm.[92] 
Chemically competent DH5α were used for re-transformation, whereas BL21 (DE3) Omp9 
and Rosetta cells were used for gene expressions. 
50 µL of chilled cells were treated with 1 µL of plasmid DNA and incubated for 30 min on 
ice. The cells were warmed for 90s at 42°C and cooled on ice immediately after the heat 
shock. 950 µL liquid LB-media were added and the cells were left for recovery at 37°C and 
225 rpm for 1h. Afterwards the cells were plated on an LB-agar plate containing ampicillin as 
selection marker. The plate was left overnight in the incubator at 37°C. 
 
3.1.6 Preparation of plasmid DNA 
 
3.1.6.1 Qiagen method 
 
The preparation of plasmid DNA was performed using the QIAprep Spin Miniprep Kit 
(QIAGEN) according to manufacturer’s instructions.[96] 4 mL of pelleted overnight culture 
were used. The cells were lysed with NaOH and chromosomal DNA as well as proteins and 
cell particles were precipitated. The plasmid purification was performed using a silica matrix 
with a capacity for duplex DNA of ≤ 10 kbp. The supernatant of the lysed cells were added to 
the column under high salt conditions and washed with EtOH containing buffer. The purified 
plasmid DNA was then eluted under low salt conditions.  
 
3.1.6.2 “Quick and dirty” method 
 
The “quick and dirty” method is based on the alkaline lysis of cells.[97] The “quick and dirty” 
method is a cheap method for the isolation of high amounts of plasmids but a final 
purification is often needed for further work with isolated plasmids. All plasmids isolated 
  3. Methods 
 
35 
with this method were analysed using agarose gel electrophoresis (see chapter 3.1.8) and 
putatively positive clones were PCR-cleaned before being sent to sequencing. 
4 mL of pelleted overnight culture were resuspended in 300 µL P1-buffer (50 mL Tris/HCl, 
pH 8.0, 10 mM EDTA, 100 µg/mL RNaseA) and 300 µL of P2-buffer (200 mM NaOH, 1% 
(w/v) SDS) were added. The sample was inverted carefully and incubated for 5 min at room 
temperature. 300 µL P3-buffer (2.55 M KOAc) were added to neutralize the solution and the 
whole sample was incubated for 15 min on ice. Chromosomal DNA as well as proteins and 
cell particles were precipitated (25402 g, 15 min, 4°C) and the supernatant was transferred to 
a new 1.5 mL Eppendorf reaction cup. 600 µL isopropanol were added and the whole solution 
was vortexed to precipitate the plasmid DNA. The precipitated plasmids were pelleted 
(25402 g, 30 min, 4°C) and washed twice with EtOH and water. The plasmid pellet was dried 
at 37 °C and 50 µL EB buffer (10 mM Tris/HCl, pH 8.5) was added for redissolution.  
 
3.1.6.3 PCR purification using the Qiagen method 
 
Isolated plasmids were purified using the QIAprep Spin PCR-purification Kit (QIAGEN) 
following the manufacturer’s instructions.[96] The purification is based on the separation of 
plasmid DNA and contaminants on a silica matrix with a capacity of ≤ 10 kbp. The plasmids 
were added to the column under high salt conditions and washed with EtOH containing 
buffer. The purified plasmid DNA was then eluted under low salt conditions.  
 
3.1.7 Determination of DNA concentration  
 
The concentration of DNA was determined by absorption at 260 nm. Contaminants like 
proteins and RNA could be identified from the proportion of the absorbance at 280 nm and 
230 nm respectively. All measurements were done at the ND-1000 Spectrophotometers 
(peqlab). Concentration calculation for double-stranded DNA were based on the following 
equation.[89] 
 
ܿ஽ே஺ ൌ ܱܦଶ଺଴ ൈ 50௡௚ஜ௅ 
(Eq 2) 
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3.1.8 Agarose gel electrophoresis 
 
The agarose gel electrophoresis was used to separate and analyse DNA fragments after the 
cleavage by restriction enzymes. Accordingly, 1% (w/v) agarose in TBE-buffer (100 mM 
Tris, 100 mM boric acid, 2 mM EDTA) was melted and poured to an electrophoresis 
equipment (mechanics tool shop, Philipps University Marburg). Following cooling of the 
agarose gel, 6x loading dye were added to the DNA solution and samples were applied onto 
the gel. The electrophoresis was performed at 100 V with constant current for 75 minutes. The 
resulting DNA bands were stained with ethidium bromide (0.5 µg/mL) and detected under 
UV light (λ = 254 nm).[98] 
 
3.2 Biochemical methods 
 
3.2.1 Overnight liquid cultures for microbiology 
 
For identification of VDAC1 variant clones as well as for the retransformation of plasmids, 
E.coli DH5α cells were used. 
5 mL LB-medium containing 100 µg/mL ampicillin was inoculated with a single colony from 
an LB-agar plate of transformants. The cell culture was grown at 37 °C over night and the 
plasmids were isolated as described in section 3.1.6. 
 
3.2.2 Recombinant gene expression  
 
Recombinant gene expression in E.coli was used for the production of proteins for further 
structural and functional analysis. 
 
3.2.2.1 Recombinant protein overproductions 
 
mVDAC1 variants, mVDAC2 and the minimal porin were produced as inclusion bodies using 
E.coli BL21(DE3) omp9 cells.[59, 99] For this, cells were transformed with pET-20b(+) 
plasmids harbouring the genes of interest without the signal sequence. All transformants were 
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tested for their expression efficiencies in a small scale before embarking on preparative scale 
experiments.  
 
3.2.2.2 Recombinant protein overproductions on an analytical scale 
 
Transformants were grown in 5 mL liquid LB-medium containing 100 µg/mL ampicillin and 
1% glucose (w/v) at 37°C and 225 rpm for approximately 4h.  After this 100 µL of the culture 
were transferred to 5 mL of fresh liquid LB-medium containing 100 µg/mL ampicillin and 1% 
glucose (w/v) and were incubated at 37°C and 225 rpm until further usage. With the 
remaining initial culture a small scale expression was performed. For this, 4 µL IPTG 
(cend = 1 mM) was added to the cell suspension and the expression was performed for 1.5 h at 
the same conditions. An SDS sample before and after induction was taken and analysed by an 
12% SDS-PAGE. The SDS-samples was prepared by taking 1 mL cell solution and 
precipitating the cells (25402 g, 3 min). The cell pellets were resuspended in 20 µL SDS-
sample buffer, heated for 5 min at 98°C and loaded on an 12% SDS-PAGE gel to identify the 
best expression clone for preparative recombinant protein overproduction (see section 3.3.1). 
10 µL of the best expressing clone was therefore transferred to 100 mL of liquid LB-medium 
containing 100 µg/mL ampicillin and 1% glucose (w/v) and were left to grow at 37°C and 
225 rpm overnight. 
 
3.2.2.3 Recombinant protein overproductions on a preparative scale 
 
The preparative overproduction of VDAC1-variants, VDAC2 and EMP variant was done in 
6 L liquid LB-medium to produce inclusion bodies. 
The liquid LB-medium was divided in 2 L medium in 5 L conical-flasks to ensure optimal 
supply of oxygen. 30 mL of starter culture (see chapter 3.2.2.2) was added to 2L of liquid LB 
medium containing 100 µg/mL ampicillin and 1% glucose (w/v). Induction was performed at 
an OD600 of ~ 0.6 by the addition of 1 mM IPTG. After induction the cells were grown for 4h 
at 37°C and 125 rpm before harvesting (6400 g, 15 min, 4°C). The cell pellets were 
resuspended in TEN-buffer (50 mM Tris/HCl, pH 8.0, 100 mM NaCl) and shock frozen in 
liquid nitrogen. The cell suspension was stored at -80°C until cell disruption. 
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3.2.2.4 BID expression in a preparative scale 
 
The BID expression was performed in Rosetta cells. Transformants were grown overnight in 
100 mL liquid LB-medium containing 100 µg/mL ampicillin and 34 µg/mL chloramphenicol. 
The preparative gene expression was done in 6 L liquid LB-medium.   
The liquid LB-medium was divided in 2 L medium in 5 L conical-flasks to ensure optimal 
supply of oxygen. 30 mL of starter culture was added to 2 L of liquid LB medium containing 
100 µg/mL ampicillin and 34 µg/mL chloramphenicol. Induction was performed at an 
OD600 ~ 0.6 by the addition of 1 mM IPTG. After induction the cells were grown for 4h at 
37°C and 125 rpm before harvesting (6400 g, 15 min, 4 °C). The cell pellets were 
resuspended in Bid IEC-buffer (20 mM Tris/HCl, pH 7.5, 250 mM NaCl and 10 mM β-
mercaptoethanol). Protease inhibitor cocktail (1mL per 100 mL of cell lysate, #P8849 Sigma 
Aldrich) was added and the cell suspension was shock frozen in liquid nitrogen. The cell 
suspension was stored at -80 °C until cell disruption. 
 
3.2.3 Cell disruption 
 
Cells were disrupted using either a high pressure homogeniser (Emulsifier EmulsiFlex C5, 
Avestin) or a French press (Sim Amico) device. Cell disruption is facilitated by the explosive 
decompression of cells (approx. 8 MPa) which inevitably leads to their lysis. [100] 
Before disruption of cells used for the recombinant overproduction of membrane proteins 
(VDAC1, VDAC2 and EMP) PMSF (cEnd = 0.375 mM) and EDTA (cEnd = 0.1 mM) was 
added. The cell disruption was performed twice (~ 1000 psi) and the insoluble inclusion 
bodies were separated from the soluble parts by centrifugation (25402 g, 30 min, 4 °C). The 
crude cell extract was discarded and the inclusion bodies were washed to obtain the denatured 
membrane proteins. 
The soluble Bid protein was disrupted using the French press device. Especially for soluble 
proteins it is important to ensure a proper cooling of the devices so that the protein remains in 
the native fold. Before cell disruption a spatula tip DNAseI (Applichem) was added and the 
cell solution was incubated for 5 min at room temperature. The cells were disrupted twice 
(~ 1000 psi) to ensure complete lysis. The supernatant containing the soluble Bid protein was 
separated via centrifugation (25402 g, 30 min, 4 °C) from the insoluble parts of the cell, 
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filtered using a syringe sterile filter (0.2 µm, Sarsted) and applied to a Ni-NTA Protino 
column (MACHERY-NAGEL) for further purification. 
 
3.2.4 Preparation of inclusion bodies 
 
The separation of inclusion bodies from E.coli lipids and other proteins was done by a multi-
step washing protocol using a homogeniser after Potter-Elvjhem (Braun).[101, 102]  
The protein-containing pellet from the cell disruption was washed three times in a detergent 
containing Triton-TEN Buffer (50 mM Tris/HCl, pH 8.0, 100 mM NaCl, 10 mM EDTA, 
2.5% (v/v) Triton-X-100) and three times in TEN buffer (50 mM Tris/HCl, pH 8.0, 100 mM 
NaCl) to get rid of the detergent (TEN buffer). The protein pellet was finally resuspended in 
TEN buffer, flash-frozen in liquid nitrogen and stored at −80 °C until further use. 
The protein content of the inclusion bodies was determined spectroscopically monitoring the 
absorbance of proteins at 280 nm. At this wavelength mainly trypthophans and tyrosines are 
absorbing. The extinction coefficients were calculated using ProtParam (ExPASy) [103].  
10 µL of washed inclusion bodies were denatured in 1 mL potassium-buffer (20 mM K3PO4 
pH 6.5, 6 M guanidinium chloride). The absorbance was measured three times and the protein 
concentration was determined using the following equation. 
 
ܿ௉௥௢௧ ൌ Eߝ௥௘ௗ ∙ 100 
(Eq 3) 
 
3.2.5 Refolding of membrane proteins 
 
mVDAC1-variants, mVDAC2 and the minimal porin were produced as insoluble inclusion 
bodies. A two-step rapid dilution protocol according to Bayrhuber et al.[25] and Hiller et al.[32] 
was used to restore the native conformation. The first step of this refolding procedure is the 
full denaturation of the membrane proteins by high concentrations of chaotropic salts. The 
following two steps of dilution in the presence of detergent-containing buffers are necessary 
to reduce the amount of chaotropic salts and to ensure the refolding in the native 
conformation. 
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3.2.5.1 Refolding of membrane proteins in an analytical scale 
 
A variety of different lipids and folding aids are commercially available. To find the right 
conditions for proper refolding, a refolding screen for mVDAC1 and the minimal porin was 
performed. In these screens different detergents, proteins concentrations as well as folding 
aids were tested to find the optimal refolding conditions.  
The refolding screen for mVDAC1 in detail is provided in table 14 and the refolding screen of 
the minimal prion is provided in table 15. 
 
Table 14: Refolding screen for mVDAC1. 
Protein concentration Folding aid Detergent 
1, 5 and 10 mg/ mL  LDAO 
1, 5 and 10 mg/ mL  n-OG 
1, 5 and 10 mg/ mL  C8E4 
1, 5 and 10 mg/ mL  DM 
1, 5 and 10 mg/ mL  n-DG 
1, 5 and 10 mg/ mL  DDM 
5 and 10 mg/ mL Glycerol (5-20%) LDAO 
5 and 10 mg/ mL Sucrose (1-25 mg/mL) LDAO 
5 and 10 mg/ mL Prolin (10 – 1000 mM LDAO 
 
Table 15: Refolding screen for the minimal porin. 
Proteinconcentration Folding aid Detergent 
10 mg/ mL  LDAO 
10 mg/ mL Glycerol 10% LDAO 
10 mg/ mL Xylitol 10% LDAO 
10 mg/ mL  n-OG 
10 mg/ mL Glycerol 10% n-OG 
10 mg/ mL Xylitol 10% n-OG 
10 mg/ mL  C8E4 
10 mg/ mL Glycerol 10% C8E4 
10 mg/ mL Xylitol 10% C8E4 
10 mg/ mL  DM 
10 mg/ mL Glycerol 10% DM 
10 mg/ mL Xylitol 10% DM 
10 mg/ mL  n-DG 
10 mg/ mL Glycerol 10% n-DG 
10 mg/ mL Xylitol 10% n-DG 
10 mg/ mL  OTG 
10 mg/ mL Glycerol 10% OTG 
10 mg/ mL Xylitol 10% OTG 
 
The inclusion bodies were separated from the buffer by centrifugation (13 krpm, 3 min) and 
the pellets were resuspended in denaturation-buffer (25 mM NaH2PO4/Na2HPO4, pH 7.0, 100 
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mM NaCl, 1 mM EDTA, 10 mM DTT, 6 M guanidinium chloride). To ensure optimal 
denaturation of the inclusion bodies, the solution was heated for 10 min at 60°C. Insoluble 
parts were separated by centrifugation (25402 g, 3min) and the supernatant was added drop 
wise to a ten-fold dilution of refolding-buffer 1 (25 mM NaH2PO4/Na2HPO4, pH 7.0, 100 mM 
NaCl, 1 mM EDTA, 10xCMC detergent, folding aid). The samples were gently mixed over 
night at 10 °C. The precipitate was removed (25402 g, 3 min 4 °C) and the supernatant was 
applied drop-wise to a ten-fold excess of refolding-buffer 2 (25 mM NaH2PO4/Na2HPO4, 
pH 7.0, 10 mM NaCl, 1 mM EDTA, 1 mM DTT, 5xCMC detergent, folding aid). The 
refolding solution was mildly mixed overnight at 10 °C. The insoluble parts were again 
removed by centrifugation (25402 g, 3 min 4 °C) and the supernatants were analysed via 
SDS-PAGE (section 3.3.1).  
 
3.2.5.2 Refolding of membrane proteins in a preparative scale 
 
After identifying the right refolding conditions the membrane proteins were refolded in a 
preparative scale. The protein refolding was accomplished by rapid dilution in a two-step 
process.  
The inclusion bodies (10 mg/mL) were denatured in denaturation-buffer (25 mM 
NaH2PO4/Na2HPO4, pH 7.0 for VDAC1, pH 7.4 for EMP and pH 6.0 for VDAC2, 100 mM 
NaCl, 1 mM EDTA, 10 mM DTT, 6 M guanidinium chloride) and heated for 10 min and 
1250 rpm at 60 °C. The insoluble parts were separated by centrifugation (25402 g, 3 min) and 
the supernatant was added drop wise to a 10-fold excess of refolding-buffer 1 (25 mM 
NaH2PO4/Na2HPO4, pH 7.0 for VDAC1, pH 7.4 for EMP and pH 6.0 for VDAC2, 100 mM 
NaCl, 1mM EDTA, 2.22% (v/v) lauryldimethylamine-oxide (LDAO), and 10% glycerol for 
EMP). The mixture was gently stirred overnight at 4°C and the insoluble parts were removed 
by centrifugation (12300g, 10 min, 4 °C) and the supernatant was added drop wise to a 
tenfold dilution of refolding-buffer II (25 mM NaH2PO4/Na2HPO4, pH 7.0 for VDAC1, pH 
7.4 for EMP and pH 6.0 for VDAC2, 10 mM NaCl, 1 mM EDTA, 0.1% (v/v) LDAO, and 
10% glycerol for EMP). The solution was mildly stirred overnight and the insoluble parts 
were removed by a sterile filter before being applied onto a pre-equilibrated column for 
further purification.  
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3.2.6 Truncation of Bid 
 
The soluble Bid protein is the inactive form of the pro-apoptotic protein. The activation of Bid 
to tBid, the truncated form of Bid, is achieved by cleavage of the premature protein by 
Caspase8.[104] For binding assays and functional analysis studies it was necessary to activate 
Bid. Following Bid truncation, hydrophobic parts become solvent-exposed.[105] Therefore, a 
buffer containing detergents was used to hinder tBid from precipitation. 
The cleavage was performed in cutting buffer (50 mM HEPES / NaOH, pH 7.5, 100 mM 
NaCl, 10 mM DTT 1 mM EDTA, 10 % Sacharose) to ensure full activity of Caspase8. 
200 µL of purified Bid in SEC-buffer (20 mM Tris / HCl pH, 7.4, 50 mM NaCl) was diluted 
in cutting-buffer to 10 mg/mL and 1 µL (5 units) of Caspase 8 (Merck Milipore) was added. 
The mixture was incubated for 30 min – 72 h at 30 °C until the Bid protein was completely 
cleaved. The success of cleavage was analysed via SDS-PAGE (section 3.3.1). The cleaved 
tBid solution was again diluted to 5 mg/mL in tBid-SEC-buffer (50 mM Hepes / NaOH pH 
7.5, 300 mM NaCl, 0.2 mM DTT, 1% OG) to prevent precipitation and further purified by 
size-exclusion chromatography. 
 
3.2.7 Protein purification 
 
3.2.7.1 Ion-exchange chromatography 
 
Ion-exchange chromatography is commonly used during protein purification. The purification 
is achieved through the interaction of charged side chains of the amino acids residues with the 
charged column material. The choice of the ion-exchange material is based on the pI of the 
protein and the pH of the buffer solution.  
 
mVDAC1-variants were purified using a pre-equilibrated Fractogel EMD-SE Hicap cation-
exchange column (5 mL volume, Merck) operated at an ÄKTA prime purification system 
(Amersham Biosciences) or an NGC system (Biorad). This special material enhances the 
protein to column interaction by providing the charged groups on flexible linkers. Especially 
for membrane proteins in detergent micelles the interaction between column material and 
protein is not trivial. Therefore the Fractogel material was found to produce the best 
separation results. [106] 
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After refolding, the sterile-filtered mVDAC1-variants were applied onto the pre-equilibrated 
Fractogel EMD-SE Hicap cation-exchange column. The cation-exchange column was used 
because of the theoretical pI of the VDAC1-variants (8.3-8.8) in combination with the buffer 
at pH 7.0. Because of the large volume obtained after refolding the column was loaded 
overnight using a peristaltic pump under circular back flow. Elution was performed using a 
multi-segment gradient of 10 - 1000 mM NaCl in elution-buffer (25 mM NaH2PO4/Na2HPO4, 
pH 7.0, 1 mM EDTA, 1 mM DTT and 0.1% (v/v) LDAO) and purification was detected at 
280 nm. The mVDAC1-containing fractions were analysed on an 12% SDS-PAGE (section 
3.3.1), pooled and concentrated using a 10-kDa Amicon concentrator (Millipore). 
 
mVDAC2 variants were purified using a pre-equilibrated Fractogel DEAE anion-exchange 
column using an adapted protocol of mVDAC1 purification. The refolding of mVDAC2 was 
performed in refolding buffer II buffer (25 mM NaH2PO4/Na2HPO4, pH 6.0, 10 mM NaCl, 1 
mM EDTA, 1 mM DTT and 0.1% (v/v) LDAO) at an pH of 6.0. The pH of the refolding 
solution was then carefully raised from 6.0 to 8.5 using 1 M NaOH and controlled by an pH 
meter. mVDAC2 was applied onto a pre-equilibrated Fractogel DEAE anion-exchange 
column operated at an NGC device (Biorad). Elution was performed using a continuous 
gradient of 10 - 1000 mM NaCl in Elution buffer (25 mM NaH2PO4/Na2HPO4 (pH 8.0), 1 
mM EDTA, 1 mM DTT and 0.1% (v/v) LDAO) and purification was detected at 280 nm. The 
mVDAC2-containing fractions were analysed on an 12% SDS-PAGE (section 3.3.1), pooled 
and concentrated using a 10-kDa Amicon concentrator (Millipore). 
 
3.2.7.2 Metal affinity chromatography 
 
The minimal porin as well as the soluble Bid protein was fused with an N-terminal His-tag 
compatible with the purification by metal affinity chromatography. The hexa-histidine tag has 
a high affinity for either Ni2+ when complexed to tetradentate ligand nitrilotriacetate 
(Ni-NTA) or Co2+ when complexed to carboxymethylated aspartate (TALON™).[107, 108] The 
histidine residues are able to coordinate the metal-ion at the remaining coordination sites and 
elution is done by different concentrations of imidazole. 
 
EMP was purified using a TALON metal affinity column (GE Healthcare). The TALON-
column has a higher affinity towards His-tagged proteins although it is more sensitive to other 
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substances like EDTA or DTT. Use of the TALON-matrix was required because the detergent 
micelle was preventing a satisfying binding of EMP to the Ni-NTA resin. After refolding, the 
sterile-filtered (0.025 µm) minimal porin was applied overnight onto a pre-equilibrated Talon-
column using a peristaltic pump under circular back flow. Elution was performed using a 
continuous gradient of 0 - 150 mM imidazole in elution-buffer (25 mM NaH2PO4/Na2HPO4, 
pH 7.4, 10 mM NaCl, 10% glycerol and 0.1% (v/v) LDAO) and purification was detected at 
280 nm. The protein-containing fractions were analysed using an 12% SDS-PAGE (section 
3.3.1), pooled and concentrated by a 10-kDa Amicon concentrator (Millipore). 
 
For the soluble protein Bid a Ni-NTA Protino column (Machery-Nagel) was used. After cell 
disruption, the lysate was sterile filtered and applied onto a pre-equilibrated Ni-NTA-column. 
Elution was performed using a continuous gradient of 0 - 400 mM imidazole in Elution-buffer 
(20 mM Tris / HCl (pH 7.5), 250 mM NaCl, 10 mM β-mercaptoethanole) and purification 
was detected at 280 nm. The protein-containing fractions were analysed using a 12% SDS-
PAGE (section 3.3.1), pooled and concentrated via a 3-kDa Amicon concentrator (Millipore). 
 
3.2.7.3 Size-exclusion chromatography 
 
Size-exclusion chromatography (SEC) separates proteins in terms of their hydrodynamic 
radii. The column matrix is a polymer of cross-linked agarose or dextran with variously sized 
pores. The separation is based on diffusion through these pores with larger proteins eluting 
earlier than smaller proteins. The reciprocal of a calibration curve of the eluted volumes and 
the logarithm of the molecular mass standards enables the calculation of the unknown particle 
size. 
 
An analytical SEC-column was used to analyse small amounts of proteins. For example the 
protein-protein complex of mVDAC1 with Bid/tBid was analysed using a Superdex™ 200 in 
150/10GL column (GE Healthcare) with a column volume of 3 mL. For preparative protein 
purification a Superdex™ 200 XK 16/60 column (GE Healthcare) with a bed volume of 120 
mL was used. The purification over a SEC was used as a polishing step and a measure of 
monodispersity for all proteins purified in this work. All proteins were sterile filtered 
(0.025 µm) before application onto the pre-equilibrated column. Elution profiles were 
detected at 280 nm. The protein-containing fractions were analysed using a 12% SDS-PAGE 
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(section 3.3.1), pooled and concentrated via a 10-kDa (3-kDa for Bid and tBid) Amicon 
concentrator (Millipore). Protein concentrations were determined from the UV-Vis 
absorbance of tested samples at 280 nm (Nanodrop ND-1000, peqLab), using extinction 
coefficients as predicted by ProtParam.[103] Purified samples were stored at 4 °C until further 
use. The SEC-buffer compositions are provided in table 16: 
 
Table 16: SEC-buffers. 
VDAC1-variants VDAC2 minimal porin Bid tBid 
10 mM 
Tris/HCl, pH 8.0 
10 mM 
Tris/HCl, pH 
8.0  
25 mM Tris/HCl, 
pH 7.4 
20 mM Tris/HCl, 
pH 7.4 
50 mM 
HEPES/NaOH, 
pH 7.5 
100 mM NaCl 100 mM NaCl 100 mM NaCl 50 mM NaCl 300 mM NaCl 
0.05% LDAO 0.05% LDAO 10% (v/v) 
glycerol 
 0.2 mM DTT  
  0.05% (v/v) 
LDAO 
 1% OG 
 
 
3.2.7.4 Desalting 
 
The PD Mini Trap G-25 desalting column (GE Healthcare) was used both for desalting of 
purified proteins as well as for the removal of excess of label according to manufacturer’s 
instruction. For several experiments like microscale-thermophoresis or EPR measurements it 
is necessary to label the proteins. Following site-specific labelling of proteins an excess of 
label would interfere with further analytical methods. The purification is based on the 
principle of the size-exclusion chromatography. The column matrix is made of SephadexTM-
G25, too small for proteins to enter. Therefore, proteins are eluted very fast, whereas labels 
diffuse into the pores and elute later.[81]  
 
 
3.2.8 Precipitation of VDAC-variants 
 
For quantitative analysis of refolding efficiencies, proteins were precipitated. The 
precipitation of proteins has two major advantages, a) the concentration of the sample is 
increased and b) agents that interfere with the analytical methods like detergents are removed. 
In this work, the acetone precipitation was used. A 4-fold excess of acetone was added to the 
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protein solution and samples were incubated for 1h at -20 °C. Samples were centrifuged 
(25402 g, 3 min, 4 °C) and pellets were washed with dH2O and EtOH respectively. The 
pellets were dried at 37 °C and resuspended in SDS-sample buffer for further analysis. 
 
3.2.9 Labelling of mVDAC1-variants 
 
For analytical methods like microscale-thermophoresis or EPR measurements mVDAC1-
variants were labelled at specific sites. The labelling methods were aiming for the reactive 
thiol groups of cysteines whether with iodoacetamides, maleimides or activated thiols as 
reaction partners. 
The challenges in every protein labelling steps are a) to achieve quantitative labelling of all 
available cysteines and b) to preserve the native fold and function of the protein of interest.  
 
3.2.9.1 Labelling of mVDAC-variants for microscale-thermophoresis 
 
mVDAC1, ∆1-11-mVDAC1-K12C, ∆1-25-mVDAC1-L26C and mVDAC2 were labelled 
using Alexa Fluor® 532 C5-maleimide (Invitrogen). 1 mM TCEP (AppliChem) was added to 
100 µM protein solution and the sample was incubated for 30 min at 10°C. After incubation 
1 mM label (cend) was added and the solution was incubated over night at 10°C and 350 rpm 
in a Thermomixer (Eppendorf). Excess of label were removed (see chapter 3.2.7.3) and 
protein concentration as well as label efficiency were determined using a Nanodrop ND-1000 
spectrophotometer (peqLab). The label efficiency was calculated using the following 
equation. 
 
ܣ௫
ߝ ∙
݉݋݈݁ܿݑ݈ܽݎ	݉ܽݏݏ	݋݂	݌ݎ݋ݐ݁݅݊
݉݃	݋݂	݌ݎ݋ݐ݁݅݊ ݉ܮൗ
ൌ moles	of	dyemoles	of	label 
(Eq 4) 
Ax = absorbance value of the dye at absorption maximum wavelength (here 532 nm) 
ε = molar extinction coefficient of dye at absorption maximum wavelength (here 81.000 L·mol−1·cm−1 
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3.2.10 Oxidation and reduction of mVDAC1-variants 
 
For effective induction of disulphide cross-linking in mVDAC1 variants, purified proteins 
were treated with 100 mM copper-phenanthroline (CuX2Ph).[109] CuX2Ph was freshly 
prepared using CuSO4 und 1,10-phenanthroline in a molar ratio of 1 to 3.5 in a DMSO 
solution. 50 - 100 µL of purified mVDAC1-variants were treated with 1.3 mM CuX2Ph and 
incubated for 1h at 10°C. CuX2Ph reactions were quenched by addition of 5 mM EDTA and 
incubated for additional 30 min at 10°C. Disulphide bond reduction was mediated by addition 
of 10 mM DTT followed by an incubation for 1h at 10°C. Excess of oxidative or reductive 
agents were removed using an Amicon Ultra-0.5 Centrifugal Filter Devices (Millipore) after 
manufacturer’s instructions. [84] The presence or absence of disulphide bonds was confirmed 
independently by non-reducing SDS-PAGE and peptide mass fingerprint spectrometry. The 
excess of DTT was removed to prevent potential interference of CuX2Ph or DTT with the 
subsequently performed assays, treated protein samples were further purified using an 
Amicon Ultra-0.5 mL Filter Device (Millipore) according to the manufacturer's instructions.  
 
3.2.11 Reconstitution into lipid vesicles 
 
For SRCD and SROCD measurements, reconstitution of refolded and purified mVDAC1 and 
EMP into DMPC liposomes was necessary. The reconstitution was performed after an 
adaption of the Klamm et al 2007 and Neves et al 2009 protocols.  
For SRCD or SROCD measurements the removal of all interfering agents like Cl- or non-
aliphatic detergents from purified porins was essential. As described in 3.2.7.3 mVDAC1 was 
desalted using a variation of refolding buffer II (25 mM NaH2PO4/Na2HPO4, pH 7.0, 10 mM 
NaF, 0.05% (v/v) LDAO). The CHAPSO:DMPC bicelles were prepared in a molar ratio of 
1:2.8 mM as previously described. [22] 100 µL of desalted protein was reconstituted in 1 mM 
CHAPSO:DMPC bicelles and incubated once for 1h at 30 °C and once overnight at 10 °C. 
Excess of detergent was removed using biobeads as previously described. [110, 111] 750 mg of 
biobeads were washed once with 10 mL methanol, trice with water and twice with 25 mM 
NaH2PO4/Na2HPO4, pH 7.0, 10 mM NaF. 1 mL of washed biobeads were incubated for 
30 min at room temperature with 100 µL lipid suspension. 1 part of mVDAC1 in bicelles was 
added to 10 parts of biobeads and incubated overnight at 30°C or 10°C. The supernatant was 
transferred to fresh, lipid-saturated biobeads and again incubated for 6 h at 30 °C or 10 °C. 
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The supernatant was centrifuged (25402 g, 2h) and protein-containing liposomes were 
carefully resuspended. 
Purified EMP was reconstituted into DMPC liposomes following previously established 
protocols by Dr Georgios Psakis. [110, 111] As described before, preformed liposomes (50 
mg/ml) were mixed with the refolded minimal porin at a molar ratio of 2000:1 and incubated 
at 30 °C for 2 h. Detergent was removed with washed lipid saturated biobeads in 25 mM NaPi 
pH 7.4, 25 mM NaCl, 10% (v/v) glycerol. Biobeads were mixed with the protein bicelles in a 
ratio of 100:1 and the absorbance of detergents was performed overnight at 30 °C. For 
identification and quantification of lipid in the proteoliposomes, and for confirmation of 
complete detergent removal, thin layer chromatography was performed as previously 
described. [112] 
 
 
3.3 Protein analytics 
 
3.3.1 Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
The sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
identify proteins, control the purity, asses refolding efficiencies and assess 
labelling/crosslinking. The method was described by Laemmli et al. 1970.[113] The gels were 
stained using either Coomassie Brilliant Blue (R) or silver staining. All analysed proteins 
were applied to SDS-PAGES containing whether 12% or 16% acrylamide in the separation 
gel. The electrophoreses were performed at 30 mA per gel and constant voltage for 45 
minutes in SDS running buffer (25 mM Tris, 0.2 M glycine, 0.1% (w/v) SDS) using a Mighty 
Small II (Hoefer Inc., Holliston, MA, USA) or a PerfectBlue Twin M device (peqlab 
Biotechnologie GmbH, Erlangen). The mixture of the gels is described in table 17.  
Coomassie Brilliant Blue (R) staining was performed in SDS-PAGE staining solution (section 
2.4.3.2 table 13) and the background was destained using SDS-PAGE destaining solution 
(section 2.4.3.2 Table 13). 
If the protein concentration was too low to identify single protein bands on the Coomassie 
Brilliant Blue (R) stained gel, a silver staining was performed as described previously.[114] In 
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short, a Coomassie Brilliant Blue (R) stained SDS-PAGE was destained completely using 
destaining solution (section 2.4.3.2 table 13) and incubated overnight in dH2O. The gels were 
sensitized for 2 min using sensitizer (0.02% (w/v) Na2S2O3). Following, the gels were washed 
trice in dH2O for 5 min and the gels were stained for 20 min in silver solution (0.2 % (w/v) 
AgNO3, 0.076% (v/v) formalin). The gels were again washed twice for 1 min in dH2O and 
developed (6% (w/v) Na2CO3, 0.05% (v/v) formalin, 0.0004% (w/v) Na2S2O3) until brownish 
protein bands became visible. The staining reaction was stopped (50% (v/v) MeOH, 12% 
(v/v) HOAc) for 5 min. The gel could be stored at 4 °C in 1% HAc. 
 
Table 17: Components of SDS-PAGE gels. 
Component 12% separation gel (60 mL) 4% stacking gel (25 mL) 
30% acrylamide 
solution 24 mL 3,33 mL 
10% SDS solution 600 μL 250 μL 
dH2O 15,18 mL 16,43 mL 
SDS resolving gel 
buffer 20 mL - 
SDS stacking gel buffer - 5 mL 
TEMED 60 μL 250 μL 
30% APS 300 μL 25 μL 
 
 
Beside the denaturing SDS-PAGE for a quick and simple protein analysis a blue native PAGE 
(BN-PAGE) was used for the determination of protein complexes.[115] BN-PAGES are 
non-invasive and therefore protein-complexes can be detected as intact complexes whereas a 
SDS-PAGE separates the components. The mixture of BN-gels is described in table 18.  
 
Table 18: Components of BN-PAGE gels. 
Component Volume 
10 x BN-running buffer 6 mL 
Acrylamide solution 30% 20 mL 
EGTA solution 0.2 M 60 µL 
APS solution 30% 300 µL 
TEMED 40 µL 
Water 60 mL 
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3.3.2 Peptide mass fingerprinting  
 
For the identification of protein as well as free cysteines and disulphide-bridges oxidized or 
reduced samples were analysed using the peptide mass fingerprint method. [116, 117] This 
method was performed following the tryptic digestion of target proteins, to allow detection of 
certain protein fragments by ESI-mass spectrometry. To cap free cysteines 2-iodoacetamide 
(Applichem) was added in a final concentration of 1 mM to the mVDAC1 samples and stirred 
over night at 8 °C. To remove free 2-iodo-acetamide the protein was precipitated as described 
in chapter 3.2.8. Pellets (341 µg each) were dried at 37 °C. Further digestion and analyses 
were done by Dr Uwe Linne and Natalia Fritzler of the mass-spectrometry unit of the Philipps 
University Marburg. The dried pellets were dissolved in 100 µL 10% acetonitrile and digested 
over night at 37 °C with 10 µg sequencing grade trypsin (Promega) containing 25 µL 50 mM 
NH4HCO3 buffer at pH 8.0. For chromatographic separation of the tryptic peptides an 1100 
Agilent HPLC system was used with a 150x3 mm Kinetex 2.6 µm C18 column (Phenomenex) 
at a temperature of 40 °C and a flow rate of 0.2 mL/min. UV-detection of the peptides was 
carried out at 215 nm. The following gradient of water (solvent A) and acetonitrile (solvent B) 
each containing 0.1% TFA was applied: 5% B for 10 minutes, linear increase to 60% B within 
150 minutes, linear increase to 90% B in additional 5 minutes and then holding B at 90% for 
10 minutes. Mass spectrometric detection of the peptides was done by online electrospray-
ionisation-mass spectrometry (ESI-MS) with an LTQ-FT mass spectrometer 
(ThermoScientific). An FTMS scan was carried out in the mass range of 400-2000 m/z, 
followed by three automated ion trap MS/MS scans.[118] The disulphide-bridged peptides were 
identified from comparisons of predicted and actual masses. 
 
3.3.5 Protein concentration using bicinchoninic acid assay (BCA) 
 
The concentration of liposome-containing samples or labelled proteins was determined using 
the BC-assay (Uptima by Interchim). The protein concentration is determined via a copper (I) 
protein complex build by an in situ Biuret reaction with bicinchoninic acid.[119] The BC-assay 
is compatible with detergents and lipids and was therefore used for the analyses of membrane 
proteins.[120]  
1000 µL of reagent A was mixed with 20 µL of reagent B and 50 µL protein solution. As 
reference a sample with 50 µL buffer instead of protein solution was added. Both samples 
were incubated for 30 min at 37 °C. If the protein concentration was too low the incubation 
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temperature was raised to 60 °C according to manufacturer’s instructions. The absorbance 
was measured at 562 nm (Ultrospec 3100pro UV Visible Spectrometer, GE Healthcare) and 
the concentration could be determined using a calibration curve. From the calibration the 
following equation could be calculated and were used for all BC-assay determined protein 
concentrations. 
 
ܿ ൌ 	ܣ െ 0.013530.00102 ∙
1
1000 ∙ ݈݀݅ݑݐ݅݋݊	 ቂ
݉݃
݉ܮቃ 
(Eq 5) 
 
3.3.6 Single channel conductance recordings 
 
Single channel conductance recordings were performed using the Black Lipid Membrane 
(BLM) technique. [57, 121-125]  This technique is based on the measurement of current (pA) 
when a certain voltage (mV) is applied. The chamber for BLM-measurements comprises two 
compartments (polystyrene cuvette: CP2A, bilayer chamber: BCH-22A, Warner Instruments) 
separated with a small 200 µm circular hole. The chambers are filled with suitable buffer and 
a lipid bilayer is painted over the hole. Upon reconstitution of membrane proteins into the 
lipid bilayer, a current can be detected after voltage is applied by two Ag/AgCl electrodes 
(Figure 13).The membrane proteins are acting as Ohmic resistance and therefore their 
conductivity can be calculated using an Ohm Plot.  
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the total recording time. BLM measurements and first analyses were done by Dr Philipp Reiss 
(Group of Prof Koert, University of Marburg). 
 
3.3.7 ThermoFluor assay 
 
The ThermoFluor assay is a quick and easy method to determine the thermal stability of 
proteins. It can be used as an alternative to CD-measurements when analysing the melting 
temperature of a protein or protein-protein/-ligand complex.[127] ThermoFluor assays have the 
main advantage that optically active samples such as detergents and liposomes do not 
interfere with this method compared to CD.[128] The method is based on the binding of a 
fluorophor dye (SYPRO Orange) to the hydrophobic patches of the protein resulting in a 
fluorescent signal. Upon unfolding, the protein is presenting more hydrophobic patches and 
the dye will therefore bind to the newly accessible patches. As a consequence the fluorescence 
will increase. The measurements were done in a Rotor-Gene Q (Qiagen) and data were 
analysed using Rotor-Gene Q series High-resolution melting analysis (HRM) software 
(Qiagen). The analysis of the melting curves includes the subtraction of the background 
(buffer + dye) and signal integration, with the inflection point representing the sample´s 
melting temperature (Tm).  
0.6 mg/ml of purified mVDAC1 was mixed with Bid / tBid in a molar ratio of 0.5 to 2. 5 µL 
SYPRO Orange 5000 (life technologies, # S-6650) was added to detect the fluorescence 
change during melting. Melting curve analysis was performed in a Rotor-Gene Q (Qiagen). 
Fluorescence was detected at 510 ± 5 nm and data were analysed using Rotor-Gene Q series 
High-resolution melting analysis (HRM) software (Qiagen). By comparing the different 
melting curves with and without the effector-protein Bid/tBid the complex stability could be 
inferred.  
 
3.3.8 Thermophoresis 
 
A temperature gradient in aqueous solution can induce a flow of molecules depending on their 
mass. This effect is also known as Ludwig-Sorret effect or thermophoresis.[129] It is argued 
that thermophoresis is a local non-equilibrium effect depending on fluid dynamics, force 
fields and particle solvent potentials. There is a great influence of the solvent-particle 
interface and particle charge to describe the thermophoretic effect. Although the effect is not 
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fully understood, thermophoresis can be phenomenologically explained by the linear drift 
response.[130] According to this, the molecule velocity (v) is linearly dependent on the 
temperature gradient (gradT) with a proportionality constant DT (thermal diffusion coefficient 
or thermophoretic mobility).[131] 
 
ݒ ൌ 	െܦ்݃ݎܽ݀ܶ 
(Eq 6) 
 
The velocity is dependent on the particle concentration as well as on diffusion constants for 
every particle in solution. To overcome dependency on concentrations, microscale 
thermophoresis is done at a nanomolar scale. The diffusion coefficients (D) depend on solvent 
interaction and therefore the whole thermophoretic assay is influenced by protein solvent 
interaction as described by the Sorret coefficient ST. 
 
்ܵ ൌ ܦ் ܦൗ  
(Eq 7) 
 
In general the Sorret coefficient depends on the molecule size, it´s charge and the interaction 
with solvents. If one of these parameters is changed, the thermophoretic migration is altered. 
In terms of experiments, thermophoresis detects the thermophoretic migration of labelled 
proteins in a temperature gradient hypothesizing that protein and protein complexes are 
migrating differently due to their size.[132, 133] In theory larger proteins and protein-complexes 
should migrate slower whereas smaller proteins or protein-complexes should migrate faster in 
a temperature gradient. 1F2 Using this, binding assays were performed to determine dissociation 
constants (KD-values). The experimental setup consists of an infrared laser coupled into the 
path of fluorescence excitation/emission. Upon a measurement, the laser heats a small spot of 
the capillary where the fluorescently labelled analyte is present. The analyte is migrating in 
the thermal field depending on its Sorret coefficient. A schematic view of the microscale 
thermophoresis (MST) is provided in Figure 14. 
 
                                                 
 
2 This is the most prevalent case, known as positive thermophoretic effect. 
  3. Methods 
 
56 
 
Figure 14:[131] (A) MST is measured in a capillary, upon laser irradiation the change of the fluorescence is 
measured through the same optical element (B) typical MST signal for one capillary. After laser (30s) irradiation 
the fluorescence signal drops (detected as thermophoresis). After the steady state region is reached the laser is 
turned off and backdiffusion as driven by mass diffusion can be detected. 
 
mVDAC1-variants and mVDAC2 were labelled using Alexa Fluor® 532 C5-maleimide 
(Invitrogen) and excess of label was removed by a PD Mini Trap G-25 desalting column (GE 
Healthcare). Protein concentration and label efficiency were measured at 280 nm and 532 nm 
by a Nanodrop ND-1000 (peqLab) spectrophotometer. Thermophoresis measurements were 
performed using the Monolith NT.115 instrument (Nano Temper). mVDAC1-variants and 
mVDAC2 concentrations were kept constant at 50 nM and Bid/tBid were added to the 
solution ranging from 15 nM to 500 µM. The protein solution was incubated in the dark for 
20 min at room temperature and centrifuged (25402 g, 5 min) to remove precipitated proteins. 
Capillaries (standard grade, Nano Temper) were filled with 8-10 µL of the protein solution 
and MST curves were recorded. KD values were calculated using the NT-Analysis software. 
 
 
3.3.9 Circular dichroism spectroscopy 
 
Circular dichroism (CD) spectroscopy is an optical method to analyse secondary structure 
elements. It is based on the absorption of circular-polarized light by chiral molecules. Chiral 
molecules are absorbing left and right polarized light in a different manner and therefore the 
difference in these absorbance characteristics is generating a CD signal which can 
subsequently be detected.[134] A schematic view of a CD-spectroscopic instrument is shown in 
Figure 15. 
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Figure 15: schematic view of a CD-spectroscopic instrument, the white unpolarised light from a high intensity 
light source is linear polarised by a monochromator. The monochromatic linear polarised light is transformed to 
left (LCP) and right (RCP) circular polarised light by the photo-elastic modulator (PEM). The absorbance of an 
optically active sample (blue square) is measured by a detector as average light intensity over time. The CD 
signal is calculated by the division of vAC through vDC to give units of millidegress of ∆absorbance. Plotting 
CD signals vs. wavelengths result in the CD spectrum. [135] 
 
The characteristic spectrum of the CD measurements is achieved by plotting the CD-signals 
against the wavelength. Not only simple chiral molecules cause a CD-signal as secondary 
structures of proteins show distinct polarized-light-interactions that can be analysed with this 
method as well. The secondary structures of proteins, like α-helix and β-sheets as well as 
random coils, show distinct CD-spectral signatures. Therefore the overall secondary structure 
of a protein or the change of secondary structure upon effector binding can be calculated on 
the basis of a CD spectrogram.  
 
The quality of a CD-spectrum depends on the quality of the sample. Interfering agents, such 
as optically active detergents or light scattering agents like liposomes can´t be used during 
normal CD-measurements. For this purpose another method of CD spectroscopy was 
developed. The light source, in conventional CD devices, is a wolfram lamp, enabling good 
emission in the near UV (260 – 320 nm) but inadequate emission in the far UV regions (170 – 
260 nm). To overcome the unwanted interference with buffer components as well as 
providing better data for the far UV region a synchrotron light source was used. A 
synchrotron source with its higher light intensity has the main advantage that lipids do not 
interfere with the absorption pattern and that much smaller protein concentrations and 
volumes can be used. Another analytical technique based on CD-spectroscopy was used at the 
ANKA source of the Karlsruher Institute for Technology (KIT), oriented CD spectroscopy 
that offers an additional analytical method for membrane proteins. With this method it is 
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possible not only to analyse secondary structures but determine the orientation of theses 
structural elements relative to the membrane-normal. This provides information on how a 
membrane protein is oriented in the membrane plane and whether it´s structure is changing 
upon effector binding. 
 
Beside pure structural analysis the stability and dynamics of proteins can be detected by 
melting curve analysis. During a melting curve analysis the measured ellipticity is plotted 
against the temperature giving information about the denaturation and spontaneous refolding 
during the heating and cooling circles. As ellipticity depends on the proteins structure the 
stability of proteins as indicated by the melting point can be calculated.[136] In this work CD 
measurements were done using a conventional J-810 or J-815 spectropolarimeter (Jasco) or 
the CD12-beamline at the ANKA synchrotron source of KIT. 
 
CD studies on refolded and purified EMP were done by Dr Georgios Psakis using a J-810 or 
J-815 spectropolarimeter (Jasco) as previously described (Psakis et al 2009, Windisch et al 
2010). Protein samples in LDAO micelles were analysed at 20 °C and spectra of samples in 
DMPC were recorded above (35 °C) and below (20 °C) the phase transition temperature of 
DMPC (23 °C). Scans were collected in a 1 mm quartz cell (110-QS, Hellma), at a speed of 
10 nm/min, 8 s response time, and 1 nm bandwidth. Thermal denaturation was followed at the 
corresponding CD minima and the temperature was varied by 0.5 °C/min from 10 °C to 
95 °C. CD spectra were collected at 20 °C before heating and after cooling. Averaged spectra 
(three accumulations) were smoothed by the adaptive smoothing algorithm (Jasco). The 
concentration of the samples was determined either by UV-Vis measurements at 280 nm 
(NanoDrop ND-1000, PEQLAB) or by the bicinchoninic acid assay (BCA).  
CD–studies on mVDAC1-variants in liposomes were performed at the CD12 beamline of the 
ANKA synchrotron. To detect a structural rearrangement of mVDAC1 in liposomes upon 
tBid binding both proteins were measured alone as well as the protein-protein complex in 
molar ratios of 1:1 and 1:2. From the separate measurements a combined CD curve could be 
calculated. By comparison of the calculated and measured protein-protein CD spectra a 
qualitative statement about the structural state was made. Scans were collected between two 
quartz-glass slides with a pathlength of 0.012 mm from 270-170 nm in 0.5 nm steps and a 
dwell time of 1500 ms.  
Secondary structure predictions of the analysed protein samples were performed using the 
CONTIN-LL [137, 138] algorithm of the DICHROWEB server [139-141] with the reference set 
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SP175.[142, 143] Confident predictions showed a normalized-root-mean-square deviation 
(NRMSD) of <0.1 for the comparison of experimental and back-calculated data. [139]  
For OCD studies of mVDAC1-variants and the minimal porin a 50-100 μl aliquot of the 
lipoprotein sample (maximum 0.2 mg lipid in 10 mM KPi, pH 7.4) was deposited on a quartz 
glass plate with a 20 mm diameter. The sample was dried at room temperature under a gentle 
stream of air, leaving a circular spot of ~12 mm diameter. Following the assembly of the 
OCD cell, samples were subsequently hydrated at the desired temperature for 15 hours, by 
using a saturated K2SO4 solution, until their relative humidity was between 97-99%.[144, 145] 
For reduction of artefacts, three spectra were recorded for every 45o rotation of the cell around 
the beam axis using the same acquisition parameters as for normal CD measurements.[145, 146] 
Baseline subtraction used the average of eight spectra from empty liposomes. Secondary 
structure predictions from the DMPC reconstituted samples were performed as described 
above.  
 
3.3.10 Electron pulsed resonance (EPR) spectroscopy  
 
EPR spectroscopy of site-directed spin-labelled proteins is a useful technique to study 
structural and conformational dynamics of protein and protein complexes. This technique is 
very useful in terms of membrane proteins, as lipids and detergents are not interfering with 
the EPR-signal.[147] The spin label (often a paramagnetic nitroxide group) can be introduced 
by various ways. The most common one is the labelling of sulfhydryl-groups of free 
cysteines. The cysteines can be introduced in recombinant proteins by site-directed 
mutagenesis. There are two different EPR methods to obtain structural and conformational 
dynamics information, a) the continuous wave (cw) and b) the pulsed EPR (DEER) 
techniques. These two methods differ by their ability to detect inter-spin-spin distances. The 
cw method is able to analyse distances up to 2 nm whereas in pulsed EPR distances up to 8 
nm can be determined. cw measurements yield information about the nitroxide chain mobility, 
solvent accessibility and the polarity of the direct environment of the label. In addition the 
distances between the nitroxide and another paramagnetic residues can be detected.[148] 
EPR sensitivity is limited due to the reorientational motion of the nitroxide side chain. The 
motion as well as the dynamics of the nitroxide incorporated into a protein is characterized by 
three correlation times, a) the rotational correlation time for the whole protein, b) the effective 
correlation time of the rotational isomerization of the label and c) the effective correlation 
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time for the segmental motion of the backbone. All these motions can be described using the 
Stokes-Einstein equation: 
 
Ʈோ ൌ ƞܸ݇஻ܶ ൌ
ƞ
݇஻ܶ ∙
തܸܯ
஺ܰ
 
(Eq 8) 
η = viscosity of the solution 
kB = Boltzmann constant 
T = absolute temperature 
V = volume of the protein 
V = the partial specific volume of the protein 
M = molecular mass of the protein 
NA = Avogadro constant 
 
This parameter is crucial for the spectral line width and therefore for the sensitivity of the 
EPR spectrum itself. A second semi-empiric parameter connected to the spectral line width 
and therefore responsible for the sensitivity is the spectral breadth, represented by the second 
moment <H2>: 
 
〈ܪଶ〉 ൌ 	׬ 	ሺܤ െ 〈ܪ〉ሻ
ଶܵሺܤሻ݀ܤ
׬ ܵሺܤሻ݀ܤ  
(Eq 9) 
 
<H2> is defined by the mean geometrical centre of the spectrum (first moment) <H>: 
 
〈ܪ〉 ൌ 	׬ 	ܤ	ܵሺܤሻ݀ܤ׬ ܵሺܤሻ݀ܤ  
(Eq 10) 
B = magnetic field 
S(B) = absorption spectrum of the spin-labelled protein 
 
 
The numeric values of the second moment increase, if the reorientational motion of the 
nitroxide label is reduced by either sterical hindering after structural rearrangement or by 
overall changes in the hydrophobic environment of the label. 
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Another EPR method is the determination of interspin-distances between two spin labels or 
one spin label and a paramagnetic centre in the protein. In this work interspin-distance-
measurements upon two spin labels were performed. The spin-spin interaction is composed of 
the static dipolar interaction, the modulation of the dipolar interaction by the protein residues 
and exchange interactions. The distance of two nitroxides can be found as a statistical 
distribution due to their mobility. Simulations of spin-spin distances can be performed using 
the EPR simulation program DIPFIT.[149, 150] The upper limit is as already mentioned up to 8 
nm due to the pulsed EPR technique. The lower limit is about 0.8 nm due to the increasing 
modes of exchange interaction by the two overlapping π-orbitals of the nitroxide. For a 
quantitative analysis of interspin distances the differences between the two second moments 
of the singly- and doubly- labelled protein can be calculated by the following formula. 
 
〈∆ܪଶ〉 ൌ 	׬ 	ሺܤ െ 〈ܪ〉ሻ
ଶܵ஽ሺܤሻ݀ܤ
׬ܵ஽ሺܤሻ݀ܤ െ
׬ 	ሺܤ െ 〈ܪ〉ሻଶ ௌܵሺܤሻ݀ܤ
׬ ௌܵሺܤሻ݀ܤ 	 
(Eq 11) 
SD = absorption spectrum of the doubly-labelled protein 
SD = absorption spectrum of the singly-labelled protein 
 
Using this equation, the analysis of interspin exchanges is independent of exchange 
interactions and therefore less sensitive towards incomplete labelling. Using two radical pairs 
equation 12 yields the interspin distance r. 
 
ݎ ൌ 2.32	〈∆ܪଶ ∙ 10଼〉ିଵ ଺ൗ 	݊݉ 
(Eq 12) 
 
The spin labelling was done with the (1-oxyl-2,2,5,5,-tetratmethylpyrroline-3-
methyl)methanethiosulfate (MTSSL).[151] This label is suitable for EPR analysis because the 
flexible chain of the label is not interfering with the protein structure and the size resembles a 
tryptophan residue. Nevertheless it has to be checked whether the protein characteristics and 
the overall fold are not affected by incorporation of the label. For this issue the BLM technic 
was used and BLM traces of mVDAC1-variants with and without the spin label were 
compared. 
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mVDAC1-variants were labelled (see chapter 3.2.9.2) and cw and DEER-EPR measurements 
were performed by Katharina Rudi and Dr Johann Klare (group of Prof Dr Steinhoff, Physics 
department, University of Osnabrück).  
 
Continuous wave EPR experiments were performed using X‐band EPR spectrometers 
(constructed by the physics department, university of Osnabrück) equipped with an AEG H103 
rectangular cavity or a dielectric resonator (Bruker). The magnetic field was measured with a 
B‐NM 12 B‐field meter (Bruker). Samples were loaded into EPR quartz capillaries (150 µM). 
Spectra were recorded with a modulation amplitude of 1.5 G, and microwave power adjusted 
to between 0.1 and 0.6 mW. A modified Oxford ESR 9 variable temperature accessory 
allowed stabilization of the sample temperature between 80 and 330K.  
 
DEER measurements were accomplished at X-band frequencies (9.3-9.4 GHz) with a 
BrukerElexsys 580 spectrometer equipped with a Bruker Flexline split-ring resonator ER 
4118XMS3 and a continuous flow helium cryostat ESR900 (Oxford Instruments) controlled 
by an Oxford Intelligent temperature controller ITC 503S. Measurements were performed 
using the four-pulse DEER sequence:[152, 153]  
 
π⁄2 (νobs) - τ1- π (νobs) - t '- π (νpump) - (τ1+ τ2- t' ) - π (νobs) -τ2- echo 
(Eq 13) 
 
A two-step phase cycling (+ 〈x〉,-〈x〉) was performed on π⁄2 (νobs). Time t’ is varied, whereas 
τ1 and τ2 are kept constant. The dipolar evolution time is given by t = t'-τ1. Data were analysed 
only for t > 0. The resonator was overcoupled to Q ≈ 100; the pump frequency νpump was set to 
the centre of the resonator dip and coincided with the maximum of the nitroxide EPR 
spectrum, whereas the observer frequency νobs was ~ 65-75 MHz higher, coinciding with the 
low field local maximum of the spectrum. All measurements were performed at a temperature 
of 50 K with observer pulse lengths of 16 ns for π⁄2 and 32 ns for π pulses and a pump pulse 
length of 12 ns. Proton modulation was averaged by adding traces at eight different τ1 values, 
starting at τ1,0= 200 ns and incrementing by ∆τ1 = 8 ns. Data points were collected in 8-ns 
time steps. The total measurement time for each sample was 24–48 h. Data analysis was 
performed with the software package DeerAnalysis2013 in the distance range 1.0 – 8.0 nm 
with a regularization parameter (α) of 100, according to the L-curve criteria.[153] 
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Inter-spin label distance distributions were simulated using a rotamer library of spin labelled 
residues as described in Polyhach et al., 2011.[154] The rotamer library implemented in the 
software package MMM2011 consisted of 210 rotamers of MTSSL bound to cysteine, which 
have been used to replace the native residues at the positions of interest in the RocCOR 
structural model. Energies and resulting populations for individual rotamers were calculated 
by means of a Lennard–Jones potential at 175 K (the glass transition temperature for a water–
glycerol mixture), and have been used as weights in the simulation of the distance 
distributions. 
 
3.4 Protein crystallisation 
 
One of the most important methods for determining the 3D structure of proteins is the x-ray 
diffraction analysis of protein crystals. The diffraction quality of protein crystals is perhaps 
the most limiting factors during structure determination by X-ray crystallography. The 
formations of well diffracting crystals depend on various factors like buffers, temperatures, 
precipitants and additives. To obtain initial crystallization conditions a sparse matrix 
screening is performed.[155] After initial hits a fine screening is performed to increase size and 
quality of the obtained crystals. 
Especially for membrane proteins, well diffracting crystals are not that easy to obtain. This is 
due to detergents that cannot be excluded because of the hydrophobic pattern in membrane 
proteins. To overcome this problem there are various methods for membrane protein 
crystallisation. In this work crystallisation trials were done with mVDAC1-variants 
incorporated in bicelles as previously described. [22] Bicelles are discs composed of lipids and 
detergents and are therefore suitable to increase the protein stability so that a single crystal 
can be obtained. Another very promising method is the crystallisation in lipidic-cubic-phases 
(LCP).[156] Here the proteins are incorporated in LCP and single crystals are growing on the 
surface of the LCP. The disadvantage here is the difficulty in picking and extracting the 
crystals from the LCP. 
The preparation of bicelles was mainly the same as for the incorporation of proteins into 
liposomes and was conducted as described by Sanders et al. [157] 10 mM CHAPSO and 10 
mM DMPC were dissolved in dH2O and mixed in a molar ratio of 1:2.8 mM 
(CHAPSO:DMPC). The clear bicelles-solution were mixed with four volume parts of 
refolded and purified protein-solution (c = 10 mg/mL) in SEC-buffer (10 mM Tris/HCl (pH 
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8.0), 100 mM NaCl, 0.05% LDAO) and incubated overnight at 10°C under mild shaking. The 
bicelles solution was mixed with nanoparticles and the pipetting to the sparse matrix screen 
was done by the Digilab Honeybee 963TM (Zinsser analytic). Crystals were obtained by 
vapour-diffusion using the sitting drop method.  
Crystallisation trials were performed with mVDAC1 and the oxidized mVDAC1-V3C-
K119C- C127A-C232A and mVDAC1-A14C-C127A-S193C-C232A variants. For all three 
variants a sparse matrix screen as well as a fine screen was performed. Accordingly, 2 mL of 
the crystallisation solutions were transferred to a 96-deep-well plate for automatically 
pipetting using the Digilab Honeybee 963TM (Zinser analytic). The device pipetted at first 
80 µL reservoir into the Innova plates (Hampton Research). Following, 300 nL reservoir and 
300 nL protein solution were mixed in the wells and the plates were sealed using VIEWsealTM 
(Greiner Bio-one). The plates were stored at either 18°C or 4°C as temperature affect crystal 
growth. The sparse matrix screens were performed using JCSG core suite I-IV, PACT, 
JCSG+, Classics, Cryos, MBC I-II AmSO4 and Anions suites (QIAGEN). The best hits were 
obtained using an optimisation screen as provided in table S1 (section 9.5). 
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4. Results 
 
4.1 Functional characterisation of mVDAC1 
 
Although VDACs were discovered in 1976 a detailed molecular characterisation was missing 
for the next three decades.[26] Early observations revealed VDACs as voltage responsive ion 
channels in 1989 by Colombini. He characterized VDAC as voltage dependent ion-channel 
which exhibits two different states, an open and a closed state.[158] VDAC exerts a weak anion 
preference in the open (P(Cl-)/P(K+): 1.7-1.9) and a strong cation preference in the closed 
states (P(K+)/P(Cl-): 2-8). Further observations showed that VDACs switch between a high 
conductance state at low voltages and several reduced conductance states at high voltages. A 
structural explanation for this behaviour was missing. In 2009, one year after the release of 
VDAC1´s crystal structure, the first model was proposed trying to explain this switching 
behaviour. In this model, Hiller and Wagner described the N-terminal α-helix located in the 
middle of the pore to be responsible for the observed switching.[33] The first part of this thesis 
is dealing with the elucidation of the switching mechanism though the crystal structures, as 
well as the switching mode, are still under debate. Most of the results shown in this chapter 
were already published in Mertins, Psakis, Grosse et al (2012).[99] 
 
4.1.1 Expression, refolding and purification of mVDAC-variants 
 
In this work all VDAC variants were expressed as inclusion bodies as described in chapter 
3.2.2.3. The used method was further optimized from the one used in my diploma thesis.[106] 
There are two ways to express and purify recombinant membrane proteins: a) produce 
membrane proteins in the membrane followed by a detergent-mediated extraction and b) or 
production as denatured proteins in the form of inclusion bodies, which can then be refolded 
in the presence of detergents or lipids. The expression of VDAC variants as inclusion bodies 
revealed yields of about 50 – 90 mg protein per litre medium. Refolding procedures of 
mVDAC1 variants were established before but still needed some optimisation.[106] 
Accordingly, an optimisation screen was performed to obtain efficient refolding conditions. 
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Figure 22: [99] Cysteine mutagenesis on mVDAC1 and cross-linking of the N-terminal segment to the barrel wall. 
(A) Cartoon representation of mVDAC1, based on the 3EMN structure [22], Location of the engineered cysteines 
and expected formation of disulphide bonds are shown as inlays. (B) 12% Coomassie-stained, non-reducing 
SDS-PAGE analysis of native and engineered mVDAC1 variants.  
 
Due to the disulphide-bond formation complete mVDAC1-CL-V3C-K119C and mVDAC1-
CL-A14C-S193C were used for analytical studies whereas the mVDAC1-CL-A2C-E121C 
variant could not be fully oxidized and was not further used (Figure 22B). For the latter the 
formation of the disulphide bridge may be structurally disfavoured. To get further proof of the 
intactness of the mVDAC1-CL-V3C-K119C and mVDAC1-CL-A14C-S193C disulphide 
bridges, peptide mass fingerprinting was performed. Here the oxidized A14C-S193C variant 
confirmed quantitative disulphide formation by detection of the S13-R15/T175-Y197 
fragment as shown in Figure 23. 
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Figure 23: [99] MALDI-MS tryptic peptide mass fingerprint of A14C-S193C-mVDAC1. Detected masses for the 
+3 and +2 ionization states are labelled (red and green) and are compared to the expected masses in the table 
below. Calculations were performed with the Peptide Mass Calculator v3.2. 
 
The peaks of the obtained chromatograms reveal the ionization profile of two cross-linked 
fragments for the 993.0-995.4 and 1489-1493 mass range (m/z) of the three- and twicefold 
ionized state respectively, confirming the quantitative oxidation of this variant. The 
corresponding fragment of the V3C-K119C variant could not be detected, most likely due to 
lack of sufficient ionization for ESI-MS analysis. 
 
Having confirmed the cross-linked mVDAC1-variants, functional analyse to elucidate the role 
of the N-terminal segment during switching could be performed.  
 
4.1.3 Electrophysiological (BLM) measurements of mVDAC1-variants 
 
To get information about the switching mechanism of mVDAC1 it was necessary to 
characterize at first the behaviour of unmodified mVDAC1. Although many different studies 
about mVDAC1´s switching characteristics were performed, no study explained in detail the 
observed behaviour. A high conductance state of ~ 4 nS was accepted to represent the open 
state (S0), whereas the low conductance state was defined by ~ 50% of the high conductance 
state. [22, 32, 35, 158, 160-162] By closer inspection of the previous reports the reduced conductance 
state can be apparently further divided to at least two substates, S1 and S2. Therefore, we 
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thoroughly characterised the electrophysiological features of mVDAC1 before heading to the 
next challenge, explaining its gating behaviour. 
 
In our studies, mVDAC1 responds linearly to the application of both positive and negative 
potentials, alternating between high and low conductance states (Figure 15B). In addition, the 
switching behaviour was characterized by its dwell times, i.e. the times where mVDAC1 stays 
arrested in one state before switching to another. Dwell times were calculated at an applied 
voltage of +30 mV and the analysis for the high conductance state (S0) revealed an average 
dwell time of 10.3 s. The channels´ conductances were determined by analysis of the 
corresponding Ohm plots (channel currents in response to voltages from -40 to +40 mV. The 
open state (S0) observed in a total of 680 measurements with a conductance of 
3.94 ± 0.04 nS, was consistent with previous reports, whereas the closed state could be 
assigned to at least two distinct states, unlike most previous reports (Table 24, section 5.1.2.1 
Figure 24A). The main question in this case was, whether the two closed states represent just 
one, as described in literature before, or truly two distinct states. Averaging both closed states 
resulted in a conductance of 2.34 ± 0.06 nS, significantly different to previously determined 
values (Table 24, section 5.1.2.1). By fitting the distribution of the low conductance states to a 
sum of two Gaussians (Figure 24A) we confirmed the existence of the two closed states, S1 
(66% of the open S0 state) and S2 (48% of the S0 state) (Figure 24A). Furthermore, it appears 
that the S2 state (0.8-2.2 nS) can be further subdivided to two additional substates (S2A and 
S2B) as proven by an additional double Gaussian fit (Figure 24A). Hence, the conductance of 
the closed conformation seems to be composed of at least three separate, low conducting 
states, S1, S2A and S2B (Table 19). This observation was strengthened by T-test analyses 
confirming a statistically significant difference between the observed states (P = 10-4).  
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instance, channel incorporation during positive potentials in the sample chamber resulted in a 
permanent open pore. By application of the reversed (negative) potential the mVDAC1 
variant switched to a low conductance state. Likewise, channel incorporation at negative 
potentials in the sample chamber resulted in an open pore until positive voltages were applied. 
It appears that the incorporation of the first channel is random as mVDAC1-CL-V3C-K119C 
channel closure was observed at positive and negative voltages in different series of 
measurements. Additionally, further channel incorporation followed the orientation of the first 
one, as proven by the gating profile observed in all measurements and in harmony with earlier 
observations [164-167]. Otherwise, a closing at both voltage signs would have been observed in 
all series of measurements if the incorporation of the second or third channel was random. 
Because of the observed asymmetry we gained confidence that the incorporation of more than 
one mVDAC1 is channel-assisted. 
 
Pre-reduction of the disulphide bond restored the native switching behaviour (Figure 28A). 
When analysing the dwell times of mVDAC1-CL-V3C-K119C an immense difference 
depending on the potential sign was observed. Accordingly, the dwell time of the initial 
potential was 7.85 s, comparable to the wild type, whereas the dwell times of the reversed 
potential was 78.5 s, significantly prolonged with respect to native mVDAC1 (Figure 28B). 
During switching the lowest closed state (1.77  0.09 nS) was similar to the S2 state of the 
native channel (n = 50) but the S1 state was avoided like in mVDAC1-CL-A14C-S193C 
(Table 19). Additional S0-to-S1 transitions occurred only in 5% of the events and were 
independent of S2.  
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4.1.5 Crystallisation trials 
 
Beside a functional analysis of mVDAC1, the 3D-structure should be characterized as well. 
Especially the structure of mVDAC1 variants used during BLM studies desired considerable 
interest. Unfortunately, it was not possible to solve the structure of mVDAC1 variants due to 
the poor diffraction quality of the obtained crystals. There were some promising 
crystallisation trials resulting in protein crystals with diffraction properties, which may be 
further optimised. The best results are provided in Table 20.  
 
Table 20: Results of the crystallisation trials on wild type mVDAC1 
 
Figure 32: X-ray scatter of an 
mVDAC1 crystal. Crystals were 
diffraction to 6-10 Å. 
 
The crystals shown in Table 20 were measured at the beam line ID 23-2 of the ESRF 
synchrotron source (Figure 32). The obtained crystals were very small and fragile. Therefore a 
proper handling during crystal harvest was very difficult. In addition, the best observed 
crystals were grown under alcoholic conditions making reproducibility difficult. Some of the 
crystals were diffracting to 6-10 Å, still low to solve mVDAC1´s structure.  
Screen Composition Picture 
Classics 4°C 0.2 M  
Calcium chloride 
0.1 M HEPES pH 7.5 
28% (w/v) PEG 400 
Core II 0.1M Tris pH 8.5 
20% (v/v) ethanol 
 
Core III 0.2M  
Tri-sodium-citrate 
0.1M HEPES pH 7.5 
10% (v/v) isopropanol  
Fine screen  0.1M HEPES pH 7.5 
0.2M MgCl2 
18% EtOH  
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4.2 Influence on VDAC by the pro-apoptotic effector Bid 
 
VDAC isoforms are able to mediate the traffic of <5 kDa metabolites through the outer 
mitochondrial membrane. Beside this feature mammalian VDAC isoforms have been 
identified as key players in apoptotic processes. Apoptosis is essential for all multicellular life 
and occurs because of either normal cell growth (intrinsic) or cell damage (extrinsic). In the 
intrinsic apoptotic pathway cellular stress factors cause activation of pro-apoptotic proteins 
which assembles in the outer mitochondrial membrane. The thereby induced rupture of the 
outer mitochondrial membrane releases apoptogenic factors like cytochrome c, AIF or 
Smac/DIABLO from the intermembrane space to the cytosol and causes finally cell death. 
VDACs have been identified to interact directly with a variety of pro- and anti-apoptotic 
factors, either members of the Bcl-2 protein family such as Bcl-xL [168, 169], Bid/tBid[170], 
Bax/Bak, [171] and hexokinases [172], or Bnip3 [173]. The precise molecular functions and 
stoichiometries of these VDAC/apoptotic factor complexes are poorly understood, although 
structural predictions for several VDAC/effector complexes have been suggested [174].  
This section is focussing on the structural and functional behaviour of VDAC1 and VDAC2 
in the presence of the activated pro-apoptotic effector protein tBid. tBid is the caspase 8 
truncated and thereby activated form of Bid. Dr Sina Oppermann demonstrated in cell line 
experiments, that the presence of VDAC1 is necessary for the glutamate- and tBid-induced 
apoptosis in neuronal cell lines (Figure 33).[20] The main question was, whether a direct 
interaction of both proteins occurs during the apoptotic process or whether these results relate 
to another cellular pathway.  
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OCD analyses of mVDAC1 in DMPC vesicles revealed that mVDAC1 is incorporated and 
preferentially orientated in the bilayer. When comparing the maximum and minimum of the 
OCD spectrum one can determine the orientation of the β-strands towards the membrane. If 
the max:min relation is about 1:1, all β-strands will align parallel to the membrane.[59] 
Another mark for the orientation of β-strands is the signal at 205 nm. If the signal is solely 
positive, a high max:min relation will occur and therefore a β-strand orientation vertical to the 
membrane can be predicted. To determine the orientation of α-helices towards the membrane 
the signal at 208 nm can be analysed.[184] Positive signals at 208 nm indicates that the α-
helices are vertical to the membrane whereas a strong negative signal indicates a parallel 
orientation of the α-helices relative to the membrane plane.  
 
The max:min relation of the mVDAC1 CD spectra reveals a value of 2,6/0,98 = 2,65 
indicating a tilt of the β-strands in the liposomes. In the oriented liposomes the strands seem 
to be even more tilted indicated by a max:min relation of 7,09/2,2 = 3,22 (Figure 45A) . The 
mVDAC1-tBid complex was analysed in OCD in the same manner than in CD spectroscopy 
by comparing the recorded and predicted spectra. OCD analyses of the 1:1 mVDAC1:tBid-
complex revealed no significant change in the max:min relation and in consequence no 
change upon the orientation of the complex in the membrane (max:min = 3.4) Contrary, the 
analyses of the 1:2 molar ratio mVDAC1-tBid complex showed a clear reorientation in the 
membrane ( max:min = 2.58). Because the relation after tBid addition is closer to 1 one may 
conclude that the β-strands are more tilted (Figure 45B). The difference-spectrum of the 1:2 
mVDAC1-tBid complex reveals a random coil-like structure, suggesting a partial unfolding 
upon tBid binding. In addition the signal at 208 nm indicates that one α-helix inserts into the 
membrane in a vertical manner (Figure 45C). 
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Table 22: Labelling efficiency of the mVDAC1-variants used for EPR measurements. 
No. mVDAC1-variant 
(cysteineless) 
Position of the label in 
mVDAC1 
Distance Label 
efficiency % 
1 mVDAC1-K12C helix -- 46 
2 mVDAC1-E59C helix -- 109 
3 mVDAC1-K32C helix -- 28 
4 mVDAC1-K12C-D30C helix 17.9 220 
5 mVDAC1-K12C-K32C helix 17.6 150 
6 mVDAC1-K12C-S57CC helix 19.6 140 
7 mVDAC1-K12C-E59C helix 18.8 170 
8 mVDAC1-E88C-K119C IMS 8.3 Å 81 
9 mVDAC1-E36C-D176C IMS 23.4 Å 93 
10 mVDAC1-E59C-S193C middle of the pore 29.4 Å 24 
11 mVDAC1-K28C-Q154C middle of the pore 30.6 Å 107 
12 mVDAC1-D78C-N214C cytosolic side 35.9 Å 94 
13 mVDAC1-A134C-D264C cytosolic side 39.5 Å 14 
 
At first, cw and DEER measurements were performed without the addition of tBid to map the 
initial state of mVDAC1 in detergent micelles. For this, 10 double-cysteine mVDAC1-
variants and 3 single-cysteine mVDAC1-variants were analysed (Figure 47). Comparison of 
the measured and calculated distance distributions shows reasonable agreement, indicating 
that the crystal structure appropriately reflects the structure of the protein in LDAO micelles. 
Interestingly, the deviations between theory and experiment suggest a slightly different and 
mainly more flexible arrangement of the α-helix relative to the β-barrel.  
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Beside cw measurements the distance distributions of the spin labels in all mVDAC1-variants 
were determined. The measurements were performed with and without the addition of tBid to 
gather information about the structural rearrangement in mVDAC1. DEER analyses of the 
mVDAC1-variants for the α-helix involvement revealed that the helix becomes less flexible 
upon tBid binding as indicated by the form factor of the DEER measurements (Figure 50). 
For example, mVDAC1-K12C-E59C shows a broad distance distribution of the labelled 
positions. After tBid addition distances over 1.7 nm disappear, suggesting that the α-helix 
becomes less flexible.  
  
102 
4. Results 
 
  4. Results 
 
103 
Figure 50: DEER analyses of mVDAC1-variants (c= 80 µM) that were used for the elucidation of mVDAC1´s α-
helix involvement in tBid interaction before and after tBid (160 µM) addition. DEER measurements were 
accomplished at X-band frequencies (9.3-9.4 GHz) with a BrukerElexsys 580 spectrometer equipped with a 
Bruker Flexline split-ring resonator ER 4118XMS3 and a continuous flow helium cryostat ESR900 (Oxford 
Instruments) controlled by an Oxford Intelligent temperature controller ITC 503S for 24-36h. Left panels: DEER 
form factor (background-corrected dipolar evolution data) and fit (dashed line) before (black) and after (red) tBid 
addition. Middle panels: DEER distance distribution before (black) and after (red) tBid addition and theoretical 
distance distribution obtained by a Rotamer Library Analysis (RLA) (dashed lines) of the mVDAC1 crystal 
structure (pdb: 3EMN). Right panels: Validation of the DEER-analysis. Uncertainties in the distance 
distributions arise from (i) noise, and (ii) insufficient background correction. The reliability of the distance 
distributions is tested by systematic variation of the background. Grey shaded areas in the validation plots 
represent contributions in the distance distribution that depend on the background correction. 
 
The remaining six double-cysteine mVDAC1-variants 7-13 (Table 22) for analysing the 
influence of tBid on the β-barrel structure were characterised by DEER measurements using 
the same setup. In accordance to the cw measurements, an influence on the form factor is 
observed when tBid binds to variants, where the spin-labels were attached to the cytosolic 
side or located in the middle of the pore. The variants, where the spin labels are located in the 
IMS, appear to be not affected in their overall structure (Figure 51). Basically, the influence 
on the β-barrel is not significant so that it can be postulated, that the overall β-barrel structure 
remains unchanged. 
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indicated by the change in cw and DEER signals. In addition, the helix is less flexible after 
tBid binding corroborating the previously postulated interaction. In agreement with previous 
results, the binding side seems to be at the cytosolic side of mVDAC1 as indicated by cw and 
DEER measurements of the mVDAC1-β-barrel variants. Beside this, DEER measurements of 
the single-cysteine variants indicate a tendency of mVDAC1 for oligomerisation. After tBid 
addition the oligomerisation becomes disrupted, although further experiments have to be 
done. 
4.3 A minimal porin reveals loop-independent channel 
closure 
 
Beside VDAC1 as exceptional porin because of a) the presence of an N-terminal α-helix and 
b) the odd β-strand number, an engineered minimal porin (EMP) was analysed in terms of 
gating characteristics and structure stability. Porins, like the outer membrane protein G 
(OmpG) of Escherichia coli, are ideal templates amongst ion channels for protein and 
chemical engineering due to their robustness and simple architecture. Though OmpG shows 
fast transitions between open and closed states, which were attributed to loop 6 (L6), it tends 
to be not an optimal template. Therefore, EMP was engineered with all remaining extra 
membranous loops being truncated to provide a stable pore as ideal template for further ion-
channel-engineering. Most of the results shown in this chapter were published in Grosse, 
Psakis, Mertins et al (2014).[59] 
 
4.3.1 Expression, refolding and purification of the minimal porin 
 
The minimal porin was overproduced as inclusion bodies analogous to mVDAC1, yielding 
80 – 150 mg EMP per litre medium. Following cell disruption, the inclusion bodies were 
washed as previously described and a refolding screen was performed to determine the 
optimal refolding conditions. Accordingly, different detergents and refolding aids were tested 
in a two-step rapid dilution procedure similar to mVDAC1 (section 4.1.1). Supernatants were 
treated with acetone and the pellets were analysed by 12% SDS-PAGE (Figure 53).  
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Another difference to OmpG is the stronger tendency of monomeric EMP to aggregate at high 
temperatures as indicated by the ~60% reduced intensity of the CD spectrum after thermal 
unfolding and cooling. This mild protein aggregation is strengthened by the observation of 
increased high voltage/dynode signals of the spectrometer´s photomultiplier during heating as 
well (particle-generated light scattering) (Figure 59). Nevertheless, EMP is a highly robust 
porin as it can be stored over weeks at 4 °C without apparent aggregation.  
 
 
 
Figure 59: (adapted from [59]) Heat denaturation profile of EMP (0.03 mg/ml) in LDAO (0.05%, v/v) (open circles). 
The dynode voltage signal (HT, solid black line) increases following the gradual denaturation of EMP, as a result 
of aggregate-generated scattering. The HT signal reaches its maximum at 80 °C. Then, following a short 
decrease, indicative of partial protein precipitation, the voltage rises again until 90 °C is reached. 
 
OCD analyses of EMP in DMPC vesicles (Figure 60) revealed that EMP is changing its 
orientation when inserted in bilayers below (20 °C) and above (35 °C) the lipid-phase 
transition temperature. Below the transition phase, the DMPC membrane is thicker and 
therefore EMP incorporates as expected in a tilted manner as indicated by the strong positive 
band at 190 nm. Interestingly, above the phase transition EMP seems to be even more tilted as 
indicated by the drop of the 190 nm band. This is not further surprising though the membrane 
is thinner and therefore EMP cannot incorporate in an upright manner. In addition the 
negative band at 218 nm is significantly increased. Therefore, and as mentioned for 
mVDAC1, the max:min relation is closer to 1, indicating that the β-strands are more tilted. 
These OCD results demonstrate clearly that EMP is sensitive to bilayer thickness. 
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Figure 60: (adapted from [59]) OCD spectra of OmpG, ΔL6I variant and EMP in DMPC; OCD spectra were recorded 
using a J-810 or J-815 spectropolarimeter (Jasco). For reduction of artefacts, three spectra were recorded for 
every 45o rotation of the cell around the beam axis. Grey arrows indicate directional changes in the EMP spectra. 
 
4.3.3 Electrophysiological properties of EMP 
 
In BLM measurements EMP channels showed 1.2-fold higher conductances (N = 38, P <10-3) 
compared to OmpG. Interestingly the EMP conductances were found in a range of 0.86 
±0.02 nS to 1.06 ±0.04 nS and dependent on pH and the type of lipids (Figure 61). For 
example, EMP showed higher conductances in DMPC than in asolectin and at pH 7.4 than at 
pH 5.0. EMP was thought to represent a permanent open pore as all essential parts for OmpG 
gating were removed. Surprisingly, distinct partly closed states of EMP were observed, where 
the pore suffered a 26-66% reduction of conductance relative to the open state. As mentioned 
above, switching to these closed states was pH- and lipid-dependent. In detail, in asolectin at 
pH 7.4, EMP channels achieved only two partly closed states with conductances of 
0.64 ±0.02 nS (S1: N = 19) and 0.38 ±0.01 nS (S2: N = 9). At pH 5.0, an open state 
(S0: 0.92 ±0.03 nS, N = 19) and two partly closed states (S1: 0.47 ±0.02 nS, N = 23; 
S2: 0.24 ±0.02 nS, N = 11) were observed. The same conductances for open and closed states 
were observed in DPhPC indicating a strong pH and a minor lipid influence on EMP. In 
detail, in DPhPC and neutral pH EMP switched between the open (S0: 1.06 ±0.04 nS, N = 21) 
and two partly closed states (S1: 0.67 ±0.05 nS, N = 17; S2: 0.42 ±0.05 nS, N = 8). Again the 
conductance of EMP at acidic pH was reduced to 0.86 ±0.02 nS (S0, N = 35), 0.52 ±0.03 nS 
(S1, N = 24) and 0.28 ±0.02 nS (S2, N = 30), respectively (Figure 61). 
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Figure 62: (adapted from [59])  Influence of pH and type of lipid on gating characteristics of EMP. (A) Typical +80 mV 
single-channel recordings of EMP at pH 7.4 or pH 5.0 in asolectin and DPhPC, used for the generation of the 2D 
distribution plots in (B) 2D event-distribution plots of the switching behaviour of EMP. Distribution of events 
for 30 s of recorded time is plotted according to the current intensity I and dwell times. I (colour code on the 
right) is expressed as a percentage of the highest intensity Io. (C) Comparison of the gating behaviour of OmpG 
and EMP (Table S2). f and the Po of EMP are expressed as a percentage of OmpG. Bars denote standard errors 
of triplicate measurements, stars statistically significant differences (paired t-test: * P ≥ 0.069; ** P < 0.0232 and 
*** P ≤ 0.0067) with respect to EMP in DPhPC (pH 7.4) values. 
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5. Discussion 
 
5.1 VDACs are the most important porins of the outer 
mitochondrial membrane 
 
With about 10 000 copies per cell the voltage-dependent anion channels (VDACs) are the 
most abundant proteins of the mitochondrial outer membrane (OM).[26] VDACs can be found 
in three isoforms in metazoa and can occur in up to 11 isoforms in plants. Although all 
isoforms are thought to share the same overall structure, their specific functions remain 
unclear.  
VDACs are located in the outer mitochondrial membrane (OMM) and are known to be 
involved in mitochondrial processes such as ATP-, calcium or ROS-transport. Beside this, 
they were identified as key players of mitochondrial physiology such as being involved in the 
mitochondria-related apoptotic pathway. Accordingly, they are acting as docking platform for 
pro and anti-apoptotic proteins. Furthermore, VDACs were found to be involved in various 
diseases like Alzheimer, Down syndrome, cancer, stroke, and amylotrophic lateral sclerosis 
(reviewed in [29, 38]) (Figure 63). As crucial exchange pore in the OMM VDACs exhibit a high 
medical relevance as being potential pharmaceutical targets. Although the key players of 
apoptosis seem to be identified the exact mechanism remains largely unclear. For this, 
elucidation of VDACs´ involvement in apoptosis and related diseases has a high relevance. 
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Figure 63:[29] Schematic representation of VDAC1´s multiple functions and interactions with associated proteins 
or drugs. (A) Cellular processes in which VDAC is involved, illustrating its multifunctional properties. (B) 
Proteins interacting with VDAC include proteins involved in processes such as apoptosis, energy production and 
regulation, and structural proteins of the cytoskeleton. Some proteins are involved in more than one function. (C) 
Several drugs act via VDAC as either inductors or inhibitors of apoptosis. 
 
In the past years an increasing number of proteins have been identified to interact with 
VDACs. These proteins were found to be pro- or anti-apoptotic or even pro-survival as found 
in cancer cells. It is not yet proven whether all these interactions happen directly with a 
specific VDAC isoform or whether the nature of these interactions is unspecific towards 
VDACs. In addition, the structural modes of interaction remain elusive although structures for 
individual components are already available. 
 
By characterising VDAC1´s gating mechanism and defining its distinct interaction pattern 
with the pro-apoptotic protein tBid, I highlight the critical role for VDAC1 as a mitochondrial 
receptor. Accordingly, the VDAC1-tBid complex provides a major control point in neuronal 
demise. 
 
5.2 Gating mechanism in porins 
 
A major class of membrane proteins are the so called porins. These large channels are located 
in the outer membrane of gram negative bacteria (OmpG, OmpF, OmpA, OmpX),[42, 185] as 
well as mitochondria (VDACs).[158] or forms parts of microbial toxins that assemble on 
membranes to form oligomeric transmembrane channels (α-HL).[65] Apart from the VDACs 
with their 19-stranded β-barrels, all prokaryotic porins possess a β-barrel structure with an 
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even number of β-strands. As consequence of the odd-numbered strands of VDACs their N- 
and C-termini are both facing inside the mitochondrial inter-membrane space.[22] 
 
The switching between high and low conductances observed in transmembrane channels is 
called “gating”. This gating occurs because of a change in the transmembrane voltage and its 
mechanism is assumed to be basically the same in all porins. A link between the observed 
gating in patch clamp and lipid bilayer measurements and a physiological relevance is not 
proven yet but may mainly reflect the distinct conformational substates adoptable by porins. 
 
5.2.1 Voltage-responsive β-barrels: Small structural changes - 
large effects 
 
Porins are classified in high-specific (LamB, ScrY), low-specific (OmpF, OmpG, PhoE) as 
well as non-specific porins (OmpX, OmpA) due to the substrates, which are capable to pass 
these channels. Additionally, there are porins formed by the polypeptide chains of toxins 
(α-HL, TolC). Because of the increasing number of solved β-barrel structures this 
classification appears to be a bit archaic. A contemporary classification scheme may arrange 
the β-barrel porins according to their gating behaviour to demonstrate common and different 
features. 
 
One of the best studied porins is the trimeric outer membrane protein F (OmpF) (Figure 64). 
The overall structure of OmpF consists of three separate channels connected by a loop 
(loop 2, L2). The monomeric channels are constricted by an additional loop (loop 3, L3) 
located at the middle of the barrels.[47] Interestingly, L3 is built of a small helix, whereas loops 
of other porins are folded as random coil. OmpF adopts open or closed conformations, 
depending on the applied voltage. To explain the achievement of these states two 
fundamentally different mechanisms have been hypothesized. One of these mechanisms 
involves the movement of L3 restricting the diameter of the pore and thereby closing it.[186] 
The second mechanism focuses on a redistribution of charges in the channel resulting in 
closure of the pore.[187] Although a structural rearrangement of L3 seems to be the most 
obvious and easiest explanation of OmpF´s closure, this hypothesis turned out to be invalid. 
Prilipov et al demonstrated by deletion variants and mutations in the loop 3 that gating is not 
dramatically affected by L3.[187] Furthermore, multiple small rearrangements of fixed charges 
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5.2.2 The N-terminus as a crucial element of VDAC´s gating 
 
Among the class of -barrel transmembrane proteins, the VDAC-like porins represent one of 
27 known superfamilies [188] showing remarkable differences to all other -barrel 
transmembrane superfamilies. After their discovery, VDACs have been extensively studied in 
terms of their structural organisation and their gating mechanism. [26, 189] Before the elucidation 
of VDACs´ 3D-structure, various hypotheses about the gating were proposed for rationalising 
the known gating patterns. For example, it was proposed that VDAC achieves the different 
conductance states by a loop region, comparable to OmpG´s gating.[34] After publishing of the 
3D structures of mVDAC1 and hVDAC1 by three independent groups using either X-ray 
crystallography, solution-state NMR or a hybrid X-ray/NMR approach (Table 23) the 
formerly proposed mechanisms had to be rejected. VDAC1 is commonly described as a 19 β-
stranded pore - yet atypical for porins - with overall dimensions of 27 x 24 Å. As consequence 
of the odd numbers of β-strands β19 and β1 are aligning in a parallel way. [22, 25, 32] The N-
terminal part of VDAC is α-helical and aligns to the inner barrel wall [22] or at least localizes 
in the pore’s interior, constricting the channel to an inner diameter of 14 Å. [32] All these 
structures are assigned as the open state and contradict earlier models of a 13-16 stranded pore 
that implied loop dependent gating. [28] 
 
Table 23: X-ray and NMR structures of VDACs and special achievements.[190] 
 
 
Isoform Origin Method Resolution PDB code Reference 
VDAC1 mouse X-ray 2.3 Å 3EMN Ujwal et al (2008) 
VDAC1 human X-ray / NMR 4.1 Å 2JK4 Bayrhuber et al (2008)
VDAC1 human solution NMR rmsd: 3.6 Å 2K4T Hiller et al (2008) 
VDAC2 zebra fish X-ray 2.8 Å 4BUM Paz et al (2014) 
     
   Achievements  
VDAC1 human NMR/LDAO 
micelles 
direct interaction between 
VDAC1 and Bcl-xL 
Malia, Wagner (2007) 
VDAC1 human NMR/DMPC 
nanodiscs 
VDAC1 in nanodiscs 
adopts native fold 
Raschle et al (2009) 
VDAC2 human NMR/LDAO 
& DMPC 
nanodiscs 
sequence-specific 
resonance assignments 
Yu et al (2012) 
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The N-terminal region in the pores interior fuelled further debates about the gating 
mechanism of VDAC. [191, 192] VDACs, as other porins, are capable to switch between a high 
and several low conductance states, representing the open and closed channel, respectively. [7, 
22, 31, 158, 178, 193] NMR-spectroscopic analyses indicate that the N-terminal helix exhibits an 
increased mobility favouring it as a tentative regulatory part. [25, 33, 194] Brownian dynamics 
calculations and molecular dynamics simulations have revealed the dependence of the 
channel’s ion selectivity on salt concentration, with low salt concentrations favouring the 
gating of anions in the open state. [181, 182, 188, 195]  
Having in mind that porins gating is mostly achieved by loops the situation in VDACs is less 
straight-forward. First, no major loop appears to be a prominent candidate in occluding the 
channel, and secondly, although the N-terminal α helix appears position-wise to exert control 
on the flux of metabolites [196], latest NMR studies [197] revealed distinct mobility only for 
strands β2-β7. Here, the N-terminal helix appeared relatively rigid, raising doubts in its 
involvement in controlling gating transitions. 
Several studies suppose different types of conformational rearrangements to explain the 
complexity of the switching events. An early model by Hiller and Wagner suggested a 
movement of the N-terminal α-helix within the pore region.[33] In general, they propose two 
modes for channel closure. The first mode is based on movement of the whole N-terminal part 
(residues 1-20) from the wall to the middle, with the hinge region displaying flexibility. The 
second mode was explained by a twist/turn motion of only the helical stretch G11-K20 within 
the pore. The problem with the latter mechanism is its failure to explain the changing 
preferences of anions and cations in the open and closed state as demonstrated by in silico 
approaches of Choudary et al. [34]  
Choudary claimed a mechanism, where the helix moves out of the barrel to induce an electric 
field capable of accounting for the changing ion preferences. In addition several other groups 
provided evidence that the N-terminus may have just a local, stabilizing effect but is not the 
final cause for VDAC gating.[198, 199] As indicated by solid-state NMR, the -barrel mobility 
itself may be responsible for the switching.[198] This observation was strengthened by 
spectroscopic data from electron impedance and surface-enhanced infrared absorption, where 
the observed results were interpreted as a sign for an overall barrel deformation that correlates 
to the different closed states.[199]  
Furthermore, Teijido et al.[189] reported that the mVDAC1-L10C-C127A-A170C-C232A 
mutant displayed native-like channel activity under oxidative conditions, and concluded that 
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To address the N-terminus as crucial element for the gating mechanism a setup of different 
experiments was performed. Like previous BLM and patch-clamp measurements [22, 32, 35, 158, 
160-162, 188] reconstituted mVDAC1 exhibits a 3.94 ± 0.04 nS conductance in the open state 
(S0), whereas the average conductance of the closed state is 2.34 ± 0.06 nS, differing 
significantly (P = 10-4) from previously published values (Table 24). Usually, VDAC1 is 
described as having one open and multiple closed states, where the overall conductance of the 
closed state is 50% of the open state. By analysis of previously published data, it is obvious, 
that the closed state is not just suffering 50% reduction of the overall current but adopts 
multiple states ranging from 35-65% of the open state. Additionally, there were at least two 
previously recognized but not well defined major states (S1, S2) [201]. In our setup, we could 
define the two closed states exhibiting 60% and 40% conductance compared to the open state. 
Furthermore, the S2 state itself splits into two further sub-states, S2A and S2B, in a 2.4:1 
ratio. S2B exhibits a 1.52 ± 0.04 nS conductance almost the half of the S1 state. This precise 
description of the closed states is not only important to decipher the channels functionality but 
also to explain the switching mechanism of different VDAC variants with potentially subtle 
gating phenotypes. In addition, the overall flexibility of the N-terminus and the high variety of 
the closed states of VDAC could be an explanation, why VDAC interacts with a range of pro- 
and anti-apoptotic proteins by adopting structural substates. 
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Table 24: Conductance values for mVDAC1 variants following their reconstitution in planar lipids. Adapted from [99] 
Protein Reference 
Open  
State (nS) 
Closed state (nS) 
Salt 
composition
mVDAC1 Ujwal et al. [22] 3.70 ± 0.40a 1.70 ± 0.20a 
1 M KCl 
5 mM CaCl2 
mVDAC1 Abu-Hamad et al. [35] 4.00 ND 
Δ 1-26-mVDAC1 Abu-Hamad et al. [35] 4.00 - 
hVDAC1 Hiller et al.[32]  3.90 ± 1.50a ND 1 M KCl 
hVDAC1 
Shanmugavadivu et 
al. [162] 
4.50 ± 0.50a ND 1 M NaCl 
hVDAC1 Engelhardt et al. [160] ~ 5.00 2.00 
1 M KCl 
NcVDAC1 Popp et al. [161]  4.0 2.00 
rVDAC Colombini et al. [158] 4.50 ND 
ScVDAC Colombini et al. [158] 4.50 ND 
mVDAC1 
 
Mertins et al. [99] 
3.94 ± 0.04b (S0)
2.61 ± 0.01b(S1) 
1.90 ± 0.06b (S2) 
 
1 M KCl 
5 mM CaCl2 
Δ1-21mVDAC1-
Y22C 
4.00 ± 0.04b (S0)
- 
 
mVDAC1-
C127A-C232A 
3.78 ± 0.09b (S0)
2.50 ± 0.12b (S1) 
1.78 ± 0.09b(S2) 
mVDAC1-CL-
A14C- S193C 
(oxidized) 
3.74 ± 0.05b 
(S0) 
1.85 ± 0.07b(S2) 
low probability 
mVDAC1-A14C- 
C127A- S193C -
C232A (reduced) 
3.70 ± 0.01b 
(S0) 
1.95 ± 0.08b (S1) 
1.67 ± 0.09b (S2) 
mVDAC1-CL-
V3C-K119C 
(oxidized) 
3.28 ± 0.04b 
(S0) 
1.77 ± 0.09b 
(S2) 
mVDAC1-V3C-
K119C- C127A-
C232A (reduced) 
3.98 ± 0.04b 
(S0) 
~2.70 (S1) 
2.05 ± 0.13b 
(S2) 
a values given with their standard deviations; b values given with their standard error; ND, not 
determined. 
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In mVDAC1-A14C-S193C the hinge region remains free and is therefore able to undergo 
conformational changes that could cause the channel's closure. 
Surprisingly, the oxidized and subsequently reconstituted mVDAC1-V3C-K119C variant, 
exhibits an asymmetric gating characteristics. It conducts in the open state at both negative 
and positive potentials, and closes only upon application of a reversed potential. Furthermore, 
the transitions between open and closed states were mediated via a series of substates 
(Figure 69). This behaviour was never described before for a VDAC variant. The final closed 
state of mVDAC1-V3C-K119C was comparable to wild type´s S2 state (Table 24, Figure 68).  
 
 
Figure 69: [99] CuX2Ph pre-treated and subsequently reconstituted V3C-K119C-mVDAC1 conducted in the open 
state upon application of both negative and positive potentials (e.g. −40 mV) but closed only at one set of 
potentials (e.g. +40 mV), depending on its orientation in the lipid layer. As indicated in the corresponding traces 
(one step closing, two-step opening) and the adjacent cartoons, the gating behaviour was dynamic in both 
directions, and was probably mediated by a series of short-lived intermediates. The probable movement of the 5–
14 residue part is sketched (dashed blue ellipticity). Cross-linking at the base of the channel is designated –S-S-. 
Polarity of the membrane is indicated.  
 
The open-to-closed state transitions of mVDAC1-V3C-K119C occur slower than in the wild 
type, extending the dwell time of the cross-linked channel in the open state to 78.6 s. As the 
switching activity surprisingly lacks the expected symmetrical behaviour of the native channel 
one can postulate that only one direction of the applied electric field relative to the membrane-
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embedded VDAC porin destabilizes its fixed helix. Furthermore, the behaviour of this 
channel upon potential reversal suggests that the residue 4-26 stretch is still capable to 
undergo structural reorganizations allowing for slower S0-to-S2 transitions.  
Taken together, the results of the cross-linked VDAC1-variants demonstrate the importance 
of the flexibility of the N-terminus. Affixing of residue 14 to the barrel wall locks the pore in 
an open state and tends to be more effective than affixing residue 3. Switching was not 
completely blocked for both variants probably because of an incomplete oxidation of these 
variants or a higher flexibility of the N-terminus as previously assumed. BLM findings for 
both variants were providing new phenotypes for gating, suggesting that the full flexibility of 
the N-terminal fragment is required for achieving transitions to and/or from the S1 state, and 
that S0-to-S2 can occur independently of S0-to-S1 transitions, probably via meta-stable 
intermediates of an alternative route (Figure 70).  
 
Figure 70:[99] Cross section of a 3D-model of mVDAC1, based on the 3EMN structure, parallel to the membrane 
plane. Cross-linking at the base and midpoint of the pore is indicated (yellow circled asterisk). Possible dynamic 
movements of the α-helix and the 1-4 residue N-terminal part are described for the two cross-linked mutants 
relative to the native channel. Arrows indicate possible directions of movement.  
As mentioned above, Teijido et al [189] reported that the mVDAC1-L10C-C127A-A170C-
C232A mutant displayed native-like channel activity under oxidative conditions, and 
concluded that voltage gating did not involve and/or require rearrangements of the covalently 
linked N-terminal fragment. Contrary to that, both our mVDAC1 double cysteine variants 
show distinct gating profiles under oxidative conditions, avoiding the S1 and relaxing only to 
the S2 state. The reasons for the observed behaviour of the mVDAC1-L10C-A170C variant 
can be manifold. For example, in situ oxidation as performed by Teijido et al [189] failed for all 
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of our mVDAC1 variants under the chosen BLM conditions. Only in vitro oxidation provided 
a complete oxidation as verified by ESI-MS. Furthermore, in all our variants the use of a 
charged N-terminal affinity tag for purification was refrained, to guarantee the absence of any 
side effects. As demonstrated by Weichbrodt [203] even a slightly prolonged N-terminus leads 
to a higher mobility of the very N-terminus and thus to flickering in BLM measurement. The 
characterisation of a VDAC1 variant with such a prolonged N-terminus (RGS) revealed 
accordingly a new gating phenotype.  
 
5.2.2.3 A model for mVDAC1 closure involving local unfolding/refolding events 
Based on the results, a model of VDACs closure mediated by the concurrence of 1) a flipping 
motion of the far N-terminal part into the middle of the channel and 2) a local 
unfolding/refolding event of the α-helix can be proposed (Figure 71). Compared to the 
literature it is obvious that this model can explain both, the ion selectivity and the observed 
substates. The closure of the cross-linked VDAC variants could be explained by another 
model based on the flexibility of the N-terminus. Here, the closure is mediated by mechanical 
strain effects, stemming from the movement of the hinge region, which can further induce 
either a) the structural collapse of the barrel wall b) the irreversible unfolding of the N-
terminal helix or c) a combination of the two. All scenarios could result in permanent channel 
closure as observed for the oxidized mutant.  
In conclusion, I have demonstrated that conformational restriction of the N-terminal α-helix 
dynamics strongly affects the gating characteristics of mVDAC1. Therefore, the question has 
to be addressed whether the substates and the observed flexibility can be linked to a biological 
relevance. It is known that VDACs are capable to interact with a plethora of different 
effectors and therefore it is highly plausible that the different substates relate to the achievable 
states after effector binding (Figure 71). Surely, and as suggested by molecular dynamics 
simulations, [34, 197] the N-terminal segment is not the only determinant of the channel’s 
activity and selectivity, but it plays, however, an essential part, supported undoubtedly by the 
structural plasticity of the barrel wall.  
  5. Discussion 
 
130 
 
Figure 71:[99] Native channel voltage gating involves concurrent movement of the very N-terminal part into the 
pore and induction of channel narrowing by partial wall collapse. In the open S0 state, the helix is located at the 
mid-point of the pore with the far N-terminus facing the IMS. Switching to the S1 closed state is initiated upon 
movement of the far N-terminus into the pore and corroborating movements of the pore’s wall. Oxidized mutants 
(yellow circled asterisk) become immobilized in an S2A state, exhibiting restricted N-terminal fragment 
flexibility and impeded barrel wall movement. In the S2B state movements of both the barrel wall and the N-
terminus are most complete. Effectors could control S1S2 transitions enabling or prohibiting interactions with 
substrates thus regulating apoptotic responses. Note that transitions to the S2 state can be S1-independent. 
 
5.2.2.4 Gating behaviour of VDAC2s - the involvement of salt bridges and 
cysteines 
 
VDAC2 is highly homologous to VDAC1 (sequence identity 71 %) and hence shares a 
common overall structure (Figure 72). Therefore, the same gating mechanism was assumed. 
Recently, the 3D crystal structure of VDAC2 from zebra fish was published showing the same 
overall structure as mVDAC1 and hVDAC1.[204] As VDACs were initially numbered 
according to the order of their discovery, a comparison of isoforms from different species can 
be however misleading. While structural predictions of β-strands in the transmembrane -
barrel proteins are generally difficult, a classification upon VDACs N-terminal sequence 
seems to be more rewarding.[190] VDACs’ N-termini vary in length between different 
isoforms, e.g. human VDAC2 has a prolonged N-terminus compared to hVDAC1. The N-
terminus of VDAC2 from zebra fish is shorter than hVDAC2 and therefore more comparable 
to hVDAC1. 
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from the observed values in VDAC1. Apparently VDAC2 is permanently impaired in term of 
conductance under these conditions although small transitions were observed. Interestingly, at 
pH 6.2 the channel restores a conductivity of 3.48 nS similar to VDAC1, although the closed 
state adopts still very low conductances of ~ 18% (0.63 nS). Having in mind how VDAC2 
was prepared for BLM it is obvious, that this pH dependent gating behaviour is reversible. 
First, VDAC2 was refolded at pH 6.0, then the pH was raised to 8.5 for purification and 
finally, the pH was lowered again only during BLM measurements. Therefore, a denaturation 
of the VDAC2 structure during preparation can be excluded.  
 
The effect of the strong pH dependency of VDAC2 is known from other β-barrels. OmpG is 
described to close not only by voltage application but also as a result of a pH shift.[56] At 
acidic pH loop 6 folds into the pore and thereby closes the whole channel as observed in 
electrophysiological measurements. The structural rearrangement of OmpG was also 
described by X-ray crystallography, where loop 6 was found to pleat into the pore.[45] 
Furthermore, pH-dependent closing was observed for OmpF where large extracellular loops 
fold into the channel at low pH or high voltages.[208] Another example for a strong pH 
dependency is the Bcl-2 family protein BAX.[209] BAX exhibits a conductance of 0.731 nS at 
pH 4.0, whereas the overall conductance drops to 0.329 nS when being shifted to pH 7.0. 
Especially this protein family is quite interesting when discussing pH-dependence of VDAC 
as many members of the family interact directly with VDACs. Therefore, a physiological 
regulatory effect of presumably all VDACs can be postulated upon pH changes.  
 
In all given examples, pH-dependency is explained by a structural rearrangement of specific 
parts of the protein. Following this, the dominant structural rearrangement in VDAC2 upon 
pH shift has to be addressed. The most obvious structure in VDACs is the N-terminal α-helix 
that forms a dominant part for switching. Therefore, this region could be involved in 
structural rearrangements as consequence of a pH shift. Clearly, when discussing pH shifts 
existing salt bridges in the protein are influenced as well. In the crystal structure of VDAC1 
(pdb: 3EMN) highly conserved salt bridges are observed between the positions K12-D16-
K20. Recent studies on VDAC1 from rat liver, reported a pH dependency on VDAC1´s 
characteristics in lipid bilayer recordings.[210] Tejiido et al described an increased anion 
selectivity at acidic pH in combination with faster channel transitions. Furthermore, an 
influence on the existing salt bridges by pH shift was discussed. As indicated by MD 
simulations, alternating forming salt bridges at low pHs may explain the faster transitions, 
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differences when the bilayer thickness changed upon going from the gel phase (20 °C) to the 
thinner liquid crystalline phase (35 °C) assuming that EMP reacts sensitive to the bilayer 
thickness. The change as visible by OCD can be interpreted in terms of an increased tilt angle 
of the -strands in response to a compression by the bilayer. Most likely this sensitivity is 
caused by the very short β-turns instead of the loops present in EMP´s template OmpG. 
Therefore, it might be that the pore interacts with lipidic head groups resulting in a 
membrane-sensitive barrel. The observed increase of the tilt angle in lipid-bilayers is a 
phenomenon well known from other proteins. For example, helical membrane proteins were 
found to increase their tilt as response to membrane thickness. [216, 217] Until now, OCD in 
combination with solid phase NMR was used to identify mostly -helical transmembrane 
elements such as the oncogenic E5 protein [145], the platelet derived growth factor receptor [218] 
and channel-forming peptides. [144, 219, 220] Therefore, this work provides a first example for the 
analysis of β-barrels with oriented CD measurements giving hints upon β-strand tilts in 
combination with biophysics to enhance the understanding on membrane protein dynamics. 
Only recently, Ruskamo et al described also an example for a -barrel protein whose 
orientation was characterised by OCD spectroscopy.[221] 
 
To address the gating characteristics of EMP, BLM measurements in different lipidic 
environments and two pH values were performed. As mentioned above porins exhibit gating 
mostly by the movement of flexible loops folding into the pore. Surprisingly, the loop-
depleted EMP exhibits strong gating, though the only element still capable of closing the pore 
is the β-barrel itself. EMP channels were highly conductive with an open state in the range of 
0.86 ± 0.02 – 1.06 ± 0.04 nS with two sub-conducting states (S1: 0.64 ±0.02 nS and 
S2: 0.38 ± 0.01 nS) comparable to the substates found in VDAC. In the less compact and 
charged asolectin at pH 7.4 EMP showed a 16.5% Po with a 5-fold lower frequency of 
transitions than OmpG. In zwitterionic DPhPC EMP showed a 46% Po and a 3-fold lower 
frequency in comparison to OmpG. At acidic conditions this behaviour is inverted, and EMP 
appears to have a higher Po, albeit fewer transitions. The corresponding Ohm plots yield a 
high- and a low-conducting state at acidic pH in asolectin and DPhPC bilayers, respectively. 
Interestingly, EMP’s current traces show remarkable similarities to current blockades 
resulting from modulators like polyethylene glycols [222] or polypeptide loops in α-HL.[223]  
Nevertheless, how EMP achieves its two distinct closed states is still elusive. OCD 
experiments suggest a -strand tilt during insertion into bilayers. It is improbable if the two 
distinct close states can be explained by a tilt of the β-strands as a deletion of two β-strands of 
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human VDAC1 [224] lead to a 2- and 3.5-fold reduction in conductance whereas the smaller 
EMP only exhibited a 1.5- to 2-fold difference in conductance, depending on pH and lipid 
composition. Therefore, a gating by the restriction of the pore size alone can be excluded. 
Apart from an ejection of a -turn substructure from the 16-stranded β-barrel, only a semi-
collapsed, ellipsoidal EMP may be suitable to explain the closing events at 35 °C and at pH 
7.4. Furthermore, and as mentioned above, not only loops can be responsible for switching 
events but salt bridges as well. Keeping in mind that strong lipid and pH dependences are 
found, EMP may follow a salt-bridge induced switching more comparable to OmpA´s gating 
then to parental OmpG´s. The interior of the pore shows a charge distribution so that various 
salt bridges between positive and negative charged amino acids can be adopted. 
Reorganisation of these interactions could enforce structural changes in the barrel, accounting 
for further reduction of the open probability at pH 5.0. Lowering the pH allows the barrel to 
acquire a more stretched conformation, due to a shift in the asolectin lipid-phase transition to 
higher temperatures, or due to the formation of stabilising electrostatic interactions 
(Figure 76). 
 
 
Figure 76:[59] Hypothetical model on the elastic movements of the EMP barrel. In the gel phase of DMPC 
(20 °C), the height of the β-barrel matches the thickness of the bilayer. At 35 °C, where the liquid crystalline 
membrane is thinner, the pore becomes compressed (red arrow) and the β-strands acquire a more tilted structure. 
In response to the membrane charge and fluidity, EMP shows inverted gating behaviour in DPhPC and asolectin 
at pH 7.4 and pH 5.0. 
 
Taken together, EMP and its characteristics may serve as a model system to resolve general 
issues of porins in terms of folding, gating behaviour and the role of structural and functional 
dynamics. 
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members of the B-cell lymphoma-2 (Bcl-2) family, such as Bcl-2-associated protein X (Bax) 
and Bcl-2 homologous antagonist killer (Bak) as well as Bcl-2 homology domain 3 (BH3)-
only proteins, such as Bid or Bcl-2 like protein 11 (Bim), that directly activate Bax or Bak.[226-
228] However, the precise mechanisms how Bcl-2 family proteins initiate the apoptotic cascade 
is still not fully understood. As a model, it was proposed that VDACs are directly involved in 
in the apoptotic cascade by providing a proteinaceous docking platform for either members of 
the Bcl-2 protein family such as Bcl-xL [168, 169], Bid/tBid [170], Bax/Bak [171] or Bnip3 [173] as 
well as hexokinases. [172] 
 
In this work, I focused on the pro-apoptotic VDAC-effector Bid/tBid. Recent studies imply 
that Bid is a key player in neuronal cell death pathways. Accordingly, Bid seems to promote 
mitochondrial demise by release of death promoting proteins in the cytosol and the 
acceleration of oxidative stress.[229-233] Furthermore, Bid-deficient neurons are highly resistant 
to cell death stimuli including oxygen-glucose deprivation (OGD) and glutamate-induced 
excitotoxicity in vitro[231, 234] and show reduced damage after cerebral ischemia and brain 
trauma in vivo.[234-236] Recent studies revealed that inhibition of Bid by small-molecules as 
well as Bid gene silencing using small interfering RNA (siRNA) is suitable for 
neuroprotection by averting mitochondrial dysfunction and neuronal cell death.[229-232, 237] 
 
Thus, I address the question whether Bid or its active truncated form Bid (tBid) is interacting 
in a direct and specific manner with VDAC1. Although a close interplay between VDAC and 
Bid has been proposed,[170] a quantitative description of the electrophysiological and the 
structural effect of Bid/tBid on VDAC has not yet been demonstrated. Accordingly, I provide 
new insights of the intrinsic cell death in neurons that might mirror the emerging non-
neuronal concepts of apoptosis. 
 
 
5.3.1 The VDAC1-tBid complex: insights to a neuronal cell death control 
point 
 
VDACs are able to interact with a plethora of pro- and anti-apoptotic proteins as well with 
small compounds as the VDAC inhibitor DIDS.[238] Although the interactions were 
phenomenologically analysed, the interaction patterns as well as the structures of these 
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complexes remain largely unclear. Recently, various structural models for VDAC2/apoptotic 
factor complexes have been proposed trying to define such interaction patterns (Figure 78). 
[174]  
 
 
Figure 78: Speculative models of VDAC2 in complexes with Bak, Bax, and tBid as analysed by molecular 
dynamics simulation and docking experiments, A Structural model of MOM-integrated VDAC2, B, C, D 
structural models of the VDAC2/Bak complex, D Bak integrates by helix 9 (red) into the membrane after 
VDAC2 binding; intermolecular polar contacts are shown as cyan (VDAC2) and orange (tBid) spheres E 
superimposition of Bax onto Bak in the best-scored VDAC2/Bak complex, F the best-scored complex 
VDAC2/Bax G Structural model of the complex VDAC2/Bak-tBid H structural model of the complex 
VDAC2/tBid; Intermolecular polar contacts are shown as blue (VDAC2) and magenta (tBid) spheres. [174] 
 
Beside these speculative models there were attempts to characterise VDAC1´s gating 
behaviour in the presence of effectors. As mentioned above, VDAC1 is adopting one high 
(referred to as open) and several low (referred to as closed) states. I quantified these closed 
states into at least three major states; S1, S2A and S2B (section 5.2.2). [99] It is still under 
debate, whether the variety of closed substates can be connected to a biological function in the 
effector response and thus to different output-signals in mitochondrial-related apoptosis. 
Accordingly, closed or partially-closed VDAC1 states can be induced by either high voltages 
or interaction with pro- and anti-apoptotic proteins. [38, 158, 168, 170, 207, 239, 240] Interestingly, both 
the anti-apoptotic protein Bcl-xL and the pro-apoptotic protein tBid similar promote channel 
closure.[168, 170] This is surprising, as prevention and induction of apoptosis should be subject 
to different input signals and may have distinct signatures in BLM measurements. A 
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quantification of the BLM data for channel closure was missing in these reports and thus it 
was not possible to connect the loss of conductivity to the observed S1, S2A and S2B 
substates  
 
In my work with the pro-apoptotic VDAC effector Bid/tBid I demonstrated not only a 
protein-protein interaction but quantified the tBid-induced closed state by BLM 
measurements and defined for the first time potential interaction patterns. I will discuss these 
findings in the next sections. 
 
5.3.1.1 VDAC1 and Bid/tBid are interacting in a direct manner undergoing 
structural changes 
 
The first hints for a stable and direct interaction of VDAC1 and Bid/tBid was gained by SEC 
and thermofluor measurements. In SEC a shift in the elution pattern was observed and 
SDS-PAGE analysis revealed the co-elution of VDAC1 and Bid/tBid. Surprisingly, the 
protein complex eluted later thus indicating that the hydrodynamic diameter was reduced 
compared to VDAC1. Apparently, the VDAC1 surrounding micelle became altered by 
effector-binding. Accordingly, the observed apparent molecular mass is explained by 
Bid/tBid-induced reduction of the VDAC1 surrounding micelle, thus generating the 
impression of a smaller VDAC1-Bid/tBid complex compared to VDAC1 alone. 
An additional hint to a stable VDAC1-Bid/tBid-complex was given by thermofluor 
measurements. Here the thermic analysis revealed a 12° C higher melting temperature of the 
VDAC1-Bid and a 17° C higher melting temperature of the VDAC1-tBid-complex compared 
to VDAC1 alone. Both SEC and thermofluor are providing first hints; not proving or 
excluding a direct interaction. 
 
These hints of a direct and stable interaction between VDAC1 and Bid/tBid could be 
corroborated by CD and OCD measurements. By CD analyses, I demonstrated that the 
structure of the VDAC1-tBid complex differs significantly from the structure of the isolated 
proteins. Interestingly, the observed structural effect only appeared in a molar ratio of 1:2 
(VDAC:tBid). Furthermore, OCD analyses indicate that the β-strands of VDAC1 rearrange 
upon tBid binding as calculations from the minimum maximum relation of the CD signal 
shows the β-strands more tilted in the membrane. The difference-spectrum of the calculated 
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and recorded mVDAC1-tBid complex reveals a random coil-like structure, suggesting a 
partial unfolding of at least one component. Additionally, the negative signal at 208 nm 
indicates that an α-helix inserts into the membrane in a vertical fashion.  
 
5.3.1.2 VDAC1´s gating is permanently affected by Bid/tBid binding 
 
In electrophysiological measurements such as BLM, VDAC1 shows unique gating 
characteristics including at least three major states; S1, S2A and S2B (section 5.2.2).[99] 
Although, an electrophysiological influence of tBid was demonstrated before,[170] a 
quantification of the BLM data for channel closure with respect to the previous observed S1, 
S2A and S2B states was missing. In my work I quantified for the first time the tBid-induced 
closed state by BLM measurements. 
 
The maximum conductivity of mVDAC1 was 3.94 nS in the open state and 2.61 and 1.90 nS 
in the closed state. After tBid addition the channel suffered a 23% reduction of the overall 
current leading to a permanent semi-closed pore with a conductivity of 3.05 nS. This 
semi-closed state is significantly different from the previously observed S1 and S2 states. 
Additionally, VDAC1 arrested in this semi-closed state and no transitions were observed after 
tBid binding. As we know from our previous reports on mVDAC1´s gating characteristics, the 
flexibility of the N-terminus is required for channel transitions.[99] Furthermore, these 
transitions are mandatory for VDAC1´s functionality. Accordingly, tBid is affecting 
VDAC1´s gating characteristics and leads to a permanent semi-closed pore. As a hypothesis, 
the N-terminus might be involved in the binding as a full flexibility of the N-terminus was 
required before to obtain the full set of closed channel substates. 
5.3.1.3 VDAC´s barrel is sufficient for Bid/tBid binding 
 
Following the BLM analyses of the VDAC1-tBid complex, I addressed the elucidation of a 
potential binding pattern. Because of VDAC´s particular structure there might be two 
potential areas that can be attacked by pro- or anti-apoptotic factors. The parallel β1 and β19 
strands close the barrel and hinder intrusion of the lipid phase into the pore interior. Hence β1 
is the shortest β-strand in the structure of VDAC1 it might represent an unstable site of 
VDAC´s barrel, i.e. a putative breaking point of barrel integrity which may be influenced by 
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structural changes at the N-terminus. Interestingly, the β1/β19 interface had been identified by 
mutational studies to be crucial for VDAC oligomerisation.[213] Furthermore, under apoptotic 
conditions the author reports a tendency of VDAC1 to form higher oligomers using a new 
dimer interface along the β16-strands. The other potential breaking point is the conserved 
membrane-facing acidic residue E73. It has been demonstrated that this residue is crucial for 
the interaction with the anti-apoptotic hexokinase I.[197] This interaction causes mainly the 
intrinsic structural plasticity of VDAC1 with its µsec–msec dynamics as shown by NMR-
spectroscopy.[241] Furthermore, it was demonstrated that E73 is important for the interaction 
with the anti-apoptotic Bcl-xL protein as well.[168]  
 
To define the crucial structural elements required for tBid binding, I performed 
thermophoresis and EPR measurements. In thermophoresis measurements, a clear preference 
of tBid for VDAC1 was found compared to the inactive Bid. tBid binds with a 52 fold higher 
affinity to VDAC1 (KD = 26.9 µM) than Bid (KD = 1.4 mM), thus demonstrating the high 
affinity of tBid towards the mitochondrial target VDAC1. Furthermore and to address an 
involvement of the N-terminus in tBid binding, thermophoresis analysis with N-terminal 
deletion VDAC1-variants were performed. Here I could clearly demonstrate that the N-
terminus is not required per se for tBid binding. In the deletion variant ∆26-mVDAC1 the 
whole N-terminus is deleted and only the VDAC1 barrel remains. Indeed, the affinity suffered 
only a 2.6 fold reduction where tBid still binds in a specific and direct manner. Surprisingly, 
the deletion variant ∆11-mVDAC1, where just half of the N-terminal helix remains, showed a 
14-fold increased affinity towards tBid binding as compared to full-length VDAC1 thus 
hinting to a supporting role of the N-terminus in effector binding. In addition, tBid binding to 
VDAC2 revealed a 3.4 weaker affinity compared to VDAC1. Accordingly, these results hint 
to a common binding pattern in VDAC1 and VDAC2, although VDAC1 most likely is the 
preferred target of tBid (see also Oppermann 2014 [20]). Overall, I demonstrated that the 
VDAC1 barrel is sufficient for tBid binding with the N-terminus exerting a supportive role. 
 
A more detailed view upon structural changes of VDAC upon tBid binding was gained by 
EPR-analysis. In accordance to the thermophoresis results, an influence on the flexibility of 
the β-barrel structure as well as the N-terminal α-helix was found. Interestingly, the 
N-terminus loses some of its flexibility after tBid binding, whereas the overall β-barrel 
structure just suffered small structural changes as indicated in the form factors of the DEER 
measurements. Especially, the cytosol-facing side of VDAC1 is influenced by tBid binding. 
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Furthermore, EPR-analysis revealed the existence of stable VDAC1 oligomers in 
LDAO-containing buffer. Surprisingly, these oligomers were disrupted as indicated by the 
disappearance of longer distances in the DEER measurements by tBid-binding.  
 
 
5.3.2 Hypothetical models for the VDAC1-tBid interaction 
 
In summary, my results clearly demonstrate that a) tBid interacts with mVDAC1 in a direct 
and specific manner, b) a reduction of the overall current is observed in BLM measurements, 
c) VDAC1 and tBid interact in a 1:2 molar ratio with a structural rearrangement, d) the 
formed VDAC1-tBid complex has an increased thermal stability and e) tBid binding might 
disrupt stable VDAC1 oligomers. To combine all these observations, three different models 
are put forward (Figure 79). 
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invasionmodel the reduced conductivity as well as the arrest in a semi-closed state can be 
explained. The model fails to explain the found stoichiometry and gives no hint to explain the 
thermophoresis results, where just VDAC´s barrel is essential for tBid binding.  
 
Model II is based on the structural predictions by Veresov and Davidovskii [242] Here tBid 
binds to the extramembranous, cytosolic periphery area VDAC1. Two tBid effectors crown 
VDAC1, so that the N-terminal helix is exposed to the pore´s surface. The helix provides 
more attainable interactions to enhance effector binding. This periphery-bindingmodel 
explains the reduced conductivity, the arrest in a semi-closed state by interaction with distinct 
parts of the N-terminus, the stoichiometry and the thermophoresis results, where dominant 
binding pattern exerted by the barrel alone. In addition it might give an explanation for the 
increased affinity of tBid towards ∆11-mVDAC1. Presumably, the promoting influence of the 
N-terminus as found in thermophoresis is located between residues 11-26 because these are 
the remaining residues in ∆11-mVDAC1. Because of the shortened N-terminus of this variant 
it could be that the remaining helix shows an increased flexibility as interactions between the 
very N-terminus and the barrel are deleted. This flexibility as well as the cytosolic-exposed 
remains of the N-terminus may lead to increased affinity. Nevertheless, this model fails to 
explain the disappearance of VDAC1 oligomers as observed in EPR measurements. 
 
Modell III rationalised the observed VDAC1 dimer-monomer-equilibrium change upon 
tBid-binding. As demonstrated by Geula et al [213] VDACs are able to form dimers in 
detergent- and lipid-containing buffer. These dimers are formed in the interface of the strands 
β1, β2 and β19, one of the weak areas in the VDAC1 structure. Interestingly, the 19 
architecture as well as the dimerization tendency reminds on other, structurally not yet 
characterized mitochondrial outer membrane proteins like the TOM40 component of the pre-
protein translocase.[243] Here, upon tBid binding the dimer interface is disrupted as a helix of 
tBid incorporates into the membrane. The recently published NMR structure of amphiphilic 
tBid reveals that only helices 3 and 5 have distinct membrane contacts whereas the others 
remain unaligned in relation to the membrane surface.[105] Nevertheless, an incorporation of a 
helix into the lipid bilayer cannot be excluded because several NOE signals are missing in the 
NMR structure. Accordingly, a helix of tBid may be involved in membrane anchoring as 
BLM measurements revealed the incorporation tendency of tBid or parts of it into lipid 
bilayers (Culmsee, unpublished data).The incorporation of helices into a membrane are 
known for pore-forming toxins such as the diphtheria and anthrax toxins.[244] A hint for the 
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incorporation of an α-helix of the tBid–VDAC1-complex is given by the OCD data, where a 
positive signal at 208 nm indicates the incorporation of an helix in an upright manner. As 
consequence of the VDAC1-dimer-disruption the VDAC1-tBid complex could be stabilized 
by higher oligomers. In accordance to Geula et al,[213] a tendency for VDAC1 for higher 
oligomers under apoptotic conditions can be assumed, where these oligomers are formed 
along the β16-strands and involve tBid as intervening component. Model III can explain the 
reduced conductivity, the arrest in a semi-closed state by constricting VDAC1 from the 
outside and thereby arresting the N-terminus, the stoichiometry, the thermophoresis results 
that the dominant binding pattern is found in the barrel and the disappearance of VDAC1 
oligomers. In addition, by constricting the pore it might be that the N-terminus is exposed to 
the barrels cytosolic surface thus exposing the previously discussed residues 11-26 generating 
the higher affinity of ∆11-mVDAC1 for tBid binding. 
 
Taken together, Model II and III are consistent with the obtained results. To decide between 
these two models, more experiments, including structural analyses have to be done to unveil 
the exact mechanism of pro-apoptotic binding. 
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6. Outlook 
 
In the past five years ~ 600 articles about VDACs have been published, highlighting the high 
impact of mitochondrial porins on biomedical and physiological aspects. Nevertheless, 
VDAC´s function and its certain role in mitochondrial-related apoptosis raises several 
questions. 
 
Although members of the VDAC family are clearly involved in the mitochondrial mediated 
apoptosis, the precise molecular mechanism is still elusive. It is known that in the intrinsic 
pathway cytochrome c is released from the IMS to the cytosol. Accordingly, there are now 
eight competing models, how cytochrome c (cyt c) is released and how VDAC is involved in 
this (Figure 79). Briefly, these models are described as a) rupture of the OMM and release of 
cyt c caused by osmotic matrix swelling as consequence of VDAC closure, b) cyt c release by 
the formation of a large permeability transition pore where VDAC is a part of it – this pore is 
formed as reply of ROS or Ca2+ overproduction, c) formation of Bax/Bak oligomers releasing 
cyt c after their activation of tBid, d) cyt c-release by Bax oligomers without the involvement 
of VDAC, e) formation of VDAC1 and Bax oligomers to release cyt c, f) release of cyt c by a 
supramolecular high-conductance channel (mitochondrial apoptosis-inducing channel), g) the 
release of cyt c by lipidic channels and g) VDAC homo-oligomers forming a cyt c releasing 
channel. By elucidation of the distinct mechanism of apoptosis it should be possible to find 
crucial control points and thereby better strategies to induce or prevent apoptosis.  
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Figure 79:[38] Schematic representation of proposed models for the release of cytochrome c from the IMS to the 
cytosol. a) rupture of the OMM by osmotic matrix swelling, b) formation of a large permeability transition pore 
(PTP), c) formation of Bax/Bak oligomers, d) by Bax oligomers, e) by VDAC1-Bax oligomers, f) 
supramolecular high-conductance channel (mitochondrial apoptosis-inducing channel) g) lipidic channels h) 
VDAC homo-oligomers. 
 
Once the mechanism of apoptosis and the involvement of VDAC are known, one may put 
more effort into the development of new pharmaceutical agents involving VDAC as target. 
Interestingly, many chemotherapeutical reagents act as mitochondrial-apoptosis inducers. 
These reagents act either indirectly with VDAC by the production of ROS 
(furanoaphthoquinones or erastin) or directly by interaction with VDAC (G3139 (oblimersen), 
floxetin (prozac), cis-platin or endostatin). Especially G3139 seems to be an interesting and 
rewarding lead for the VDAC targets. G3139 is an oligonucleotide that was developed to 
target initiation codons of Bcl-2 mRNA but interacts directly with VDAC and reduces its 
channel activity. Having this in mind other biocompatible reagents such as small peptides can 
be assumed to affect VDACs activity. If it becomes possible to trigger VDAC in a specific 
way, a huge influence on all mitochondria-related diseases can be assumed. 
 
Furthermore, I have demonstrated the relevance of direct VDAC-effector interactions. 
Although many VDAC effectors have been identified, the binding patterns or the overall 
structures of the VDAC1-effector complexes remain elusive. In future studies one has to 
focus to unravel the biochemical and structural basis for the VDAC-effector interactions and 
to understand how they modulate the channel’s gating characteristics. With this a deeper 
understanding in cell survival will be given. Clearly, satisfying answers about VDAC-effector 
complexes can only be given on the basis of crystal-structures.  
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While mVDAC1 and mVDAC3 share high sequence identity and are capable of signalling in 
similar ways, mVDAC2 appears to deviate from these two other isoforms because of its 
prolonged N-terminus, the presence of 11 internal cysteines, an antagonist function in 
apoptosis and the deviating gating characteristics when compared to VDAC1. Future studies 
highly will unravel the unique functions of VDAC2 with respect to the role of its prolonged 
N-terminus and the abundance of cysteines facing the IMS. 
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9. Appendix 
 
9.1 Abbreviations 
 
Å      angstrom 
A      ampere 
Amp     ampicillin 
APS     ammoniumperoxidisulfate 
AU      absorption units 
BLM     black-lipid-membrane 
bp     basepair 
CHAPSO  3-[(3-cholamidopropyl)-dimethylammonio]-2-hydroxy-
1-propanesulfonate 
CMC      critical micellar concentration 
Da     dalton 
dH2O (dest. H2O)    distilled water 
ddH2O(bidest.H2O)    double distilled water 
DMF      dimethylformamide 
DMPC     1,2-dimyristoyl-sn-glycero-3-phosphocholine 
DMSO    dimethyl sulfoxide 
DNA      desoxyribonucleic acid 
dNTPs     2’-desoxynucleotide 
DTT      dithiothreitol 
EDTA     ethylenediaminetetraacetic acid 
EPR     electron paramagnetic resonance 
EtOH      ethanol 
g      gram 
h     hour 
HPLC      high pressure liquid chromatography 
IB      inclusion bodies 
IEC     ion exchange chromatography 
IPTG     isopropyl-β-D-thiogalactopyranoside 
  
 
 
L      litre 
LDAO     lauryldimethylamine-N-oxide 
TOF      time of flight 
m      meter 
M      molar (mol/L) 
MCS      multiple cloning side 
min     minutes 
mVDAC     murine voltage dependent anion channel 
MWCO     molecular weight cut off 
NMR      nucleic magnetic resonance 
NaOAc     sodiumacetate 
OD      optical denisity 
OG      n-octyl-β-D-glucopyranoside 
Omp      outer membrane protein 
PCR      polymerase chain reaction 
rpm      rotations per minute 
RNA      ribonucleic acid 
RT      room temperature 
S      Siemens 
SDS      sodiumdodecylsulfate 
SDS-PAGE     sodiumdodecylsulfate poly-acrylamide gel   
     electrophoresis 
TCA      trichloroacetic acid 
TCEP      tris(2-carboxyethyl)phosphinhydrochloride 
TMEDA     tetramethylenethylenediamine 
Tris      tris(hydroxymethyl)-aminomethane 
UV      ultraviolett 
V      Volt 
  
 
 
9.2 Abbreviations of amino acids 
 
Amino acid Three letter code One letter code 
Alanin Ala A 
Arginin Arg R 
Asparagin Asn N 
Aspartat Asp D 
Cystein Cys C 
Glutamat Glu E 
Glutamin Gln Q 
Glycin Gly G 
Histidin His H 
Isoleucin Ile I 
Leucin Leu L 
Lysin Lys K 
Methionin Met M 
Phenylalanin Phe F 
Prolin Pro P 
Serin Ser S 
Threonin Thr T 
Tryptophan Trp W 
Tyrosin Tyr Y 
Valin Val V 
 
  
 
 
9.3 nucleotide and amino acid sequence of the used proteins 
 
mVDAC1 
 
nucleotide sequence: 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGCTGTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTCGACCCTGATGCCTGCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGL
ETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIK
TGYKREHINLGCDVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAVG
YKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQVD
PDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA 
 
  
 
 
mVDAC2 
 
nucleotide sequence: 
ATGGCCGAATGTTGTGTTCCGGTTTGTCCGCGTCCGATGTGTATTCCGCCTCCGTATGCAGATCTGGGTAAAGCA
GCACGTGATATTTTCAATAAAGGTTTTGGTTTCGGCCTGGTGAAACTGGATGTTAAAACCAAAAGCTGTAGCGGT
GTTGAATTTAGCACCAGCGGTAGCAGCAATACCGATACCGGTAAAGTTAGCGGCACCCTGGAAACCAAATACAAA
TGGTGTGAATATGGTCTGACCTTCACCGAAAAATGGAATACAGATAATACCCTGGGCACCGAAATTGCCATTGAA
GATCAGATTTGTCAGGGTCTGAAACTGACCTTTGATACCACCTTTAGCCCGAATACCGGCAAAAAAAGCGGTAAA
ATCAAAAGCGCCTATAAACGCGAATGCATTAATCTGGGTTGTGATGTGGATTTTGATTTCGCAGGTCCGGCAATT
CATGGTAGCGCAGTTTTTGGTTATGAAGGTTGGCTGGCAGGTTATCAGATGACATTTGATAGCGCAAAAAGCAAA
CTGACCCGTAGCAATTTTGCAGTTGGTTATCGTACCGGTGATTTTCAGCTGCATACCAATGTTAATAACGGCACC
GAATTTGGTGGTAGCATTTATCAGAAAGTGTGCGAAGATTTTGACACCAGCGTTAATCTGGCATGGACCAGCGGC
ACCAATTGTACCCGTTTTGGTATTGCAGCAAAATATCAGCTGGATCCGACCGCAAGCATTAGCGCCAAAGTGAAT
AATTCAAGCCTGATTGGTGTTGGTTATACCCAGACCCTGCGTCCGGGTGTTAAACTGACACTGAGCGCACTGGTT
GATGGTAAAAGCTTTAATGCCGGTGGTCATAAACTGGGTCTGGCACTGGAACTGGAAGCATAA 
 
amino acid sequence: 
MAECCVPVCPRPMCIPPPYADLGKAARDIFNKGFGFGLVKLDVKTKSCSGVEFSTSGS
SNTDTGKVSGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQGLKLTFDTTFS
PNTGKKSGKIKSAYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGYQMTFDSA
KSKLTRSNFAVGYRTGDFQLHTNVNNGTEFGGSIYQKVCEDFDTSVNLAWTSGTNC
TRFGIAAKYQLDPTASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSFNAGGHK
LGLALELEA. 
 
  
 
 
mVDAC1-C127A-C232A 
 
nucleotide sequence: 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA 
 
 
Δ 1-11-mVDAC1-K12C 
 
nucleotide sequence: 
ATGTGTTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGCTTAATAAAACTTGATTTGAAAACGAAGTCA
GAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAAACCACCAAAGTGAACGGCAGCCTGGAAACC
AAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGGAACACAGACAACACCCTGGGCACTGAGATC
ACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGATTCGTCATTCTCGCCGAACACTGGGAAAAAA
AATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTCGGCTGTGACGTGGACTTTGACATCGCTGGG
CCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTGGCTGGCTACCAGATGAATTTTGAGACCTCG
AAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACGGATGAATTCCAGCTTCATACTAATGTGAAT
GACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAGAAGTTGGAGACTGCTGTCAATCTCGCCTGG
ACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTATCAGGTCGACCCTGATGCCTGCTTTTCGGCC
AAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACCCTAAAACCAGGTATCAAACTGACGTTGTCA
GCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTTGGCCTAGGACTGGAATTTCAAGCATAA 
  
 
 
amino acid sequence: 
MCSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGSLETKYRWTEY
GLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINL
GCDVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAVGYKTDEFQLH
TNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQVDPDACFSAKV
NNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA 
 
 
Δ 1-21-mVDAC-Y22C 
 
nucleotide sequence: 
ATGTGCGGCTTTGGCTTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGC
TCTGCCAACACGGAAACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACG
TTTACAGAGAAGTGGAACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTG
AAGCTCACCTTTGATTCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGG
GAGCACATCAACCTCGGCTGTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGC
TATGAGGGTTGGCTGGCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCA
GTTGGCTATAAGACGGATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTAC
CAGAAGGTGAACAAGAAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGA
ATAGCAGCCAAGTATCAGGTCGACCCTGATGCCTGCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTA
GGGTACACTCAGACCCTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCG
GGTGGCCACAAGCTTGGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MCGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGSLETKYRWTEYGLTFTEKWNT
DNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDVDFDIAG
PSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFG
GSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQVDPDACFSAKVNNSSLIGLGYT
QTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA 
 
  
 
 
Δ1- 25-mVDAC1-L26C 
 
nucleotide sequence 
ATGTGTATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACG
GAAACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAG
TGGAACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTT
GATTCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAAC
CTCGGCTGTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGG
CTGGCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAG
ACGGATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAAC
AAGAAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAG
TATCAGGTCGACCCTGATGCCTGCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAG
ACCCTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAG
CTTGGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MCIKLDLKTKSENGLEFTSSGSANTETTKVNGSLETKYRWTEYGLTFTEKWNTDNTL
GTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDVDFDIAGPSIRG
ALVLGYEGWLAGYQMNFETSKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQ
KVNKKLETAVNLAWTAGNSNTRFGIAAKYQVDPDACFSAKVNNSSLIGLGYTQTLK
PGIKLTLSALLDGKNVNAGGHKLGLGLEFQA 
 
 
mVDAC1-A2C-E121C-C127A-C232A 
 
nucleotide sequence 
ATGTGCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGTGCCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
  
 
 
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
amino acid sequence: 
MCVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKRCHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFA
VGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQ
VDPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA 
 
mVDAC1-V3C-K119C-C127A-C232A 
 
nucleotide sequence 
ATGGCCTGCCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGCTGTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTCGACCCTGATGCCTGCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MACPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYCREHINLGCDVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
  
 
 
mVDAC1-K12C-C127A-C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCTGCTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGCSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1-K12C-D30C-C127A-C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCTGCTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTTGTTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
  
 
 
 
amino acid sequence: 
MAVPPTYADLGCSARDVFTKGYGFGLIKLCLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1-K12C-K32C-C127A-C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCTGCTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGTGCACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGCSARDVFTKGYGFGLIKLDLCTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
  
 
 
mVDAC1-K12C-S57C-C127A-C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCTGCTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCTGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGCSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGC
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1- K12C -E59C-C127A-C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCTGCTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGAAGCTTGTGCACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
  
 
 
amino acid sequence: 
MAVPPTYADLGCSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LCTKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1- A14C -C127A- S193C-C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCTGCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTGCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGKSCRDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGCIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
  
 
 
mVDAC1-K28C -C127A-Q154C -C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATATGTCTTGATTTAAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTA
GCTGGCTACTGTATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLICLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYCMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1-K32C- C127A-C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCTGCTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGTGCACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
  
 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLCTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1-E36C -C127A-D176C -C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCATGTAATGGATTGGAATTCACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACA
TGTGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSCNGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTCEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
  
 
 
mVDAC1-E59C- C127A-C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGAAGCTTGTGCACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LCTKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1-E59C -C127A-S193C -C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGAAGCTTGTGCACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTGCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
  
 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LCTKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGCIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1-D78C -C127A-N214C -C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACATGCAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACGGCAGGATGCAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTCNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGCSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
  
 
 
mVDAC1-E88C -K119C-C127A -C232A 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGTGTGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACTGCAGGGAGCACATCAACCTC
GGCGCCGACGTGGACTTTGACATCGCTGGGCCCTCGATCCGGGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCGATGGCAAGAACGTCAATGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVCDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYCREHINLGADVDFDIAGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA. 
 
mVDAC1 -C127A-A134C -C232A–D264C 
 
nucleotide sequence 
ATGGCCGTGCCTCCCACATACGCCGATCTTGGCAAGTCCGCCAGGGATGTCTTCACCAAGGGCTACGGCTTTGGC
TTAATAAAACTTGATTTGAAAACGAAGTCAGAGAATGGATTGGAATTTACCAGCTCAGGCTCTGCCAACACGGAA
ACCACCAAAGTGAACGGCAGCCTGGAAACCAAGTACAGATGGACTGAGTATGGGCTGACGTTTACAGAGAAGTGG
AACACAGACAACACCCTGGGCACTGAGATCACTGTGGAAGACCAGCTTGCTCGTGGACTGAAGCTCACCTTTGAT
TCGTCATTCTCGCCGAACACTGGGAAAAAAAATGCTAAAATCAAGACAGGGTACAAGAGGGAGCACATCAACCTC
GGGGCTGACGTGGACTTTGACATCTGTGGGCCCTCGATCCGCGGCGCTCTGGTGCTTGGCTATGAGGGTTGGCTG
GCTGGCTACCAGATGAATTTTGAGACCTCGAAGTCCCGAGTGACCCAGAGCAACTTCGCAGTTGGCTATAAGACG
GATGAATTCCAGCTTCATACTAATGTGAATGACGGGACAGAGTTTGGTGGCTCCATTTACCAGAAGGTGAACAAG
AAGTTGGAGACTGCTGTCAATCTCGCCTGGACTGCAGGAAACAGTAACACTCGCTTCGGAATAGCAGCCAAGTAT
CAGGTGGATCCTGATGCCGCCTTTTCGGCCAAAGTGAACAACTCTAGCCTGATTGGCTTAGGGTACACTCAGACC
CTAAAACCAGGTATCAAACTGACGTTGTCAGCCCTGCTCTGTGGCAAGAACGTCAACGCGGGTGGCCACAAGCTT
GGCCTAGGACTGGAATTTCAAGCATAA 
  
 
 
amino acid sequence: 
MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVNGS
LETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKI
KTGYKREHINLGADVDFDICGPSIRGALVLGYEGWLAGYQMNFETSKSRVTQSNFAV
GYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQV
DPDAAFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLCGKNVNAGGHKLGLGLEFQA. 
 
 
Enhanced minimal porin (EMP) 
 
nucleotide sequence 
ATGGAAGAACGCAATGATTGGCACTTTAACATTGGCGCCATGTATGAAATTGATAATGGTGTTGCAGAACCGAGC
GTGTATTTTAACGCAGCAAATGGTCCGTGGCGTATTGCGCTAGCCTATTATCAAGAAGGTAATTTTGATCGTCCG
GAACTGGAAGTGCATTATCAGTTCCTCGAGAATGATGATTTTAGCTTTGGCCTGACAGGCGGTTTTCGTAATTAT
GGTAATACACAGCGCTGGAAAATTGCACCGGATTGGGATGTTAAACTGACCGATGATCTGCGTTTTAATGGTTGG
TTATCGATGTACAAATTTGCCGGTGATACCCGTGTTGAAACCGAAACCGGTCTGCAGTATACCTTTAATGAAACC
GTTGCACTGCGCGTGAACTATTATCTGGAACGTGGTGGTGAATTTAGCACCCAAGAAATTCGTGCATATCTGCCG
CTGACCCTGGGTAACCACAGCGTGACCCCGTATACCCGTATTGGTCTTGATCAGGCAGGCCATGATTTTAATCGT
GTTGGTCTGTTTTATGGCTACGATTTTCAGAATGGTCTGTCCGTCTCGCTGGAATACGCGTTTGAATGGAATGAT
AGCGATAAATTCCATTATGCAGGTGTGGGTGTGAACTATAGCTTTCATCATCATCACCATCATTAA 
 
amino acid sequence: 
MEERNDWHFNIGAMYEIDNGVAEPSVYFNAANGPWRIALAYYQEGNFDRPELEVHY
QFLENDDFSFGLTGGFRNYGNTQRWKIAPDWDVKLTDDLRFNGWLSMYKFAGDTR
VETETGLQYTFNETVALRVNYYLERGGEFSTQEIRAYLPLTLGNHSVTPYTRIGLDQA
GHDFNRVGLFYGYDFQNGLSVSLEYAFEWNDSDKFHYAGVGVNYSFHHHHHH. 
 
 
  
 
 
Bid 
 
nucleotide sequence 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGACTCTGAGGTC
AGCAACGGTTCCGGCCTGGGGGCCAAGCACATCACAGACCTGCTGGTGTTCGGCTTTCTCCAAAGCTCTGGCTGT
ACTCGCCAAGAGCTGGAGGTGCTGGGTCGGGAACTGCCTGTGCAAGCTTACTGGGAGGCAGACCTCGAAGACGAG
CTGCAGACAGACGGCAGCCAGGCCAGCCGCTCCTTCAACCAAGGAAGAATAGAGCCAGATTCTGAAAGTCAGGAA
GAAATCATCCACAACATTGCCAGACATCTCGCCCAAATAGGCGATGAGATGGACCACAACATCCAGCCCACACTG
GTGAGACAGCTAGCCGCACAGTTCATGAATGGCAGCCTGTCGGAGGAAGACAAAAGGAACTGCCTGGCCAAAGCC
CTTGATGAGGTGAAGACAGCCTTCCCCAGAGACATGGAGAACGACAAGGCCATGCTGATAATGACAATGCTGTTG
GCCAAAAAAGTGGCCAGTCACGCACCATCTTTGCTCCGTGATGTCTTCCACACGACTGTCAACTTTATTAACCAG
AACCTATTCTCCTATGTGAGGAACTTGGTTAGAAACGAGATGGACTGA 
 
amino acid sequence: 
MGSSHHHHHHSSGLVPRGSHMDSEVSNGSGLGAKHITDLLVFGFLQSSGCTRQELEV
LGRELPVQAYWEADLEDELQTDGSQASRSFNQGRIEPDSESQEEIIHNIARHLAQIGDE
MDHNIQPTLVRQLAAQFMNGSLSEEDKRNCLAKALDEVKTAFPRDMENDKAMLIM
TMLLAKKVASHAPSLLRDVFHTTVNFINQNLFSYVRNLVRNEMD. 
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9.7 EMP design 
 
 
 
(C) The topology of OmpG (opaque) with rainbow coloured transmembrane -strands. Strand 14 is repeated on 
the N-terminal side reflecting the -barrel assembly. Grey lines between strands indicate the H-bonding network; 
topology of EMP is in black, introduced mutations in red. (D) Sequence alignment of OmpG and its variants, 
strands coloured according to (C). 
 
